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Summary 
RNA virus recombination is a key evolutionary mechanism and a driver of genetic 
diversity. In recent studies using an in vitro “CRE-REP” assay involving replication-
compromised parental genomes, recombination was shown to be a biphasic process 
involving an initial imprecise crossover event which was followed by a resolution 
process that resulted in the formation of genome-length recombinants (Lowry K. et 
al 2014). We have extended this study to investigate recombination during dual 
infection by unmodified parental viruses in the absence of selection.  
Recombinants were generated by co-infecting HeLa cells with poliovirus type 1 
Mahoney and type 3 Leon for 5-hours, followed by RNA extraction, cDNA 
synthesis, and PCR amplification. Amplified PCR products of both type 1/3 and type 
3/1 recombinants were readily detected, cloned individually and sequenced by 
Sanger sequencing. Within 25 clones sequenced, 18 unique recombination junctions 
were detected. To get a comprehensive overview of the range of recombination 
junctions within the virus population the data produced from next generation 
sequencing of pooled amplified cDNA from dually infected cells was analysed. A 
bioinformatics pipeline was developed to specifically detect and quantify 
recombinants within this population.  
Three types of junctions were identified, precise (i.e. at the same position in both 
genomes) and imprecise, including both insertions (as seen in the Lowry 2014 study) 
and deletions. In an analysis of the P2 region of the poliovirus genome, we identified 
several hundred different precise and imprecise junctions. The data analysis suggests 
that recombination is a random event; no correlation between the nucleotide base 
composition or RNA structure near the junctions’ locations of both donor and 
recipient viral genomes and the recombination frequency was detected. These studies 
contribute to our understanding of the molecular mechanism of genetic 
recombination in RNA viruses and suggest ways in which it might be controlled 
during the development of novel vaccines with reduced recombination potential.  
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VP1 Encodes Capsid Protein  
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1 Introduction 
Positive strand RNA viruses, including important human pathogens like poliovirus 
(PV) and rhinovirus, are known for their ability to evolve rapidly. They possess 
error-prone RNA-dependent RNA polymerases, which are responsible for the high 
mutation rate in these viruses. Coupled with their short replication cycle and high 
yields, this allows for their rapid adaptation to altered environmental conditions such 
as host immune responses. Additionally, they have the ability to exchange or acquire 
large regions of the virus genome through the process of recombination, which 
results in more extensive variations.   
Sequence analysis and phenotypic characterisation of numerous animal and plant 
viruses have suggested that recombination has been a major driving force in the 
emergence of many natural strains of RNA viruses. Nonetheless, other than an 
understanding of the underlying principles, little is known about the recombination 
mechanism and the cellular and viral factors that influence the process. The difficulty 
in studying recombination stems from the rarity of this biological event, which 
renders its isolation, from a mixed population, a challenging process.  
Poliovirus, a member of the genus Enterovirus of the Picornaviridae family, is one 
of the most thoroughly studied and best understood viruses, and was used as a model 
system in this study. It was used extensively throughout this project; therefore this 
literature review will focus majorly on poliovirus. The review briefly discusses 
classification, the life cycle of the virus, evolution and recombination. It reviews the 
different aspects of recombination as an evolutionary process, including the 
mechanisms, the types, the influential factors. Moreover, it discusses the role of 
recombination as an evolutionary process. 
1.1  Poliovirus history and virus characteristics  
Poliovirus, the etiologic agent of poliomyelitis, was discovered in 1909 by 
Landsteiner & Popper who experimentally transmitted the disease from man to ape 
(Flexner and Amoss, 1919). Since then, poliovirus has been intensively studied to 
better understand and control its pathogenicity. In 1949, John Enders and his 
colleagues performed a milestone experiment showing that poliovirus could be 
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propagated in cultured human cells (Enders et al., 1949), which paved the way for 
the development of highly effective vaccines against poliovirus and facilitated the 
study of the molecular mechanisms of the poliovirus life cycle in cell culture. As a 
result, many basic virology techniques were established using poliovirus, such as 
virus purification protocols (Bachrach and Schwerdt, 1952), tissue culture system 
(robbins and enders, 1950), and plaque assay analysis (Dulbecco and Vogt, 1954). 
1.1.1 Classification 
Poliovirus is a member of the genus Enterovirus of the Picornaviridae, a large 
family of small – pico is a very small measurement unit – non-enveloped, positive 
sense single stranded RNA viruses. The genus Enterovirus is divided into 12 species 
with the poliovirus prototype strains (PV1, PV2, PV3) forming the Enterovirus C 
type species (Table 1-1). The Picornavirus family includes other members such as 
Rhinovirus (cause of the common cold), Hepatitis virus, Encephalomyocarditis virus 
(EMCV) and Foot-and-mouth disease virus (FMDV). Nevertheless, its classification 
is being continuously updated and currently consists of 54 species grouped into 31 
genera (Picornavirus Home, 2016).  
1.1.2 Particle structure  
Poliovirus possesses a small icosahedral particle approximately 30nm in diameter 
(Hogle et al., 1985) that is made up of 60 copies of the heteromeric structural unit. 
Each unit contains one copy of each of the capsid proteins VP1, VP2, VP3, and VP4. 
Proteins VP1–3 together form the icosahedral shell of the virion while VP4 is 
distributed on the inner surface of the particle (Racaniello, 2007) (Figure 1-1). 
Therefore, the poliovirus capsid is described as a pseudo T = 3 structure (T is the 
triangulation number which describes the triangular face in the icosahedral structure, 
and its subdivisions into smaller triangles). Each protein of VP1-3 contains a ‘core’ 
composing of an eight-stranded antiparallel beta barrel with two flanking helices. As 
the protein backbones of β-barrel are folded in the same way among the proteins 
VP1-3, they possess the same topology. However, the differences among these 
proteins can be attributed to the loops that connect the β-strands to the N- and C- 
terminal segments that extend from the central β-barrel domain, these differences are 
responsible for receptor binding specificities and antigenic characteristics (Hogle et 
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al., 1985). The interactions between the β-barrel domains of adjacent proteins 
stabilise the capsid structure around the RNA. The interaction of the C termini of 
VP1 and VP3 form the depression or ‘canyon’, around the 5–fold icosahedral 
vertices of the capsid; the site of the virus receptor attachment to enter the cell 
(Olson et al., 1993). 
1.1.3 Genome organisation  
Enclosed within the capsid is the RNA genome which is ~7.4kb in length (Figure 
1-1). At the 5’ end of the genome the non-translated region (NTR) of 743 nts length 
is located, followed by a single open reading frame of 2209 amino acids (Kitamura et 
al., 1981). The first 88 nucleotides of the 5’ end of the genome make up a clover 
leaf-like secondary structure, which has an important role in organising the cellular 
and viral proteins involved in positive strand synthesis (Andino et al., 1990). From 
nucleotide 89 to 124 is a region called ‘spacer’ and until recently, no special function 
was assigned to the spacer region. However, it was found that this region is strongly 
affecting the neurovirulent phenotype of poliovirus (Toyoda et al., 2007). The 
remaining nucleotides of the 5’ NTR until the start codon of the polypeptide 
constitute the Internal Ribosomal Entry Site (IRES), so-called because of its 
propensity to initiate the translational process (Jang et al., 1989). As opposed to most 
eukaryotic mRNAs, the RNA of poliovirus does not contain a m7G cap structural 
that is essential for translational initiation. Instead, a small viral protein, VPg, is 
covalently linked to the 5’ terminus (Lee et al., 1977). At the 3’ end of the genome is 
a 70 nts non-translated region (NTR) followed by poly A (Schwartz and Farman, 
2010) which contains two stem loops that may interact to form a tertiary pseudoknot 
structure (Pilipenko et al., 1992) (Figure 1-2).     
1.1.4 Receptors and Tropism 
Receptors are cell-surface molecules that bind to the virus and play a fundamental 
role in the entry of the virus into the cell. Additionally, they can be determinants of 
tissue tropism; the preference of a virus to invade and reproduce in a particular cell 
type. This is reflected by the fact that poliovirus can infect primates and primate cell 
culture but not mice or mouse cell cultures (Flint et al., 2015, p. 123). This is because 
mouse produce the poliovirus receptor (PVR) CD155 (The mouse orthologue of 
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human CD155 has been identified as Tage4, cell-surface protein expressed in rat 
colon). The absence of the PVR amongst mice suggests that the virus did not emerge 
from an animal reservoir (Mendelsohn et al., 1989). 
  
Figure 1-1 Virion structure.  
The capsid consists of 60 structural units, each made up of a single copy of VP1, VP2, VP3 and VP4. Examples 
of these proteins within the capsid are coloured blue, green, red, and yellow. One of the icosahedral faces has 
been removed to show the packaged RNA strand (green line). This figure is adapted from Flint et al. (Flint et al., 
2015)  
 
 
Figure 1-2 Genomic structure of poliovirus type 1 (Mahoney) and proteolytic processing of its polyprotein. 
The Poliovirus genome consists of a single-stranded positive RNA that encodes a single polypeptide and is 
covalently linked to a VPg protein from the 5’ end. The cloverleaf and the internal ribosome entry site (IRES) are 
located at the 5’ non-translated region (NTR,). The 3’ (NTR) is poly-adenylated. This figure is adapted from De 
Jesus. (De Jesus, 2007).   
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Family Genus Species Serotype Type-Strain Receptors 
 
Picornaviridae 
 
Enterovirus Enterovirus C 
PV1 Mahoney 
CD155 PV2 Lansing 
PV3 Leon 
Table 1-1 Poliovirus strains and classifications 
Polioviurs is a member of an Enterovirus C species, the genus Enterovirus within the Picornaviridae family. All 
the poliovirus serotypes share the same receptors to enter into the host cell. 
1.1.5 Life cycle 
Poliovirus enters the cells via attaching to the PVR; once inside the cells the genomic 
RNA is uncoated and the VPg linked protein is cleaved from the RNA, which allows 
the translation of the poliovirus genome to proceed (Ambros et al., 1978). The 
translation product polypeptide is cleaved by virus-encode proteinase 2Apro and 
3CDpro into mature viral proteins (Toyoda et al., 1986, Cameron et al., 2010). The 
host machinery of the protein synthesis is hindered as a result of cleaving the 
translation factor eIF4G – that is required for the translation of capped messenger 
RNA – by 2Apro (Svitkin et al., 2001). As soon as enough proteins have been 
produced, RNA synthesis can begin. The same strand used for protein synthesis is 
used for minus strand RNA synthesis. Therefore to avoid collisions between the 
RdRp (moving from 3’ to the 5’) and the ribosome translating in the opposite 
direction, there must be a signal for this transition. It is believed that this is mediated 
by the newly synthesised viral protein 3CD, which together with the poly (rC) 
binding protein (PCBP), binds to the 5’ cloverleaf forming a ribonucleoprotein 
complex (RNP) to stop the further initiation of viral translation at the 3’ end of the 
viral genome. Another RNP complex is formed by 3CD and the poly (A)-bound 
protein (PABP) that binds to the poly A tail (Barton et al., 2001, Herold and Andino, 
2001). 
For the minus strand RNA synthesis to begin (the first step in replication), the two 
RNP complexes need to interact. It has been suggested that this interaction is a 
prerequisite for minus RNA synthesis initiation (Herold and Andino, 2001). The 
second step in replication is the plus strand RNA synthesis, which takes place after 
several modifications in the partially double-stranded replicative intermediate (RI). 
The primer for this process is VPg-pUpU , which was found to be synthesised on the 
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cis-acting element CRE within the 2C coding region (Goodfellow et al., 2000, Paul 
et al., 1998). The RNA replication then occurs within a tightly closed rosette-like 
replication complex composed of vesicles derived from the intracellular membranes 
(Rust et al., 2001, Egger et al., 2000). After several rounds of RNA replication, the 
positive strand virus genome is packaged into a newly formed capsid structure by a 
process called encapsidation (Oh et al., 2009).  
1.2  Evolution 
Viral evolution indicates the genetic changes, such as mutations, that a virus 
accumulates during its lifetime, which can arise as an adaptational response to 
environmental changes or the immune responses of the host. In RNA viruses there 
are three features that help the virus to evolve rapidly and survive; a) a high mutation 
rate b) the production of large numbers of progeny, and c) a short replication cycle. 
Consequently, RNA viruses replicate as a complex and dynamic mutant swarm, 
called the viral quasispecies (Domingo and Holland, 1997). The quasispecies theory 
seeks to explain the evolution of life in RNA viruses by exploring the consequences 
of error-prone replication and large population sizes for genome evolution (Lauring 
and Andino, 2010). In addition to the high-mutation rate, virus recombination also 
contributes to the quasispecies nature of RNA virus populations (Freistadt et al., 
2007a). This section will discuss the principles and consequences of these 
mechanisms, focusing on recombination as this project’s feature of interest.  
1.2.1 High error mutation  
All nucleic acid polymerases incorporate incorrect nucleotides during elongation. 
DNA-dependent DNA polymerases have proofreading capabilities due to the 
exonuclease activity they possess. These allow them to correct their mistakes. Most 
RNA-dependent RNA polymerases (RdRp) do not have this capability, which results 
in high error frequencies in RNA replication (Domingo et al., 2002). The poliovirus 
RdRp has been shown to have an estimated miss-insertion rate that ranges from 1.2 x 
10-4 to 1 x 10-6 mutation/nt for transition mutations and 3.2 x 10-5 to 4.3 x 10-7 
mutation/nt for transversion mutations (Freistadt et al., 2007a). The low fidelity of 
RdRp, together with the large population size, contributes vastly to the quasispecies 
of the RNA viruses. It has been estimated that every possible point mutation and 
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many double mutations are generated by each replication cycle, and may be present 
within the population at any time (Lauring and Andino, 2010). The existence of 
RNA viruses as a mixture of genotypically different viruses makes the selection of 
viral mutants a relatively frequent process. A good example of this is the selection of 
the three attenuated poliovirus serotypes that compose the oral poliovirus vaccine 
(OPV). All the three serotypes were individually serially passaged in primates and 
primate cells in culture to eventually select variants with different point mutations 
that are no longer neurovirulent in humans, but can still replicate sufficiently to 
induce protective immunity. Adversely, it has been demonstrated that a point 
mutation at position 472 (C472U) of PV3 Sabin OPV within the 5’ noncoding region 
is linked to vaccine-associated paralytic poliomyelitis (VAPP) (Evans et al., 1985). 
This point mutation was found to reduce the efficience of binding of polypyrimidin 
tract-binding protein (PTB) to the IRES, which is required for initiation of translation 
(Guest et al., 2004).  
Owing to the high error rates, it has been predicted that RNA viruses with high 
mutation frequencies exist close to the edge of error catastrophe, i.e. viruses may 
undergo a sharp drop in viability after an increase in mutation frequency. (Crotty et 
al., 2001, Acevedo et al., 2014). By decreasing the fidelity of RdRp, which in turn 
will increase the mutation rate, the virus population will be forced into error 
catastrophe. On the contrary, increasing the fidelity of RdRp will reduce the 
adaptability of the virus population to the selection pressure in the host (Vignuzzi et 
al., 2006). However, these observations don’t consider the nature of the selection 
pressures that optimise the evolutionary rate, and therefore cannot fully explain the 
range of evolutionary dynamics seen in viruses (Duffy et al., 2008). In fact, an 
extensive sequence analysis has shown that evolutionary rates differed depending on 
the genomic region studied (Hyypia et al., 1997). Understanding the fidelity and 
quasispecies theories are crucial in order to make predictions about evolutionary 
dynamics.  Nonetheless, in a biochemical study performed by Fresistadt et al. the 
poliovirus RdRp fidelity was found to be higher than it should have been as predicted 
by the poliovirus sequence variation rate. Moreover, they observed a correlation 
between the mismatches and the RNA dissociation, upon which basis they suggested 
that the high variations of RNA viruses may be due to recombination (Freistadt et al., 
2007a). 
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1.2.2 Recombination 
Genetic recombination is the formation of chimeric molecules by the exchange of 
nucleotide sequences between genetically related RNA viruses. It is termed 
recombination when it happens amid non-segmented viruses and reassortment if it 
occurs amongst segmented viruses (Simon-Loriere and Holmes, 2011). Although 
RNA recombination and reassortment are mechanistically very different, they both 
require that two or more viruses infect the same host cell (Egger and Bienz, 2002).  
Recombination in poliovirus was discovered in the early 1960s (Agol, 1997). Two 
different strains of poliovirus that bore mutations providing resistance to either 
guanidine or horse serum were used to co-infect cells. The yield of putative 
recombinants (containing double resistance mutations) in the dual infection was 
found to be 15-20 times higher than the same yield from the single infection 
(Ledinko, 1963). Using a similar approach recombinants were isolated from the foot-
and-mouth disease virus (Pringle, 1965). Subsequently, a recombination map was 
built by Cooper who used a collection of temperature-sensitive (ts) mutants of 
poliovirus and determined the frequency of recombination between different ts 
markers. Nonetheless, until that time, the presence of double mutants during the 
mixed infection was the main indicator of the presence of RNA recombination. The 
definitive proof was provided by King and his colleagues in 1982, who analysed 
proteins induced by recombinants among the aphthovirus (King et al., 1982, Lai, 
1992).  
The isolation of a recombinant virus from a natural infection was reported in 1984. 
After an examination of viruses isolated from children who had received poliovirus 
vaccines, a recombinant containing sequences derived from the three serotypes of 
poliovirus was found (Lai, 1992). Subsequently, additional recombinants were 
isolated from poliovirus vaccinees (Cammack et al., 1988, Cuervo et al., 2001). This 
indicates that poliovirus recombination can occur naturally and thus might contribute 
to outbreaks of poliomyelitis in areas of low vaccination coverage (Kew et al., 2002).  
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1.3  The mechanism of recombination  
The mechanism by which recombination occurs can be conceived in two different 
ways: 1) copy-choice mechanism and 2) break-joining mechanism. The former is 
coupled with the process of genomic replication, and is widely cited as the most 
favoured mechanism of recombination, while the latter does not depend on 
replication occurring.  
1.3.1 Copy-choice mechanism 
The copy-choice mechanism is a mechanism by which a synthesis of the negative 
RNA strand is interrupted on the donor strand for the reasons discussed below. As a 
result, the incomplete nascent strand dissociates – either with the RdRp or without - 
from the original template and serves as a primer to resume elongation on the 
acceptor strand. The product of this process is a chimeric negative sense RNA 
derived from both parental genomes (the donor and the receptor) (Lai, 1992). This 
mechanism has been commonly accepted since the work of Kirkegaard and Baltimor 
on recombinants in poliovirus. They co-infected cells with wild-type poliovirus that 
was guanidine sensitive and temperature resistant with a poliovirus that bore double 
mutants which made it guanidine resistant and temperature sensitive. After 6 hours, 
they collected the progeny and looked for recombinants that were both guanidine and 
temperature resistant (Kirkegaard and Baltimore, 1986). The results of their 
experiments were strongly in favour of copy-choice mechanism. Additionally, it 
could be predicted - under restrictive conditions for one or the other of the parental 
genomes – to differently affect the frequency of recombinants if they were generated 
during the positive and/or negative strand synthesis. Their experimental results 
strongly supported the hypothesis that recombination occurs during the negative 
RNA strand synthesis (Agol, 1997). Moreover, two factors may further support this 
hypothesis. First, it is suggested that the recombination frequency depends heavily 
on the availability of the acceptor strand (Jarvis and Kirkegaard, 1992), taking into 
consideration the fact that positive strands are much more abundant than negative 
strands in the infected cell. Second, the availability of the negative strands would be 
lower than the positive strands due to the fact that negative strands are involved in 
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the replicative intermediate structure. Therefore they are likely to exist 
predominantly in a double-strand rather than in a single strand (Agol, 1997). 
1.3.2 Forced copy-choice and non-replicative recombination 
Forced copy-choice predicts that a breakage of the donor strand can promote RdRp 
switching. It is similar to the copy-choice model, except that it requires a break in the 
donor to occur (Coffin, 1979). In contrast the non-replicative model suggests that a 
chimeric RNA molecule can be formed without the involvement of polymerase 
activity (Gmyl et al., 2003). The non-replicative model was suggested to be mediated 
by a transesterification (Chetverin et al., 1997) or cellular exonucleases and RNA 
ligase (Scheel et al., 2013). 
There is a little doubt that a non-replicative process occurs, but the evidence is that it 
is probably much less efficient. One of the few attempts to quantify and compare the 
recombinant viruses progeny between the replicative and non-replicative was 
performed by Lowry et al. They found that the recombinants produced by non-
replicative assay are only 3.8% of the yield produced by the replicative assay (Lowry 
et al., 2014).  Because of this, the following sections will be within the framework of 
the copy-choice replicative mechanism, unless otherwise mentioned.  
1.3.3 Factors influencing recombination 
In an attempt to understand the reasons that cause the RdRp to pause, the results of 
many separate recombination events have been characterised. For example, it has 
been suggested that A/U-rich or U-rich sequences promote RdRp slippage, resulting 
in an accidental incorporation of nontemplated nucleotides at the 3’ of the growing 
strand (Nagy and Bujarski, 1997, King, 1988). Other factors believed to play an 
important role in promoting the RdRp to pause include the ability of the parental 
genome to form stable hetroduplexes near to or at the junction location (Romanova 
et al., 1986, Nagy and Bujarski, 1993). Moreover, the presence of internal stable 
hairpin structures within one or both parental strand(s) was found to correlate with 
the distribution of the junction location (Dedepsidis et al., 2010). What also does 
facilitate polymerase switching is the presence of both strands (donor and acceptor) 
within the same replication complex. In fact, by using a fluorescent in situ 
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hybridisation technique (FISH), Egger et al. were able to locate the RNA sequences 
of both PV serotypes (PV1 and PV2) in HeLa cells co-infected with both viruses. 
They found a high percentage (>85%) of individual replication complexes containing 
both viruses (Egger and Bienz, 2002).  
1.3.4 Models of RdRp switching templates  
Several models have been proposed as to how the polymerase manages to switch 
templates, and whether it dissociates from the donor template only or from the 
nascent RNA strand as well. There are two possible pathways by which the 
switching might happen, which are termed processive and non-processive (Jarvis and 
Kirkegaard, 1991). In the processive pathway there are two possible scenarios have 
been proposed to facilitate the switching. 
1. It was postulated that the donor and acceptor template might be brought 
together and fixed by a third assisting sequence. In this scenario the 
polymerase may switch templates through shunting rather than dissociation 
(Kuge et al., 1986).  
2. The second scenario wherein several nucleotides at the 3’ of the nascent 
strand –within the complex – may dissociate from the donor strand and 
anneal to the template strand. The template strand in this case is presumed to 
accommodate itself within the complex (Jarvis and Kirkegaard, 1991).  
On the other hand, in the non-processive pathway, another two possibilities have 
been suggested to explain the switching of the polymerase between templates:  
1. The polymerase dissociates from the donor but not from the nascent strand 
(Cascone et al., 1990) .  
2. The polymerase dissociates from the donor and the nascent strand. In this 
scenario, it was proposed that the free incomplete nascent RNA strand could 
be used again in RNA recombination via a copy-choice mechanism (Makino 
et al., 1986). 
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1.3.5 Types of recombination 
Based on the nature of the RNAs involved and the sites of crossing over, Lai 
classified recombination into three types (Lai, 1992): 
Type I (homologous recombination), recombination in this type involves two closely 
related or similar RNA genomes with extensive sequence similarity. Moreover, the 
switching template occurs at related sites between the two parental genomes i.e the 
resulting recombinant RNA retains the exact sequence and structural organization of 
the parental genomes. Therefore, the word ‘homologous’ refers not only to the 
presence of similarity between the two parents, but also to the occurrence of a 
crossover at a comparable site between the two parental RNA molecules. Usually, 
this type is used in the literature to refer to the intratypic recombination where the 
parental genomes are from the same serotypes (Jarvis and Kirkegaard, 1991). 
However, the term ‘homologous’ was used by King to refer to ‘precise 
recombinants’ in both intertypic and intratypic recombination (King, 1988) Figure 
1-3. Examples of homologous recombination can be found in many recombination 
studies (Jarvis and Kirkegaard, 1992, Runckel et al., 2013, King, 1988, Kirkegaard 
and Baltimore, 1986, Freistadt et al., 2007b).  
Type II (aberrant homologous recombination), recombination of this type involves 
two RNA molecules with similar sequences. Unlike Type I, the crossover occurs at 
unrelated – but usually nearby – sites (Figure 1-3). The resulting recombinant 
contains duplication, insertion or deletion. An example of this type was found 
between satellite RNAs of turnip crinkle virus (Cascone et al., 1990).  
Type III (Non-homologous or illegitimate recombination), in this type, 
recombination occurs between parental genomes that don’t show similarity - see 
Figure 1-3. This type may account for gene arrangements that are found in the RNA 
genomes such as insertion and deletion (see next section). Nonetheless, the term 
‘non-homologous’ is used sometimes in the literature to refer to intertypic 
recombination. This can be exemplified by defective interference (DI) particles (see 
1.3.6). 
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Lai’s classification is widely used to differentiate between the different types of 
recombination. Nonetheless, Nagy et al. argued that using the terms ‘homologous’ 
and ‘non-homologous’ to describe RNA recombination was not straightforward and 
could be confusing (Nagy and Simon, 1997). The confusion that occurs from using 
such classical terms can be attributed to three reasons that they discussed. 
Firstly, the word ‘homologous’ in Type I implies that the two parental genomes are 
similar rather than the sequence within which the recombination occurred. This is 
problematic because short identical sequences (5-15nt) were found to influence 
recombination (Nagy and Bujarski, 1995); it is quite possible that these short 
sequences exist among dissimilar RNAs as well. Secondly, the naming system 
suggested by Lai does not take into consideration other factors that might affect 
recombination such as the secondary structure. For example, imprecise 
recombination between two satellite RNAs that share sequence similarity in the 
region of recombination fits under Type II of Lai’s classification. By contrast, 
imprecise recombination that occurs between satellite RNA and genomic RNA fits 
under Type III. Nonetheless, both recombination events were found to depend on the 
RNA structure in the acceptor strand. Thirdly, the term ‘homologous’ is not always 
precise as it implies that the sequences in question have a common ancestry 
(Pearson, 2013). Based on this, Nagy et al. has suggested a new classification system 
that takes into consideration the structure of intermediates, the recombination end 
products, and the recombination machinery. Briefly, Class I is called ‘similarity 
essential’ in which substantial sequence similarity between the parental genomes is 
required. Class II is called ‘similarity non-essential’ in which instead of similarity, 
other RNA features are required such as the RdRp binding sequence, secondary 
structure, and hetroduplex formation. Class III is called ‘similarity assisted’, which 
combines both Class II and I. (Nagy and Simon, 1997).   
In addition to that, the terms homologous and non-homologous in Lai’s system don’t 
define the characteristics of the recombination junction with regards to the parental 
virus genome. Therefore Lowry et al. suggested the terms ‘precise’ and ‘imprecise’ 
recombinants (Lowry et al., 2014). Moreover, Jarvis C. et al. have suggested using 
the term ‘homologous’ to refer to intertypic and intratypic recombination. This is 
because intertypic recombination occurs between viruses of different serotypes 
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whose sequences typically differ by 10-15%. They used the term ‘non-homologous’ 
for those recombination events in which little or no similarity is required (Jarvis and 
Kirkegaard, 1992).  
 
Figure 1-3 Recombination based on Lai’s classification system. 
A schematic illustrating the types of recombination as classified by Lai (Lai, 1992). The grey and black 
rectangles refer to the parental genomes, where their nucleotide composition is depicted by numbers. The arrows 
between the parents refer to the RdRp paths. The red highlighted regions indicate identical sequences between the 
parents. The top panel represents Type I homologous recombination, which could happen within a homologous 
(or non-homologous) sequence (RdRp path A) or identical sequence (RdRp path B). In both cases the resulting 
recombinant retains the same length and structure of the parental genomes. The bottom panel denotes the two 
other types. Type II aberrant-homologous is represented by RdRp path C where the switching occurs within an 
identical sequence and between unrelated nearby sites (the dashed line refers to the part of the genome that RdRp 
skipped). On the other hand, Type III non-homologous recombination is where the switching involved two 
unrelated non-homologous sites RdRp path D. 
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1.3.6 Defective Interfering Particles 
Recombinants that have part of their genome deleted can result from a downstream 
relocation of the RdRp on the acceptor strand during the replication. These 
recombinants correspond to Type II in Lai’s classification if similarity between the 
parental genomes was involved during the recombination or to Type III if there was 
no similarity (Lai, 1992). The best-known example of this type of recombination are 
defective interference (DI) particles. These have lost the capacity to code for all the 
necessary viral proteins for independent replication and thus are defective in the 
absence of the parent (also called helper) virus (Pathak and Nagy, 2009). It was first 
discovered upon serial undiluted passages of poliovirus (Cole et al., 1971). The DI 
then was reported in many RNA viruses such as the influenza virus (Nayak, 1980) 
and the Mengovirus (McClure et al., 1980). 
In poliovirus, the deletions carried by these DIs map to the P1 region of the genome 
(largely VP2 and or VP3), and occupy between 4.2 and 13.2 % of the genome size 
(Omata et al., 1986) keeping the polyprotein reading frame preserved (Agol, 1997). 
Sequence analysis of the DIs indicated that deletion occurred between nucleotides 
1226-2705 (Kuge et al., 1986). The formation of the DI virions was only possible in 
the presence of viral structural proteins provided by the intact virus (or the helper 
virus) (Kuge et al., 1986).  
RNA viruses (with the exception of the retroviruses) lack the ability to integrate 
fragments of their genome into eukaryotic host cell chromosomes. Therefore they 
may rely on alternative mechanisms of attenuation such as DIs to achieve long term 
virus-host cell association (Perrault, 1981). The generation of DIs is supposed to 
occur by recombination through copy-choice mechanism (Lundquist et al., 1979) or 
looped-out mechanisms (Kuge et al., 1986). The latter requires a presence of residues 
– adjacent to the junction location - that are complementary to other regions in the 
genome, which may facilitate the formation of transient structures in which the 
deletion regions are looped out.  
It was suggested that the structure of naturally occurring DIs may reflect the 
mechanism by which they are generated rather than indicating the minimal 
requirement for their viability (Barclay et al., 1998). However, genome deletions are 
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restricted to the P1 region since all detected DIs have had their P2 and P3 
nonstructural open reading frame maintained (Cole and Baltimore, 1973a). 
Moreover, engineered out of frame deletions in P1-2A-2B (in respect to the initiation 
codon) resulted in a defective genome (Collis et al., 1992). Nonetheless, in the same 
study, a construct with an in-frame deletion placed at P1-2A (nucleotides 910 to 
3519) showed the ability to replicate at a significantly reduced level. This indicated 
that 2A was a trans-acting protein and that 2B and possibly other viral proteins were 
cis-acting and showed the importance of viability in determining the structure of the 
DIs. The DI particles contain all the information needed for replication rendering 
them potentially useful tools to express foreign genes in place of the capsid proteins 
(P1 region). This strategy was applied in many studies (Barclay et al., 1998, Lowry 
et al., 2014, Kaplan and Racaniello, 1988, Percy et al., 1992) 
1.3.7 Recombinants contain insertions  
Recombinants that contain insertions in their genomes result from an upstream 
relocation of the RdRp on the acceptor strand during the replication. As in the 
deletion case, these recombinants correspond to Type II if similarity between the 
parental genomes was involved, and Type III if there was no similarity (Lai, 1992). 
Insertion provides important evolutionary opportunities by creating a new genetic 
materials of novel gene functions (Innan and Kondrashov, 2010).  It is important to 
differentiate between two forms of insertion: 
• Form one (gene duplication): insertion that causes gene duplication; a piece 
of the genome is copied one or more times. There are several previously well-
characterised gene duplication events that have shaped extant picornavirus 
genomes. Examples include the capsid proteins (VP1-3), which share a 
common structure (Hogle et al., 1985), and the three contiguous VPg proteins 
of foot and mouth disease (Forss and Schaller, 1982). 
• Form two (random insertion): insertion that changes the number of genome 
nucleotides of a certain gene or region of the genome (insertion), where the 
source of insertion may be from the same genome or from a cellular genome. 
This can be exemplified by the insertion of cellular RNA in bovine viral 
diarrheal virus (BVDV). In tissue culture two, BVDV biotypes, 
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cytopathogenic BVDV (cpBVDV) and non-cytopathogenic BVDV (non-
cpBVDV), can be distinguished (Baker, 1987). Both biotypes are involved in 
pathogenesis of mucosal disease (MD) in cattle, the most severe clinical 
manifestation of BVDV (Meyers et al., 1991). The persistent infection with 
non-cpBVDV is a prerequisite for MD. The cpBVDV can always be isolated 
from MD animals in addition to the persisting non-cpBVDV (PMC, 1984). 
When analysing the sequences of the two cpBVDV strains (Osloss and 
NADL), two different insertions were found, one in each of them. In the first 
strain, Osloss, the insertion (228 nts) showed a strong homology with the 
host-cellular ubiquitin gene while the insertion (270 nts) in NADL was 
almost identical with another bovine mRNA sequence. Based on this, it was 
suggested that the insertions introduced via recombination between the viral 
and cellular RNA were responsible for the development of the 
cytopathogenic viruses (Meyers et al., 1991). 
Despite the evolutionary importance of insertion, it has been reported only rarely in 
RNA viruses, either in natural isolates or cell culture. It has been suggested that one 
of the main difficulties in recovering recombinants with insertion is due to the length 
of the genome, which can decrease the fitness of the virus. This because the increase 
of the genome size is likely to increase the load of mutations and thus reduce fitness 
(Holmes, 2003). In addition to this, the longer the genome, the more time the 
replication process would take, which could also be selectively disadvantageous 
(Simon-Loriere and Holmes, 2013). Nevertheless, Lowry et al. have recently used a 
novel reverse genetic approach in poliovirus that resulted in the isolation of 
intermediate intertypic recombinants with duplicated sequences at the junction 
location. The serial passage of these recombinants yielded virus progeny with 
increased fitness, which had lost the duplicated sequences (Lowry et al., 2014).  
1.3.8 Origin and purpose of recombination 
Recombination occurs in many RNA viruses and it is believed to play a key role in 
virus evolution (Worobey and Holmes, 1999). Several evolutionary aspects were 
found to be associated with recombination such as the expansion of the viral host 
range (Brown, 1997), the evasion of host immunity (Malim and Emerman, 2001), the 
evolution of resistance to antivirals (Nora et al., 2007), and an increase in virulence 
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(Khatchikian et al., 1989). It is a common belief that recombination is a mechanism 
evolved by viruses to counteract the heavy mutational loads associated with their 
high mutation rates. That is, it serves to eliminate deleterious mutation and thus 
contributes to genome conservation and maintaining the replication fitness. 
Additionally it enables the creation and spread of advantageous traits (Agol, 1997). 
Although recombination is an important factor in evolution, there is no 
straightforward answer to the question, why do viruses recombine? The major 
theories to answer this question can be categorised into two major themes: a) the 
elimination of deleterious mutation, and b) the creation of advantageous genotypes 
(Worobey and Holmes, 1999, Egger and Bienz, 2002). Additionally, it has been 
suggested that the importance of recombination can be determined from the 
environment within which it happens (Jarvis and Kirkegaard, 1991).   
Eliminating deleterious mutation 
In a high-mutational population like an RNA virus, the mutation-free genomes 
become rare and can be lost by genetic drift. This mutational hypothesis is known as 
Muller’s ratchet (Chao, 1990) or the mutational stochastic hypothesis (Hurst and 
Peck, 1996). Muller observed that the loss is irreversible in asexual populations 
(which cannot recombine) and that the load of deleterious mutations accumulate in a 
ratchet-like manner (Muller, 1964). Nonetheless, recombination by combining free 
mutation parts of each genome can reduce the mutational load in a population (Chao 
and Tran, 1997). This hypothesis assumes that genomes with a minimum number of 
deleterious mutations will be lost randomly. Moreover, the effect on the fitness of a 
new mutation is independent of the number of mutations already in the genome 
(Hurst and Peck, 1996). This contrasts with the mutational deterministic hypothesis 
wherein mutations are assumed to synergistically interact (epistasis) so that they stop 
the destructive effect of Muller’s ratchet (Hurst and Peck, 1996). Nevertheless, both 
hypotheses have been subjected to much debate. For example, are the population 
sizes of RNA viruses small enough for the Muller’s ratchet to take place (Egger and 
Bienz, 2002)? Or big enough so that the accumulation of deleterious mutations can 
be counterbalanced by compensatory mutations (Elena et al., 2006) that they can 
protect the virus from the fatal effects of the deleterious mutations?  
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Creation of advantageous genotypes 
Recombination allows advantageous mutations that arise from different viral RNAs 
to be united in one genome. It does so by reducing the linkage disequilibrium 
between mutations, which allows selection to operate independently on individual 
mutations. This in turn causes the advantageous mutations to accumulate faster 
(Rice, 2002). However, it is not clear if this alone can explain the purpose of 
recombination; most cases of antiviral resistance in viruses have been associated 
with the accumulation of a single point mutation (Egger and Bienz, 2002).  
The relative importance of recombination 
Jarvis and Kirkegaard have argued that the dynamics of RNA virus populations in 
different environments could affect the relative importance of recombination for the 
virus to survive (Jarvis and Kirkegaard, 1991). Based on the assumption that 
recombination has an evolutionary advantage, they categorised the dynamics within 
specific environments into three categories, to show the levels of relative importance.    
1. Taking into consideration the high error rates of RNA viruses, the larger the 
population size, the greater the number of mutations that can arise without 
the need for recombination.  
2. In a small founding population subjected to a selective pressure, 
recombination should play a more important role.  
3. This importance is increased even further if more than one allele is involved 
in creating a specific trait.  
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1.4  Next Generation sequencing (NGS) and Bioinformatics 
Next generation sequencing (NGS) is one of the methodologies that are shaping the 
understanding of viruses, especially in the area of genome sequencing, evolution, 
transcriptomics and the discovery of new pathogens. Applying this technology in the 
field of virology has resulted in an ever growing number of viral genome sequences 
being deposited within the International Nucleotides Sequence Database 
Collaboration (INSDC) databases (Brister et al., 2015). As a result of this surge of 
data, bioinformatics, an analysis tool that uses computer science, has become 
indispensible for efficiently translating the virus genomes’ sequencing data into 
biological implications.  
1.4.1 NGS methods 
The studies in virology have largely benefitted from two groundbreaking and 
revolutionary methodologies. These techniques have allowed virologists to amplify 
the virus of interest and then sequence the amplicon (Radford et al., 2012), namely 
Polymerase Chain Reaction (PCR) (Mullis et al., 1986) and Sanger sequencing with 
chain-termination inhibitors (Sanger et al., 1977). However, the main limitations for 
these technologies are their restricted scalability and their high cost when applied to 
a large genome. These limitations, among others, have been overcome through NGS 
technology, which, based on sequencing of a dense array of DNA, works through 
iterative cycles of enzymatic manipulation and imaging-based data collection (Mitra 
and Church, 1999). Although there are several NGS platforms available on the 
market (454 [Roch], Miseq [Illumina], HiSeq [Illumina], SOLiD [Life Technology]) 
their work flows are conceptually similar (Shendure and Ji, 2008). Library 
preparation involves DNA fragmentation, followed by in vitro ligation of a common 
adaptor sequence. Successively, the DNA fragment templates are immobilised on a 
solid surface or support and then clonally amplified by PCR (Metzker, 2010). The 
subsequent sequencing process consists of alternating cycles of enzyme-driven 
biochemistry and imaging-based data acquisition (Shendure and Ji, 2008). Finally, 
nucleotide sequences obtained from sequencing each cloned fragment of DNA (reads 
or NGS reads) will be written into output files called FASTQ (Cock et al., 2010). 
Although most of the NGS platforms share similar biochemical concepts, they use 
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slightly different methodologies to achieve clonal amplification and sequencing 
(Barzon et al., 2013).  
1.4.2 NGS data analysis (Bioinformatics)  
With this phenomenal rate of increase in the data generated by NGS sequencing 
(Reichhardt, 1999), the application of computational techniques to understand and 
organise the flux of biological data has resulted in the emergence of novel 
bioinformatics strategies. The aim of bioinformatics is threefold: to organise data in a 
accessible way for researchers, to develop tools and resources that aid in analysing 
the data, and to use these tools to analyse and interpret the data (Luscombe et al., 
2001) . Typically, there are two different approaches when using bioinformatics tools 
to analyse the NGS data. Firstly, if a reference genome is available then the resulting 
NGS reads can be aligned directly to the reference using an aligner like Bowtie 
(Langmead et al., 2009). This allows the detection of insertion, deletion, and 
mutation. Additionally, in the case of recombination where there are two parental 
reference genomes the NGS reads can be aligned to both; this can be achieved by an 
algorithm like ViReMa (Routh and Johnson, 2014) (see Chapter 3). Secondly, if the 
reference sequence is not available, the NGS reads are used to generate contigs (de 
novo assembly); overlapping NGS reads that together represents a consensus region 
of DNA.  
1.4.3 NGS usage to study RNA virus evolution 
NGS has been utilised in RNA virus studies to investigate their diversity, evolution 
and clinical consequences. For example, it was used to study the within-host 
evolution of hepatitis C virus (Bull et al., 2011) and dengue virus (Parameswaran et 
al., 2012). These studies and others were carried out mainly to detect the 
evolutionary aspects other than recombination such as a genetic bottleneck during 
the infection (Bar et al., 2010), a mutation hot spot (Tapparel et al., 2011), or low 
frequency escape variants (Henn et al., 2012). Only a few studies have utilised NGS 
to study recombination in RNA viruses. For example, Routh et al. carried out a NGS 
study to profile RNA recombination within the encapsidated genome of Flock House 
Virus (FHV) (Routh et al., 2012). Another example is represented by a study 
performed to establish a high-resolution map of the poliovirus type 1 coding region. 
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In their study Runckel et al. co-infected the cells with a synthetic genome (derived 
from PV1) containing 368 engineered-markers and wild-type PV1 virus. These 
synthetic markers allowed them to trace the recombination reads in the NGS dataset 
(Runckel et al., 2013). The major obstacles in conducting an NGS study on RNA 
viruses may be attributed to the low frequency at which recombination exists and the 
possible chimeric artefacts that can be produced by the PCR amplification (Di 
Giallonardo et al., 2013, Beerenwinkel and Zagordi, 2011). On the other hand, NGS 
has been employed in identifying recombination events that occur within the 
genomes of higher organisms. For example, it has been used to detect fusion genes 
between different chromosomes, an event that has recurrently been implicated in the 
development of cancer (Maher et al., 2009).  
1.5  Aims 
Based on this brief review, it is clear that the occurrence of recombination is well 
established as an important evolutionary key player in RNA viruses. Nonetheless, the 
underlying mechanisms remain poorly understood. Although NGS provides an 
efficient approach to studying recombination, the recombination studies using this 
approach are quite limited. This can be mostly attributed to the paucity of 
recombination, which complicates the isolation of recombinants from a mixed 
population in vitro and the subsequent detection of recombination NGS reads among 
the parental reads in silico. The aim of this study is two-fold: 1) to develop an 
approach that can efficiently isolate recombinants, and 2) to establish a 
bioinformatics method that can be used to detect recombination junctions from the 
NGS datasets.  
Specific aims: 
• To develop a reproducible method to specifically isolate and PCR amplify 
intertypic recombinants between wild-type polioviruses type 1 and 3, in the 
absence of selection pressures and at an early stage of infection. Note: All the 
work described in this thesis was performed on the PV1 isolate Mahoney and 
PV3 isolate Leon. For simplicity these isolates will be hereafter referred to as 
PV1 and PV3 
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• To use NGS technology to sequence all possible recombinants generated 
from the above method. 
• To establish a method of using NGS simulation tools to optimise 
recombination analysis. 
• To define a bioinformatics pipeline to detect the junction location from the 
NGS reads.  
• To test the randomness of the recombination event. 
• To determine the underlying mechanism of RdRp template switching at the 
nucleotide level.  
• To compare the findings with the original Lowry (Lowry et al., 2014) system 
to gain an understanding of the recombination event itself and the subsequent 
resolution process.  
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2 Methodologies 
2.1  Cell culture and virology method  
2.1.1 Cell maintenance  
Human cervical (HeLa) were grown as monolayers in Dulbecco’s Modified Eagle 
Medium (DMEM) supplemented with 100µg/ml of streptomycin, 100 U/ml of 
penicillin, 2mM L-glutamine, and 10% heat inactivated (HI) foetal bovine serum 
(FBS). Trypsinisation was carried out by trypsin-ethylenediaminetetracetic acid. 
2.1.2 Virus infection  
Cell monolayers were infected with virus at 10 Multiplicity of Infection (MOI). 
Virus was absorbed onto monolayers for 30 mins at 37ºC/5% carbon dioxide CO2 air. 
Virus supernatant was removed and replaced with medium supplemented with 10% 
H1-FBS. Virus was extracted from the cells 5h post infection before the appearance 
of cytopathic effect. 
2.1.3 Plaque assay  
Cells were seeded in 6-well plates and grown to 90% confluency. Ten-fold dilutions 
of virus stock were made in medium/10% FBS/Penicillin and Streptomycin (PS). 
Once medium was removed from seeded wells, cells were washed with sterile PBS 
then inoculated with 500µl of prepared virus and incubated for 30 mins at 37ºC in 
the presence of 5% CO2 /air to allow absorption to occur. Plaque overlay media (see 
section 2.3 ) was added to each well and plates were incubated inverted for two to 
three days at 37ºC in the presence of 5% CO2/air. Cells were stained with crystal 
violet solution and re-stained post removal of the plaque overlay media. Plaques 
were counted and the virus titre expressed as plaque forming units per millilitre 
(PFU/ml).  
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2.2  Molecular Genetic Techniques 
2.2.1 Transformation of E.coli with plasmid DNA  
Around 3µl ligation mixture (or 1µl plasmid) was added to 50µl ice-thawed α-Select 
Chemically Competent Escherichia coli (Bioline) and stored in an ice bath for 20 
mins. The mix was placed in a 42ºC waterbath for 35 seconds before being returned 
to ice for 2 mins. Five hundred microliters of SOC medium (Sambrook et al., 2000) 
was added before incubating the tube in a 37ºC shaker (225 rpm) for 1 hour. From 
this, 100µl (containing the cells) were plated onto Luria-Bertani (LB) agar plates 
supplemented with appropriate antibiotic selection and incubated inverted overnight 
at 37ºC.    
2.2.2 Plasmid DNA extraction from E.coli  
Overnight cultures (5 ml or 100 ml) of transformed E.coli in LB broth with the 
appropriate antibiotic for selection were incubated in preparation for mini- and midi-
preps respectively. Small-scale isolation was carried out using GeneJET™ Plasmid 
Mini-prep kit (Fermentas) according to the manufacturer’s instructions. Plasmid 
DNA was eluted in 5µl distilled H2O (dH2O). Medium-scale isolations were 
performed by QIAfilter™ plasmid Midi Kit (Qiagen) according to the protocol 
provided. The DNA was re-suspended in 200µl dH2O. A list of plasmids used in this 
project are provided in Table 2-1. 
2.2.3 Virus RNA extraction from cell culture supernatant 
 QIAamp Viral RNA Mini Kit (Qiagen) was used for RNA extraction from 
supernatant recovered from the infection according to the manufacturer’s protocol. 
RNA was stored at -80ºC and was thawed in an ice bath when required. 
2.2.4 PCR product clean up  
Wizard® SV Gel and PCR Clean-Up System was used for purification of DNA from 
PCR reactions according to the manufacturer’s. PCR products were eluted in 30µl 
and stored at -20ºC until required.   
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2.2.5 Extraction of DNA from agarose gel 
Deoxyribonucleic acid fragments were extracted from agarose gel using DNA 
extraction kit (Qiagen) according to the manufacturer’s instructions. DNA was stored 
at -20ºC until required.  
2.2.6 Ligation of DNA fragments  
Digested DNA fragments or PCR products were ligated into vectors at a molar ratio 
of 3:1 (insert:vector) in a 20µl reaction containing 1x Ligation Buffer (400 mM Tris 
–HCL, 100 mM MgCl2, 100 mM dithiothreitol (DTT), 5mM adenosine triphosphate 
(ATP) (pH 7.8 at 25ºC) and 5 U T4 DNA Ligase (Fermentas). Reactions were 
incubated at room temperature for 2 hrs and used directly within further purification 
for bacterial transformation.   
2.2.7 DNA Sanger sequencing 
All sequencing reactions were set up in a 10µl total volume mix using 25pmol of 
appropriate primer. Plasmid sequencing required 400-500ng, whereas PCR 
fragments sequencing required 100-400ng. All samples were sequenced by 
University of Warwick Genomics Facility. 
2.2.8 Restriction enzyme digestion  
Restriction endonuclease digestion of DNA was carried out using the manufacturer’s 
recommended amount of enzyme in a solution containing 1x of the specific supplied 
buffer. Incubation temperature and the subsequent thermal inactivation were also 
carried out according to the manufacturer’s instruction. The digestion reaction was 
incubated from 45 to 60 mins before being run on a 1% weight per volume total 
(w/v) agarose gel for size/banding pattern analysis. 
2.2.9 In vitro reverse transcription (cDNA synthesis) 
Reverse transcription reactions were carried out using Superscript III reverse 
Transcriptase (Invitrogen). Ten microliters containing 3µg of purified RNA was 
incubated in a mixture containing 100pmol oligo dT, 10 mM dNTP mix for 5 mins at 
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65ºC. Following a 2 mins cool on an ice bath, 0.2µmoles DTT, 1x Superscript Buffer 
(250 mM Tris-HCL pH 8.3, 375 mM KCL, 15mM MgCl2), and 20 U RiboLock 
RNase inhibitor (Fermentas) was added and incubated for 2 mins at 42ºC. Two 
hundred units of Superscript III were added to the reaction before the final 50 mins 
incubation at 50ºC and reaction termination at 70ºC for 15 mins. The cDNA mixture 
was stored at -20ºC until required.  
2.2.10 In vitro transcription 
Linearised plasmid for RNA transcription was first prepared by column purification 
using QIAquickPCR® Purification Kit (Qiagen) and re-suspended in RNase-free 
water. T7 MEGAscript kit® (Ambion) was used for in vitro transcription following 
the manufacturers protocol. Between 1 and 2µl of RNA was confirmed on a 1% 
agarose gel before column purification using RNeasy mini kit (Qiagen) and 
quantified on a spectrophotometer.  
2.2.11 PCR amplification  
Promega PCR Master Mix 2x was used. A 50µl reaction mix was prepared 
containing final concentration of the following: 25µl PCR Master Mix 1x ( 25 
units/ml of Taq DNA polymerase, 200µM dNTP, and 1.5mM mgCl2), 0.5µm of the 
relevant forward and reverse primers. For the template, 5µl from the cDNA synthesis 
reaction was used. Nuclease-free water was added to adjust the reaction at 50µl.  
The optimised conditions of the thermal cycling for the two-targeted regions studied 
in this project were set as follows:  
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2.3  Stock Solutions and Buffers 
Crystal violet 
0.5g crystal violet powder in 20 ml 100% ethanol, 880ml dH2O containing 0.9 g 
NaCl and 100 ml 40% formaldehyde. 
DNA agarose gel loading buffer (6x) 
25mg bromophenol blue to 3ml 100% glycerol. Make up to 10ml with dH2O. Stored 
at room temperature 
Plaque overlay medium 
10% v/v Minimum Essential Medium (EMEM) with Earle’s salts (10x), 1% v/v/ L-
glutamin, 3% v/v 7.5% sodium bicarbonate, 2% v/v FCS, 1% v/v PS, and 30% v/v 
2% agar. 
 
 
2 mins at 95°C  
1 min at 95°C  
30 sec at 58.1°C 
1.2 mins at 72°C  
5 mins at 72°C 
Denaturation  
Denaturation  
Annealing  
Elongation  
Final Elongation 
39 cycles 
2 mins at 95°C  
1 min at 95°C  
30 sec at 59°C 
1.2 mins at 72°C  
5 mins at 72°C 
Denaturation  
Denaturation  
Annealing  
Elongation  
Final Elongation 
To amplify the P2 region from the end VP1 coding region  to the CRE   
To amplify the P2-P3 region from the CRE to the 3C coding region 
39 cycles 
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Agar for plaque overlay medium 
2% w/v bacto-agar (Dibco) in distilled water. Microwaved to dissolve powder and 
stored at room temperature. 
2.4  NGS library preparation 
Nextera XT DNA kit (Illumina, 2015a) was used to prepare the NGS samples for 
sequencing. All the steps were carried out according to the manufacturer’s protocols. 
The samples were sequence at National Institute for Biological Standards and 
Control (NIBSC) on Illumina MiSeq instrument. The generated FASTQ files (Cock 
et al., 2010), which contained all the sequences and their related quality score 
information,  were uploaded to a specific account on Illumina Basespace cloud 
(basespace.illumina.com). The files were downloaded later for analysis. 
2.5  Recombinant nomenclature  
Based on the lack of consistency of the names that have been used to refer to 
recombinants (see section 1.3.5), it was important in this project to find a suitable 
way to refer to the recombination events. As this project did not aim to suggest an 
alternative naming system a simple naming system based on Lowry et al. was used 
that merely served the purpose of this research (Lowry et al., 2014). The 
recombination that occurred at related site with no deletion or insertion was called 
‘precise recombination’. If, however, deletion is involved the name became 
‘imprecise-deletion recombinants’, and ‘imprecise-insertion recombinants’ if the 
resulted recombinants included an inserted fragment. This naming method does not 
take into consideration the characteristics of recombinants such as sequence identity 
or RNA structure. Accordingly these were contextualised based on the type of 
analysis within the text.  
2.6  Statistics used in data analysis 
Mann-Whitney U test was used to test the null hypothesis (H0) that two samples 
came from the same distribution against an alternative hypothesis (Ha), this 
particularly was used when tested the randomness of recombination. Spearman test 
was used to test for correlation between the presence of sequence similarities or 
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RNA secondary structure and the occurrence of recombination. To measure the 
significance in difference between the expected and the observed values in the 
sequence composition analysis Chi-square and Binomial tests were used. 
2.7  Computers and clusters 
The majority of the bioinformatics analysis (unless otherwise mentioned) was run on 
the Nero cluster (University of Warwick) through command-line via Terminal on 
Mac OS X system.  
2.8  Bioinformatics algorithms and scripts 
2.8.1 Simulation 
MetaSim (Richter et al., 2008) was used as the major simulator in this project to 
simulate the NGS datasets, which were used to optimise the bioinformatics pipeline 
(chapter 3). Additionally, a custom Perl script was written to simulate recombinants 
reads for other type of analysis including the sensitivity of detection recombinants 
(Appendix 1). In both cases the read sequences were saved into FASTA files (NCBI, 
2016). Unlike FASTQ files, the FASTA files do not contain any information about 
the quality score.  
2.8.2 Aligning 
The algorithm Bowtie2 (Langmead and Salzberg, 2012) was used to map the 
simulated and the real NGS reads to the reference sequences. The output files were 
kept for subsequent analysis. 
2.8.3 Manipulate the aligning output Sequence Alignment/Map (SAM) file  
The resulting SAM file - from the alignment - that contained all the information of 
the aligning process was further converted into another file called Binary 
Alignment/Map format (BAM) for some analysis such as the coverage. This was 
carried out by using the algorithm SAMtools (Li et al., 2009).  
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2.8.4 Coverage 
The coverage of each recombinant, during the optimisation process, was measured 
by the algorithm BEDtools (Quinlan and Hall, 2010).  
2.8.5 Mutation simulation 
An online Python script (Appendix 2) was used to insert random mutations into some 
datasets. The code inserts mutations (the mutation rate is defined by the user) 
randomly and directly into the FASTA files that contain the NGS simulated reads. 
The mutation rate was confirmed by calculating the mutation rate of the dataset 
manually (see next section). On the other hand the Jukes-Cantor (JC) mutation model 
(see section 3.4.3) was inserted into the dataset by the simulator algorithm MetaSim 
during the simulation process.  
2.8.6 Calculation of the mutation rate in the NGS dataset 
The calculation of the mutation rate within the resulted dataset, either with the 
random mutation inserted by the Python script (Appendix 2) or with the JC model, 
was carried out in three steps. Firstly, the dataset in-question was aligned by Bowtie2 
against its corresponding reference sequence. To ensure that all the reads in the 
datasets would be mapped regardless of the number of mutations (mismatches) per 
read, a large value was assigned to the minimum alignment score needed for an 
alignment to be considered "valid" (Bowtie 2: Manual, 2016). This would make the 
alignment process inclusive so that every reads would map to the reference. As a 
result, the number of mismatches in each read would be written into the output SAM 
file. Secondly, the number of mismatches in every read was extracted from SAM 
file. The SAM file composed of 19 fields separated by tabs, each filed provides 
information about the mapping process such as the names of the reads, the names of 
the references, and mapping quality. Field 14, where the number of mismatches was 
written, was extracted by the bash command ‘cut –f ‘. Thirdly, the number of 
mismatches was divided by the number of the total bases of the dataset that was 
generated by MetaSim.  
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2.8.7 Recombination detection  
To detect the recombination junctions from the NGS datasets, the Python-
implemented algorithm Virus Recombination Mapper (ViReMa) was used (Routh 
and Johnson, 2014). 
2.8.8 Recombination event extraction from ViReMa outputs 
Analysing the NGS dataset by ViReMa produced several output files; one of these 
would contain the junction location’s information. To extract this information, a 
custom Perl script was written and used for this purpose (Appendix 3). The code was 
designed with the help of Dr. Jonathan Moore to recognise the format by which the 
output file from ViReMa was produced. Subsequently, the code would transfer all 
the information into another text file, which was kept for further analysis.     
2.8.9 Recombination read extraction 
To confirm the junction location found in the previous steps, some recombination 
reads were extracted and aligned separately to a reference sequence. To extract the 
reads that represent the in-question junction’s location two steps were considered. 
First, as ViReMa reported the names of the reads and not the sequences, the names - 
based on the junction’s location - of the reads were extracted by using the bash 
command ‘grep’ on Terminal OS X software. The result was written into another text 
file, which in turn served as an index for the reads’ names to extract their 
corresponding sequences from the major FASTQ file, or FASTA file. In the case of 
the former, Perl code (Appendix 4) was used to extract the sequences based on the 
reads’ names while for the latter an online small algorithm called faSomeRecords 
was used. The algorithm faSomeRecords was downloaded from UCSC Genome 
Bioinformatics Site (http://hgdownload.soe.ucsc.edu/admin/exe/linux.x86_64/) 
2.8.10 Dotplot 
The dotplot graph was generated by Java Dot Plot Alignments (JDotter) software; a 
Java application with a graphical user interface. (http://athena.bioc.uvic.ca/virology-
ca-tools/jdotter/) 
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2.8.11 Analysis of recombination junction  
The sequence composition around the recombination junctions was analysed by 
several custom Perl scripts (Appendices 5-9), each of which was developed to 
analyse a different feature. For example, in the case of GC-content, the Perl script 
would calculate the ratio of GC and AT within a window of 50 nucleotides upstream 
and downstream to the junction location. In the case of mononucleotides, the ratio of 
‘A’, ‘T’, ‘C’, and ‘G’ would be calculated. To allocate the junctions’ locations, the 
scripts depended on an external tab-separated value (.tsv) file that contained the 
locations of the junctions on both viruses.  
2.8.12 Identical sequence 
The lengths of the identical sequences around the junctions were calculated by 
ViReMa.  
2.8.13 Visualisation of the mapped reads  
The alignment was visualised by Tablet (Milne et al., 2013), a graphical viewer for 
visualisation of the assembly and read mappings. Tablet is Java software with a 
graphical user interface.  
2.8.14 Visualisation of the recombinants on the genomes   
To visualise recombinants in terms of their locations on both viruses a visualisation 
method called Parallel Coordinates was used. This was adapted from the original 
model on the Data Driven Documents website (https://d3js.org). 
 
2.8.15 Text Editing Software 
Fraise and TextEdit software were used interchangeably to manipulate the texts. For 
scripting, the integrated development environment Komodo was used. 
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2.9  List of the plasmids used in this study 
 
Plasmids’ names Restriction enzyme 
used for 
linearisation 
Description  Reference  
pPV1FLC ApaI Full-length PV1 
Mahoney 
infectious clone  
This project 
pT7FLC SalI Full-length PV3 
Leon infectious 
clone 
(Goodfellow et 
al., 2000) 
pJC105B ApaI Molecular clone 
of an imprecise-
insertion 
recombinant 
This project 
Table 2-1 List of full-length clones used in this study 
 
 
2.10  The accession numbers of the virus genomes used in this study (NCBI)  
 
Virus NCBI Accession # 
PV1 (Mahoney)  V01149 
PV3 (Leon) K01392 
Table 2-2 List of the National Centre for Biotechnology Information (NCBI) accession numbers of the 
virus genomes used in this project 
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2.11  List of primers used throughout the study.  
Region in 
the 
genome  
Name Sequence Location  (5’- 3’) 
Recombination 
Products 
P2  
PV3-
3235F CTCCAAAGTCCGCATTTACA 
3235-
3255 recP2-RLDM PV1-
4548R ATCAGGTTGGTTGCTACA 
4548-
4530 
PV3-
4521R CAATTAGGTTAGTCGCAACT 
4541-
4521 
recP2-RMDL PV1-
3241F CTCCAAAATCAGAGTGTATC 
3241-
3261 
P3  
PV3-
5647R GGTGATTTCCAGATTAGTG 
5647-
5628 
recP3-RLDM PV1-
4579F GCTGAAAGAGAAAACACG 
4579-
4590 
PV3-
4552F GCTGAGAAAGAGAACACC 
4552-
4570 
recP3-RMDL PV1-
5610R GCATCCAAGATCTCCACT 
5610-
5592 
 
P2-PV3-Specific P2-PV1-Specific P3-PV3-Specific P3-PV1-Specific 
 
Table 2-3 The primers used throughout the project.  
The first column lists the targeted regions within the virus genome. The second column demonstrates the chosen 
names for each primer. The first part of the name before the hyphen refers to the virus type, at the right of the 
hyphen is the location regarding the 5’ end of the primers followed by direction of the primers (F=Forward, R= 
Reverse). The third column shows the sequences of each primer. The fourth column lists the location of each 
primer from the 5’ to the 3’ end. The last column defines the recombination products that result from each primer 
pair. The letters ‘rec’ within the name means ‘recombination products’, followed by the name of the region 
within the genome either P2 or P3. At the right of the hyphen the letter ‘R’ and ‘D’ refers to the ‘recipient 
genome’ and the ‘donor genome’ respectively, the subscripted ‘M’ and ‘L’ refers to the virus strain Mahoney and 
Leon. For example the name ‘recP2-RLDM’ refers to the recombination product in which the PV1 (Mahoney) is 
the donor genome and the PV3 (Leon) is the recipient genome. Finally, the colours refer to the type-specific 
recombinants for each genome. The types and the regions for each colour are demonstrated separately in the 
bottom raw. Blue = primers specific for poliovirus type 3 within the P2 region. Dark grey = primers specific for 
poliovirus type 1 within the P2 region. White = primers specific for poliovirus type 3 within the P3 region. Red = 
primers specific for poliovirus type 1 within the P3 region 
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3 Bioinformatics (pipeline development)    
3.1  Introduction 
Viral recombination is a key evolutionary mechanism. Determining whether 
recombination has occurred and identifying the location of the junctions is therefore 
of major importance to understanding the underlying molecular process of 
recombination. With no prior knowledge of recombination junctions, the detection of 
recombinants becomes complicated. With ever-decreasing costs, the use of NGS has 
increased significantly in virus discovery and the identification of emerging 
pathogens. In addition, it offers advantages and new opportunities to study 
recombinants and recombination. NGS is characterised by the ability to parallel 
sequence vast numbers of genomic fragments to produce millions of short sequences 
called ‘reads’ (see section 1.4.1). Isolating the NGS reads derived from 
recombination molecules amongst other reads remains a challenge, especially in the 
context of all the other errors that could be introduced into the NGS dataset through 
sample preparations and virus replication. 
The critical step in identifying the NGS reads derived from recombinants is to map 
these reads to the reference genome. Current mapping strategies include alignment 
procedures designed to localize Illumina, Roche, and Ion Torrent reads to a known 
location in the genome, which can be achieved using software like Bowtie 
(Langmead et al., 2009), that matches – effectively aligns – sequence reads to a 
reference sequence. However, whenever an NGS read spans a recombination 
junction point, part of the read will not map contiguously to the reference, which 
causes the mapping procedure to fail for that read. Consequently, the read will 
receive a low mapping score, and eventually end up being excluded from the 
analysis.  For this reason, several approaches have been developed to specifically 
identify recombination junctions within NGS datasets. 
Many recombination detection algorithms are based on the detection of a splice 
junction in eukaryotic mRNA or in the detection of chromosomal rearrangements or 
fusions genes in tumours. These include Tophat (Trapnell et al., 2009), Tophat 
fusion (Kim and Salzberg, 2011), FusionMap (Ge et al., 2011) and MapSplice 
(Wang et al., 2010). These programmes remove any potential false positive aligned-
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read, and putative junctions must be verified by the presence of multiple aligning 
reads. Filtering the reads based on these two criteria is a valid approach in the case of 
eukaryotic RNA splicing, as there should be only one or a limited number of 
biologically correct fusion junctions. Also, these junctions are likely to contain a 
known splicing site i.e. there are sequence motifs characteristic of real splice sites.  
However, this is not the scenario when it comes to the viral genomes, which may 
produce thousands of copies in a single replication cycle. Coupled with the high 
mutation rate and the short replication cycle, this will create a large pool of viral 
quasispecie. Therefore, an NGS dataset generated from a viral genome might contain 
a broad range of possible recombination sites as found in this study and in a previous 
study by Rrunckel et al. (Runckel et al., 2013). Some NGS reads within the dataset 
would represent different possible recombination junctions, which can be located 
anywhere in the viral genome and do not necessarily correlate with sequence motifs, 
which makes the process of recombinants’ detection by NGS a challenging process.   
An algorithm implemented in Python called ViReMa (Viral Recombination Mapper) 
was written by Routh et al. (Routh and Johnson, 2013) to overcome the difficulty 
mentioned above. It uses a flexible aligning mechanism; rather than splitting the 
reads into segments and aligning them independently, it attempts to align the 5’ end 
of a read to the reference genome(s) and then dynamically generates a new read 
segment. Thereby, generating a new read from the nucleotides at the 3’ end of the 
read that failed to align to the first parental genome. Subsequently, it maps this new 
read again to the second parental genome. In this way, ViReMa can find a wide 
range of potential recombinants taking into account the variable nature of the virus 
population. 
In the studies described in this thesis, ViReMa was combined with another algorithm 
(Bowtie2), and several custom-written Perl scripts to create an optimised 
bioinformatics analysis pipeline. In the preliminary analysis, many parameters were 
found to affect the specificity and sensitivity of the pipeline, such as the number of 
mismatches allowed in the alignment, the location of the junction, and the length of 
the NGS reads. To model the influence of these parameters, it was decided to 
generate simulated datasets of known variability and composition and determine the 
consequences for analysis. Simulated NGS datasets, using parental poliovirus 
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genomes (type 1 and type 3) and predefined recombinants constructed in silico, were 
generated by the simulation package Metasim (Richter et al., 2008). 
3.2  Aims of optimizing the bioinformatics pipeline 
 
a) Identify the junction location of recombinants among NGS datasets. 
b) Develop knowledge of the relation between the location of the junction 
and its representation in the dataset. 
c) Evaluate the overall sensitivity and specificity of detecting NGS reads 
spanning recombination junctions. 
d) Assign different sensitivity and specificity profiles for potential 
recombination junctions based on their location either in the genome or 
the NGS read.  
e) Define a function that can predict the sensitivity of ViReMa detectability 
over the amplicon.  
3.3  Sequencing factors considered for optimising the bioinformatics analysis  
There are several factors that can affect the resolution of the output datasets from 
NGS. They can vary from the sequencing platform to the length of the reads. Based 
on the nature and the available resources of this project, several factors were chosen 
to achieve the best quality. These factors were then used in the data simulation and 
the bioinformatics analysis optimisations. 
3.3.1 NGS platform 
Despite differences in sequencing methods, all current NGS platforms have several 
shared features, such as library preparations and amplifications. For this project, 
Illumina MiSeq was selected to sequence the recombination samples. The main 
reason is that there are many accessible bioinformatics tools that support Illumina, 
which are efficient in reducing the analysis time. Additionally, recent studies have 
shown evidence that MiSeq produces greater depth than other platforms (Frey et al., 
2014), which is an important factor when studying rare biological events like 
recombination in poliovirus. 
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3.3.2 Targeted sequencing 
Targeted sequencing is a sequencing procedure that focuses on a specific gene or a 
fragment of DNA or cDNA, in contrast to whole genome sequencing (Grada and 
Weinbrecht, 2013) where the whole genome is sequenced. Sequencing the entire 
poliovirus genome (7.5kb) with ~300 nts read-length will result in only a small 
proportion of the reads spanning the recombination junction location. The rest of the 
reads will match one or other partners in their entirety, thus, will not be informative 
regarding understanding where the recombination junctions are (Figure 3-1). Based 
on this, targeted sequencing was chosen, focusing on a ~1.3kb region of the virus 
genome (nucleotides 3235-4548) within which recombination had already been 
analysed in a previous study (Lowry et al., 2014).  
3.3.3 Number of reads 
The number of reads produced by a particular NGS sequencing run determines the 
depth of coverage of that sequencing run.  Increasing the coverage depth was found 
to increase the resolution of the data (Xie and Tammi, 2009, Medvedev et al., 2010). 
The combination of targeted sequencing and a high number of reads (coverage) is a 
common methodology to detect rare Single Nucleotide Polymorphism (SNPs) with 
high confidence, such as in cancer where the variant can be present at <1% (Schuh et 
al., 2012). Although identifying SNPs is not the goal of this study, the expected 
rarity of recombination within a population (Jiang et al., 2007) means that such a 
combination would be useful to detect and quantify them. Moreover, this procedure 
will increase the chance of those junctions located at the ends of the amplicon to be 
detectable in the dataset (see 3.7.1). To achieve this, the number of reads for a 1.3kb 
amplicon was set to 2-million paired-ends in simulated datasets, to be considered 
later for the real NGS experiment. 
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Figure 3-1 Targeted sequencing vs. whole genome sequencing 
A comparison between sequencing the whole poliovirus recombinant (left panel) and the targeted region from the 
recombinant; where the recombination junction occurred (right panel). In the former, no previous treatment was 
needed while a PCR amplification was needed in the latter. The horizontal two lines represent the recombinants 
molecule, the grey part derived from PV1 and the black-dashed part derived from PV3. The downward black 
arrows represent the sequencing step. Reads generated from sequencing are depicted in small arrows. The colour 
and style of the arrows correspond to the reference sequences they have derived from. The generated reads were 
first aligned against the parental genome to concentrate the recombination reads in the dataset. The remaining 
reads represent recombination reads (the reads in the circles), which are aligned to the corresponding recombinant 
reference  
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3.3.4 Read-length 
The major advantage of elongating the read length is to improve the mappability, 
also known as the uniqueness (Derrien et al., 2012), of a sequence. The uniqueness 
stems from the likelihood the longer reads can encompass a unique sequence that 
anchors all the remaining sequences. This study does not rely on mappability per se, 
as recombinant reads by definition will not align to either parent. Nonetheless, the 
longer read will provide a higher uniqueness to identify the junction point, increase 
the probability of a single read spanning a junction site (Töpfer et al., 2013), and 
increasing the detectable range (see section 3.7.2). The read length chosen was 250-
300 nts to optimise the bioinformatics pipeline and to be used later in the NGS 
experiment. 
3.3.5 Fragmentation 
In order to sequence numerous molecules in parallel using NGS technology, the 
DNA has to be fragmented into pieces, this process (termed fragmentation) is 
indispensable for NGS. It can be achieved either by a hydrodynamic or enzymatic 
methods. Although the hydrodynamic shearing showed bias towards the linear DNA 
termini in the fungal genome (Schwartz and Farman, 2010), it was found that both 
methods perform equally on PCR products, with only minor differences  (Knierim et 
al., 2011). The fragmentation step was performed in the simulation data to produce a 
~500nts fragments to best reflect the situation in the real experiment, which was 
carried out latter by Illumina Nextera kit (see chapter 5) This length was suggested to 
ensure a uniform sequence coverage depth (Harismendy and Frazer, 2009).  
3.3.6 Paired-end reads (PE sequencing)  
Paired-ends sequencing technology is the updated version of single-end sequencing. 
It sequences the same DNA fragment from both ends, thereby facilitating the 
detection of genomic rearrangements and repetitive sequence elements (Illumina, 
2015b). The paired-end reads will increase the sensitivity of finding the true 
crossovers by giving the algorithm two chances to find the correct junction (Figure 
3-2). This is important as ViReMa cannot detect recombination junctions in the last 
or first 25nts of the NGS reads (see section 3.5 ). Therefore, the availability of 
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paired-end reads on the opposing strand should avoid such junctions being missed 
during analysis. This means the paired-end reads will be used as two different 
separate reads in this project to inform about recombination, i.e., a FASTA file (see 
section 2.8.1) of 2-million paired-end reads would become a FASTA file of 4-million 
single-end reads. All the simulations and sequencing recombinant populations 
carried out in this research project are Paired-ends reads.  
 
 
Figure 3-2 Schematic representation of paired-end reads spanning the junction 
If the junction is spanned by the last 25 nts of the read, ViReMa would not be able to detect it. However, in 
paired-end sequencing, the chance for the same junction to be spanned by the opposite read is high. The 
horizontal grey-black line represents a 500 nts fragment which has resulted from the fragmentation process while 
the arrows represent the paired-end reads (forward and reverse) with the junction location indicated. The blue line 
is a measure line marked from 1 to 500 to reflect the length of the fragment and the reads. The transparent 
vertical line is to facilitate the visualisation of the junction location either in the fragment or the reads. In this 
example, the forward read spans the junction at position 220, which is a detectable site for ViReMa as it is more 
than 25 nts away from both ends of the read. On the contrary, the reverse read sees the junction by nucleotide 
280, which is undetectable by ViReMa as it located within the last 25 nts of the reverse read. 
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3.4  Synthetic data. 
MetaSim, a simulation algorithm (Richter et al., 2008), was used to simulate a set of 
NGS datasets to optimize the parameters of the pipeline (Table 3-1). Human 
poliovirus type 1 and type 3 genomes (see section 2.10 ) were used as major 
references, from which, in addition to artificially constructed recombinants, all the 
datasets were simulated. The simulation maintained all the sequencing factors 
preferred for this study, besides a range of alternative configurations, which were 
tested such as mutation rate, and the level of similarities. These were used in various 
settings to test the sensitivity and accuracy of ViReMa to analyse recombination 
events. 
3.4.1 Synthetic recombinants  
Three main recombinants were found in the laboratory by cloning and Sanger 
sequencing (see chapter 4) were used in the simulated study as major models for 
optimizations (Figure 3-3). These recombinants were selected on two main criteria. 
Firstly, each one of them possesses a junction point in a different location, 
representing three major sites of possible locations for the junction to be placed over 
the amplicon. Secondly, they show a different level of sequence similarities around 
the junction location, which could influence the sensitivity of the system. They were 
named based on the location of the junction with respect to the 5’ end of the 
amplicon.  For example 5’-330 is a recombinant with a junction located 330 nts away 
from the 5’ end of the amplicon. A custom Perl code (Appendix 1) was used to 
generate the recombinant sequences. 
 
Figure 3-3 Synthetic recombinants reference sequences used in the data simulation 
Three main recombinants based on findings from the experimental study were built in silico. Each line reflects a 
recombinant molecule composed of two parts, the thin grey line indicates the PV3 part of the recombinant and the 
black-dashed line indicates the PV1 component. The numbers above each recombinant indicate the chosen name, 
which is defined by the distance of the junction from the 5’ of the amplicon.  
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3.4.2 NGS coverage simulation  
The theoretical coverage is defined as the number of times that each nucleotide in the 
sequenced DNA molecule is expected to be sequenced given a certain number of 
reads of a given length (Sims et al., 2014), and is based on the assumption that reads 
are randomly distributed across an idealized genome. The depth of coverage for a 
particular base correlates with the number of reads which see that base. That is, the 
more each base is sequenced, the more depth of coverage it would receive.  
To estimate the number of times a base is expected to be sequenced, the Lander and 
Waterman (LM) equation was used (Lander, 2015, Lander and Waterman, 1988). 
This equation (Equation 3-1) measures the depth of coverage by calculating the 
average number of reads each base in the DNA would receive.  
Before simulating all of the datasets, a verification step was carried out to ensure the 
reliability of Metasim in generating the correct coverage as defined in the 
configuration. For this purpose, a trial dataset that contained no mutation and was 
composed of 10000 paired-end reads was simulated to test Metasim (Dataset G, 
Table 3-1). The NGS reads were first counted in the resulted FASTA using bash 
command "grep -c" within the terminal OS X, which was found to match the defined 
value passed to Metasim in the configurations. All the reads were then aligned 
against recombinant 5’-330 reference sequence - which was arbitrarily picked as a 
source genome for this simulation - resulting in a uniform distribution (Figure 3-4). 
Coverage was then confirmed by comparing the theoretical coverage which was 
found to be ~2300 (calculated by the LM equation) with the coverage produced by 
Metasim (calculated by BEDtools (Quinlan and Hall, 2010)). The coverage was 
found to be the same as the theoretical coverage, which indicates that Metasim had 
generated the expected coverage.  Note: the words coverage and depth of coverage 
are used interchangeably in this study, as they refer to the same technical aspect. 
 
 
 
Equation 3-1 Lander and Waterman equation to calculate the average coverage 
C stands for coverage, G for genome length, L for read length and N for the number of reads. 
 
 
  
𝑪 = 𝑳𝑵/𝑮 
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Figure 3-4 Depth of coverage distribution  
The coverage calculated from dataset G in Table 3-1. The chart shows a uniform distribution of the reads over the 
amplicon with uneven coverage coverage. The X-axis indicates the location on the amplicon, and the y-axis 
refers to the depth of coverage (number of reads). 
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3.4.3 Mutations & Substitutions in the simulated datasets 
Challenges for the interpretation of recombination mapping data are due to the error 
rate of PCR enzymatic amplification and Illumina sequencing. Moreover, poliovirus 
exists in a genetically diverse population, as it is liable to error-prone genome 
replication due to a lack of polymerase proofreading capacity (Domingo, 1992). To 
optimise the bioinformatics pipeline to work through these errors, simulated datasets 
with mutations were produced. Two types of errors were introduced to some datasets 
used in the optimizations (Table 3-1), namely random mutation and substitution. The 
latter can be divided into substitution by selection and systematic substitution (Figure 
3-7).  
1) Random Mutation 
Mutations result from biochemical processes that can cause genetic changes by 
introducing errors along the genome (Figure 3-5, left panel). Based on the 
experimental approach used in this study, several possible sources of such 
mutations might be considered influential; PCR amplification with an error rate 
of 10-4 -10-6 mutations/nt (McInerney et al., 2014), virus replication error with an 
error rate of 4.5*10-4 mutations/nt (Wells et al., 2001) and cDNA synthesis 
process with an error rate of 5*10-5 mutations/nt (Invitrogen, 2015). The 
summation of these error rates would bring the total error rate to 5.2*10-4. This 
type of mutation was inserted by a script implemented in Python (Appendix 2) 
which dispersed random mutations within the NGS dataset (Parnell et al., 2011).  
2) Substitution 
 
a) Substitution by selection. These are mutations that result from biochemical 
processes such as replication errors, editing, or nucleic acid damage. 
However, because their spread and fixation is a population-genetics process 
that takes place over a much broader scale, the subsequent fixation of 
mutations in populations is termed substitution (Belshaw et al., 2011, 
Sanjuán, 2012) (Figure 3-5, right panel). This type of substitution was 
inserted by applying the Jukes-Cantor model on the simulation process using 
the default settings (constant rate of 0.01 substitutions). This model assumes 
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the rate of nucleotide substitution is the same for all pairs of the four 
nucleotides A, T, C, and G. However, because the experiment developed in 
this project involved harvesting the virus after 5h post infection, JC model 
was considered to optimise the bioinformatics pipeline only and does not 
reflect the experimental condition. For example, JC model would be valid as 
a reflection of the experimental condition if serial passages were considered. 
b) Systematic substitution. Illumina sequencing is a base-by-base sequencing 
technology using a reversible terminator-based method, enabling the 
detection of single bases as they are incorporated into growing DNA strands 
complementary to the template (Huang et al., 2012). Since this technology is 
reading out one base at a time, the errors introduced are substitutions rather 
than insertions or deletions. The published substitution rate ranges from 0.1% 
to 1% , increasing towards the 3’ of the reads (Figure 3-6) (Schirmer et al., 
2015, Loman et al., 2012, Wright et al., 2011). Illumina substitutions rate 
were inserted to some of the simulated dataset (Table 3-1).  
 
 
 
Figure 3-5 Mutation & Substitution simulation visualised by NGS mapping viewer Tablet  
Screenshots from Tablet of forward and reverse reads aligned against the corresponding references in Dataset C 
(left panel) and Dataset D (right panel) (Table 3-1). The reads are reflected by four columns separated by 
different colours; Dark blue = reverse reads, pale green = forward reads. The bright dots in the left panel 
represent the random mutations in regards to the references, but appear as vertical lines in the right panel when 
the mutations went through fixation (JC model).  
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Figure 3-6 Probability curve of substitution errors for a 300 nts Illumina read inserted by MetaSim  
The substitution is increasing towards the 3’ ends of the reads. The x-axis denotes the position over a 300 nts 
read. The y-axis represents the substitution rate. 
 
 
Figure 3-7 Flow diagram of the error sources that inserted into NGS datasets 
In the random mutation branch, the rate of every error is written in the same box of a particular error, and the 
total error of all three is located at the bottom. The substitution branch demonstrates two errors that are likely to 
occur. These are, Illumina, which was published to be 0.1-1%, and substitution by selection (JC model) which 
was calculated and found to be ~2.5% from the default settings of the JC model. For the calculation method (see 
section 2.8.6) 
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Dataset Reads number Variation 
Fragmentation 
length 
Source genome 
sequence Simulator 
A 
2 million 
Paired-End 
reads 
Nil 
500 nts (+/- 50 
nts) 
All the three 
recombinant 
sequences: (5’-
330), (5’-768), 
(5’-1176) 
Metasim 
B 1% Illumina 
All the three 
recombinant 
sequences: (5’-
330), (5’-768), 
(5’-1176) 
Metasim 
C 
Illumina(1%) + 
random 
mutation 
(0.054%) 
All the three 
recombinant 
sequences: (5’-
330), (5’-768), 
(5’-1176) 
Metasim 
D Illumina (1%) + JC (2.5%) 
All the three 
recombinant 
sequences: (5’-
330), (5’-768), 
(5’-1176) 
Metasim 
 G 10000 reads Nil 500 nts (+/- 50 nts) 5’-330 Metasim 
I 
2 million 
Paired-End 
reads 
Nil 500 nts 
All the three 
recombinant 
sequences: (5’-
330), (5’-768), 
(5’-1176) 
Metasim 
J1 
1252 reads 
(Precise 
Recombinant
s) 
Nil Not Applicable 
The sequences 
correspond to the 
targeted region 
(nucleotides 
3235-4548) in 
both PV1 and 
PV3  
Rec-
generator 
Perl code 
J2 
1252 reads 
(Precise 
Recombinant
s) 
1% mutation Not Applicable 
The sequences 
correspond to the 
targeted region 
(nucleotides 
3235-4548) in 
both PV1 and 
PV3 
Rec-
generator 
Perl code 
K1 
1252 reads 
(Imprecise 
Recombinant
s) 
Nil Not Applicable 
The sequences 
correspond to the 
targeted region 
(nucleotides 
3235-4548) in 
both PV1 and 
PV3 
Rec-
generator 
Perl code 
K2 
1252 reads 
(Imprecise 
Recombinant
s) 
1% mutation Not Applicable 
The sequences 
correspond to the 
targeted region 
(nucleotides 
3235-4548) in 
both PV1 and 
PV3 
Rec-
generator 
Perl code 
Table 3-1 Simulated NGS Datasets used in bioinformatics analysis optimisation  
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Several databases were created with different features to optimise the bioinformatics pipeline. The ‘dataset’ 
column on the left shows the names that chosen for each dataset. The ‘reads number’ column includes the number 
of reads generated for each dataset. The ‘variation’ column presents the type of mutation that was inserted into 
the datasets and the error rate%. The ‘fragmentation length’ column lists the fragment size of the fragmentation 
process step in the NGS library simulation. The ‘source genome sequence’ column lists the names of the source 
genomes used in the simulation to generate the reads. Ref. refers to references in Figure 3-3, PV1 and PV3 
indicate complete poliovirus type 1 or 3 genomes. The ‘simulator’ column shows the simulation tool used to 
generate the data. (Note: When using the Rec-generator Perl code (Appendix 1) as a simulation tool, the 
fragmentation step was omitted as the code generates reads directly, by appending two sequences together.)  
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3.5  ViReMa mechanism 
ViReMa is a Python script that iteratively calls the small read alignment program 
Bowtie (Langmead et al., 2009) to try and map all portions of a candidate read. 
Bowtie aligns the read using a sequence of 20-30 nts length as a seed sequence 
(hereafter known as seed and set to 25nts throughout this project) and reports the 
location of a successfully mapped seed. Therefore, ViReMa cannot find the 
junction’s location if it was spanned by the putative seed regions which are the first 
or last 25 nts of the reads. In this process, Bowtie takes into account the quality 
scores to report the mismatches, i.e. mismatches will be declared as a sum of quality 
scores if they don’t exceed a user-defined value: the “-e-value”. ViReMa exploits 
this method of mapping by purposely assigning a very high ‘-e’ value to allow 
Bowtie to report a successful mapping of a read regardless of the number of 
mismatches that follows it. The mismatches are reported in the standard Sequence 
Alignment Map (SAM) output (Li et al., 2009). From this, ViReMa can decide how 
many nucleotides from the read have been successfully mapped, and determine the 
nucleotides that did not map. For example, if a forward read of 300 nts was found to 
be successfully aligned at its first 150 nts, then this part corresponds to the 5’ region 
of a putative crossover. 
The algorithm can be set to allow no mismatch to happen when searching the 
junction site; as a result, the first encounter mismatch would be considered as a 
potential recombination junction. ViReMa cuts the read at the mutation site 
(hereafter known as the cutting-site) and builds another read composed from the 
mismatched nucleotide to the end of the read. Subsequently, it aligns this subread 
against the other parental genome before reporting the junction location (Figure 3-8). 
Alternatively, the algorithm can allow 1-2 mismatches (‘–N’ parameter in the 
command line) to be present in the seed and the remainder of the read. To ensure the 
differentiation between a mismatch and a real junction point, the mismatch cannot 
occur among the nucleotides immediately preceding or following a putative 
recombination site. This process is controlled by the “ –X parameter” passed to 
ViReMa in the command line, which can be set to scrutinize a fixable range of 
nucleotides before declaring the mismatch a real crossover. For example, if -X set to 
5 and –N to 1, ViReMa would allow one mismatch and the cutting-site would be 
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relocated to the next met mismatch. However, as the –X set to 5, ViReMa checks if 
there is another mismatch within five nucleotides of the first met mismatch, and if 
not then the second mismatch will be reported as a potential breakpoint. On the 
contrary, if a mismatch was found within the five nucleotides, then the first 
mismatch will disallow the second mismatch, reverting ViReMa back to the first 
mismatch (Figure 3-9). 
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Figure 3-8 ViReMa mechanism with no mutation allowed (N = 0) 
The figure illustrates an example read mapped with ViReMa. 1) 300 nts recombinant read with a mutation 
represented by ‘X’ in the middle. The first 25 nts of the read represents the seed 2) A good alignment found at 
nucleotide 3000 in PV3 reference sequence 3) 150 further nucleotides are found to be aligned after the seed until 
a mismatch is found. The remaining nucleotides thus form a new read. 4) A new seed is extracted from the new 
subread, but successful mapping cannot be found because of the mutation. Therefore, the first nucleotide is 
trimmed, and again a new segment is generated. 5) A good alignment is found for the seed and the subsequent 5 
nucleotides from 3177 to 3207 until a mismatch is found, this time, the mutation is the junction point. The 
remaining nucleotides are written in a new file again. 6) Alignment found for the seed and the rest of nucleotides 
from 3208 to 3300 in PV1. 7) The results of the mapping are recorded in the output file. 8) The name of the 
recombinant as it appears in the output file. (Note: The length of the seed appears different between the steps, this 
is for the sake of demonstrating the mechanism in this figure only as they should be in the same length). The 
figure was adapted from Routh et al. (Routh and Johnson, 2014) 
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Figure 3-9 ViReMa mechanism in deciding on the junction location when one mismatch is allowed (N=1, 
X= 5) 
The figure illustrates the mechanism by which ViReMa operates when 1 mismatch and 5 similar nucleotides are 
allowed to happen. The two references are in the middle (PV3/blue and PV1/red). ViReMa will start aligning the 
5’ side of the recombination read towards the 3 ‘ end. Above the reference sequences is the forward read of a 
particular recombinant and lower to the reference sequences is the reverse read. The vertical lines show the 
mutation sites, and are named 1 and 2 for the forward read and 1’ and 2’ for the reverse read. Forward read) 
ViReMa would align the PV3 part first, and when it reached the junction site it would encounter the first 
mismatch  ‘site 1 in the figure’. Because ViReMa would allow for one mismatch when N=1, then it would accept 
this point and move on to the next mismatch ‘site 2 in the figure’. At this point ViReMa would check how many 
nucleotides were aligned correctly between 1 and 2, in this case it is only 2. Therefore the first mismatch ‘1’ 
would disallow the second mismatch ‘2’, and the location of the first mismatch would be reported as a potential 
junction location. Reverse read) The lower panel represents the reverse read of the same recombinant. The same 
strategy is applied on this read. The difference is, however, that ViReMa would find more than 5 aligned 
nucleotides between 1’ and 2’. Based on this, it would mistake the real junction, and rather report 2’ as a potential 
junction point, which can influence the sensitivity and the specificity of ViReMa.   
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3.6  Measuring ViReMa sensitivity by Receiver Operating Characteristic 
Curve (ROC) 
ViReMa can tolerate up to two mismatches defined by ‘–N’ parameter and allow 
different lengths of sequence identity between the first mismatch and the putative 
junction location set by the ‘–X’ parameter. The algorithm can use several 
combinations of ‘-X’ and ‘-N’ values that can affect the way of searching for 
recombination junctions and accordingly change the sensitivity and specificity of the 
analysis. Different combinations of these parameters (termed modes) were tested by 
Receiver Operating Characteristic Curve (ROC) to define the cut-off values of their 
specificity and sensitivity in detecting recombination, and based on this the best 
mode for this study was decided. 
A ROC curve graph is a two-dimensional graph in which the true positive rate is 
plotted on the y-axis (sensitivity) and the false positive rate is plotted on the x-axis  
(1 - specificity). Since every mode in ViReMa outputs a false positive rate and a true 
positive rate - together defining a single point in ROC curve space - they are called 
discrete classifiers (Fawcett, 2006). There are three important points in ROC space 
that are worth noting. The first one is the lower left point (0,0), which represents the 
strategy of never producing a positive result; such a classifier commits no false 
positive errors but also gains no true positives. The second one is the upper right 
point (1,1), which represents the opposite strategy of unconditionally issuing positive 
classifications. The third one is point (0,1), which represents perfect classification 
(100% sensitivity and specificity). The line connects (0,0) and (1,1) meaning no 
discriminative values; sensitivity = ( 1 – specificity)  
Sensitivity and specificity were calculated by Equation 3-2, wherein three main 
values were considered: 
1) True positive (TP); the number of reads derived from real junctions found by 
ViReMa. 
2) False positive (FP); the number of reads derived from false junctions found 
by ViReMa 
3) False negative (FN); the number of reads derived from real junctions that 
were not found by ViReMa 
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Six different modes were considered for ROC curve to test the performance of 
ViReMa (Table 3-2). These modes would allow ViReMa to tolerate different number 
of mismatch and different length of sequence identity between the first mismatch and 
the putative junction’s location. ViReMa was used with these six different modes 
individually to search recombinants in three different datasets (Datasets A, C, and D, 
Table 3-1), resulting in different sensitivity and specificity profiles reflected by the 
ROC curve (Figure 3-10). 
 
 
 
 
 
 
.   
N0X5 No mismatch 5 nts 
N0X8 No mismatch 8 nts 
N1X5 1 mismatch 5 nts 
N1X8 1 mismatch 8 nts 
N2X5 2 mismatches 5 nts 
N2X8 2 mismatches 8 nts 
Table 3-2 ViReMa modes used in ROC curve  
The Mode column indicates the values used in each mode; the number next to N defines the number of 
mismatches allowed, and the number next to X defines the length of the identical sequences that can be tolerated 
by the algorithm around the junction. The remaining two columns list the values of N and X respectively. 
 
Mode Mismatch (-N) 
Identical sequence (-X) 
length 
𝑇𝑃𝑅 (𝑆𝑒𝑛𝑠𝑖𝑡𝑖𝑣𝑖𝑡𝑦)  = 𝑇𝑃𝑇𝑃 + 𝐹𝑁 	
𝐹𝑃𝑅 (𝑆𝑝𝑒𝑐𝑖𝑓𝑖𝑐𝑖𝑡𝑦)  = 𝑇𝑃𝑇𝑃 + 𝐹𝑃 
Equation 3-2 Sensitivity and Specificity Calculation 
TPR= True Positive Rate. FPR = False Positive Rate. TP= True Positive, FN = False 
Negative. . FP= False Positive 
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Figure 3-10 Receiver Operating Characteristic Curve (ROC) of ViReMa performance 
 The ROC curve is built on testing six ViReMa modes using three different datasets with different mutation rates 
(Dataset A, C, and D from Table 3-1). The table at the right bottom corner assigns a number for every mode to 
facilitate fitting them in the ROC curve. The x-axis represents the 1-specificity, and the y-axis indicates the 
sensitivity. The black line is placed to facilitate reading the data, it connects (0,0) and (1,1) (negative control); 
any classifiers located on this line will be non-discriminative (sensitivity = 1 - specificity). The grey line 
addresses the positive control; the line passes (grey line) through the point (0,1) reflects the best classifier 100% 
sensitivity and specificity (note: 100% sensitivity is 1 on the y-axis, 100% specificity is 0 on the x-axis). The 
numbers assigned to each mode were used to represent the modes in the curve area; they were given different 
colours to differentiate the datasets. Red, black, and blue denote dataset A, C, and D respectively. 
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Unsurprisingly ViReMa behaved equally at mode N0X8 and N0X5, because in these 
modes ViReMa allows no mismatches (-N is zero), thus neither ‘-X=5’ nor ‘-X=8’ 
were functioning in these cases. This equality is reflected on the ROC curve by 
placing the numbers assigned for these modes next to each other and separating them 
by a comma (Figure 3-10) in the curve area. In terms of specificity and sensitivity, 
these two modes demonstrated the greatest specificity in all of the three datasets 
analysed, with the sensitivity decreasing as the mutation rate increased. When no 
errors were permitted in the dataset the sensitivity with modes N0X5 and N0X8 was 
shown to be ~84% (Figure 3-10, red 1,2), which is the theoretical maximum 
sensitivity ViReMa could reach with 300 nts read length (see 3.7.2). The sensitivity 
reduces with the rest of the modes to reach ~20% at the mode N2X8. This drop in 
sensitivity resulted from the change in the ViReMa mechanism imposed by modes 3-
6, which set ViReMa to expect mutation in the datasets. Therefore, ViReMa would 
report the real junctions as a potential mutation in a dataset that was free of error 
(Figure 3-10, red 3-6). This was reflected by incorrect positions reported as true 
junctions (false positive) in the ViReMa output. When ~1% random mutations were 
introduced to the datasets (Dataset C, black numbers in the curve), the sensitivity 
generated by modes 1 and 2 decreased to ~64% with ~99.9% specificity (almost no 
false positives). On the other hand, mode 3 "N1X5" displayed a slightly better 
sensitivity than modes 1 and 2 with a slight decrease in specificity. The small 
increase in sensitivity in mode 3 in Dataset C in comparison to Dataset A is 
explained by the actual presence of mutations, which helped ViReMa to re-find some 
of the actual recombination junctions. While in Dataset D where a fixed substitution 
rate of  ~2.5% was inserted into the dataset, ViReMa sensitivity and specificity had 
dramatically decreased (blue numbers in the curve). None of the modes of Dataset D 
reached any sensitivity higher than ~30% with small differences in the sensitivity 
and specificity between all the modes, which is reflected by a clustering of the 
numbers near to each other in the chart.  
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3.6.1 Erroneous reads that can affect the sensitivity and specificity 
ViReMa modes 1 and 2 (hereafter known as N0X5 mode) showed high specificity of  
~99.9% and a sensitivity of ~64% with Dataset C (Table 3-1), the dataset that has the 
closest mutation rate to the estimated mutation in the real data (Figure 3-7). Further 
investigation was performed on the unreported reads (false negative) and the 
misreported reads (false positive) which resulted from analysing Dataset C with 
ViReMa N0X5 mode to determine the nature of these reads. The analysis revealed 
three types of erroneous reads that ViReMa would either reject or misreport. The 
first two represent the false negative and the last one represents the false positive.  
1. Reads that spanned the junction with their last or first 25 nts (within the seed 
sequence). 
2. Reads that included a mutation within 25 nts of the junction location. 
3. Reads that represent junctions located next to an identical sequence and 
included a mutation right next to the actual junction site. 
The first type (constituting 14% of the total) are reads in which the recombination 
junction was located within the terminal 25 nts of the read, which ViReMa would not 
detect based on the way the algorithm was implemented (Figure 3-8).  
The second type (constituting ~21.9 % of the total reads) are those reads which had a 
mutation occurring within 25 nts of a junction (Figure 3-11 – read C). Because in 
N0X5 mode ViReMa would deal with any mutation as a potential junction site; it 
would cut the read at that mutation site, aligned to the references. If no valid 
alignment were found, ViReMa would trim the mutation and re-align the read 
(Figure 3-8). In this type of erroneous read, the presence of the mutation within 25 
nts of the junction site would cause ViReMa to cut the read at a site that would 
generate a subread that had less than 25 nts from one parent and the rest from the 
other parent. Subsequently, the chance that ViReMa would find a seed for the next 
round of alignment was rare. For example, if the junction lies at location 150 of a 
300 nts read, and the mutation lies at nucleotide 140 of the same read, then ViReMa 
would cut at nucleotide 140. The resulting 160 nts subread would contain 10 
nucleotides from one parent and 150 from the other. In this case ViReMa would not 
be able to find a unique seed, unless it trimmed 10 nucleotides from this read. In this 
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process, ViReMa would consider the trimmed 10 nucleotides as an insertion and 
would not report this read; rather it would keep it in a separate file called ‘unknown 
recombinants’. However the junction site could be detected if the number of trimmed 
nucleotides is less than or equals 5. This is the default value and can be modified 
from the ViReMa settings.  
The third type (constituting 0.1% of the total reads) are misreported reads due to a 
misincorporation that occurred right next to the actual junction locations located next 
to an identical sequence (Figure 3-11 – read D). For instance if the junction - in a 
recombinant amplicon composed of PV3 in its first 1000 nts and PV1 in its last 300 
nts - locates near to a short identical sequence of two nucleotides, ViReMa would 
report it correctly if there was no mutation (Figure 3-11 – read A). Nevertheless, if a 
mutation occurred at nucleotide 1001, the starting part of PV1, and happened to be 
the same nucleotide as PV3 at that location, then ViReMa would report the junction 
three nucleotides downstream to the actual junction. As a result, a read with the 
wrong junction location will be reported. 
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Figure 3-11 The mechanism of ViReMa in reporting false negative and positive recombination junction  
The first panel shows four different reads for one recombinant that has its junction located at the connection point 
between the grey and black-dashed line. Downstream to the junction, there is one nucleotide that belongs to PV1 
before an identical sequence is encountered (the red line), then the remaining nucleotides are unique for PV1. The 
black X refers to a nonspecific mutation, i.e., it could happen anywhere, while the red X is a mutation that 
occurred at the nucleotide belonging to PV1 before the identical sequence changing it to the same nucleotide that 
PV3 possesses at this location. By this mutation, the identical sequence has become one nucleotide longer; 
therefore, it is coloured red (Read D). In the second panel, ViReMa mapped the reads to the PV3 reference until it 
encountered the mutation. Read A) It is a straightforward recombinant read without any mutation, the first part 
aligned to PV3 and the other part aligned to PV1 reference (shown in the fourth panel). This read will appear in 
the result output file with the correct junction location. Read B) ViReMa cut the read at the mutation site, formed 
another seed, and re-aligned the new seed to PV3 reference (shown in panel 3). The rest of the read aligned 
successfully to PV1 reference sequence (shown in panel 4). This realigning process happened because ViReMA 
found enough nucleotides (>25) to form a new seed after the cutting site. This read will appear in the result 
output file with the correct junction location. Read C) ViReMa cuts at the mutation site, it did not find valid 
nucleotides to form a new seed; as a result, it started to trim the nucleotides and re-aligned the trimmed read. 
After trimming the 7 nucleotides of PV3 part of the read and finding a satisfactory alignment for the PV1 part, 
ViReMa would consider this as an insertion (as it is > 5 nts) and save the read in another file as unknown 
recombinant. The trimmed part is showing in a circle in the fourth panel. Read D) This read has a mutation on the 
PV1 nucleotide that was located before the identical sequence. ViReMa would not recognise this mutation, as it 
happened to be identical to PV3 nucleotide at this location. Rather, it would consider this nucleotide part of PV3 
and would report an incorrect junction location located after at the 3' end of the identical sequence. This read 
would appear in the output results file with an incorrect junction location. 
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3.7  Different elements affect the sensitivity of ViReMa 
As shown in the ROC curve graph (Figure 3-10), the presence of mutations in the 
dataset would affect the sensitivity and specificity of finding recombination junctions 
by ViReMa. To cope with such mutations, ViReMa utilises different modes that 
adjust the algorithm mechanism. Nonetheless, mutation is not the only factor that 
impacts on the process of searching recombinants’ reads in an NGS dataset by 
ViReMa. In this section, there are three elements – divided into categories – that can 
influence the searching capacity that was studied. They are either technical or 
biological factors: 
• Technical 
a) Location of the junction in the amplicon   
b) Location of the junction in the NGS reads 
• Biological 
a) The context of the junctions: similarity and divergence.  
3.7.1 Analysing the effect of the location of the junction in the amplicon on 
the sensitivity ViReMa  
The Lander and Waterman assumption (Lander and Waterman, 1988) is that the 
NGS reads are randomly distributed across the genome. This is also reflected in the 
random nature of fragmenting the DNA in the real experiment (Syed et al., 2009). 
Therefore, the extremities of the amplicon are liable to receive less coverage than the 
internal region. Consequently, this will result in a lower number of reads 
representing recombination junctions located at the ends of the amplicon. For 
example junction A in (Figure 3-12) is covered by 3 reads, while only 1 read covers 
junction B.  
To examine how the NGS reads’ underrepresentation of the termini would affect 
finding recombination junctions, Dataset A (Table 3-1) was used. The reads of this 
dataset correspond to the three primary recombinants, used in this study (Figure 3-3) 
with no mutations applied. The reads were first aligned against the three reference 
sequences (Figure 3-3) using Bowtie 2 (Langmead and Salzberg, 2012), to isolate 
and quantify the reads that cover each junction. Bowtie 2 was configured to not 
allow any mismatches to prevent non-specific alignments.  The aligned reads were 
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then separated into forward and reverse reads, BAM files (see section 2.8.3) 
generated using SAMtools and finally the coverage calculated by BEDtools (Quinlan 
and Hall, 2010) (Figure 3-13). The average coverage was calculated from the files 
produced by BEDtools, and charted in (Figure 3-14).  
From the total number of reads (4 million reads), the maximum coverage for all the 
recombination reads was 11.7%. Dissecting the coverage by looking at the coverage 
for each synthetic recombinant (see section 3.4.1) of each read orientation (forward 
and reverse), three different patterns can be observed. Recombination junction 5’-
330 was found to be predominantly covered by the forward reads (~3%) and partially 
covered by reverse reads (~0.6%). As for recombination junction 5’-768, it was 
equally covered by forward and reverse reads (~3%) and recombination junction 5’-
1176 was covered by the reverse reads (~1.2%) and hardly covered by the forward 
reads (0.007%). From these patterns, it is clear that the closer the junction to the ends 
of the amplicon, the less depth of coverage it receives. How this can be translated in 
the context of ViReMa is discussed in the next section.  
 
 
Figure 3-12 Schematic drawing illustrates the level of coverage for recombination junction located close to 
the end of the amplicon 
In this example, the coverage of two different junctions is demonstrated. The circles refer to the junctions’ 
locations. The arrows indicate the reads. When the junction is closer to the end, it is covered by one read 
(Junction B), but when it is closer to the middle, the number of reads increased to three reads (Junction A). The 
bottom blue line denotes the amplicon.  
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Figure 3-13 Summary of the method used in measuring the depth of coverage  
The number of total reads is 4 million when they are treated as single-end A) Reads from the major FASTA file 
were sorted into their original recombinants sources. B) Forward and reverse reads were separated using the bash 
command ‘grep –A’. C) Re-aligned the forward and reverse reads with the major references (synthetic 
recombinants) separately to generate SAM files for each of them. The SAM files were then converted into BAM 
files using ‘SAMtools’ D) Finally, BEDtools was used to measure the average of depth of coverage from the bam 
files. fw = Forward reads, rv = Reverse reads. AVG depth = Average of Depth Coverage. 
 
Figure 3-14 The coverage profile of the forward and reverse NGS reads of the synthetic recombinants 
Three patterns can be observed based on the distance between the junction location and the ends. The x-axis 
represents the name of recombinants and the orientation of the reads. The y-axis represents the average of depth 
of coverage. The black bin refers to all the reads that spanned the junctions within the whole population (3 
synthetic recombinants). 
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3.7.2 Analysing the effect of the junctions’ location in the NGS reads on the 
sensitivity of ViReMa  
The position at which the read spans the junction adds yet another challenge for 
ViReMa in identifying recombination junctions. This stems from the mechanism 
used by ViReMa to find the junction, i.e. extracting 25 nts fragment as a seed (see 
section 3.5 ) from the beginning of the read sequence and aligning it to the reference 
genomes (Langmead et al., 2009). The anchoring of the seed (set to 25 nts in this 
study) to the reference genome is the signal for ViReMa to start the searching 
process. Therefore, reads that span the recombination junction within the first 24 nts 
will not be identified during the analysis. It is 25 undetectable locations, because if 
the junction locates on nucleotide 25 of the seed it will be detectable by ViReMa. If 
we applied this on 300 nts read length, the length chosen for this study, a 
recombination junction occurring at the first or last 24 nts would not be detected 
leaving 252 possible detectable sites. Consequently, the maximum theoretical 
sensitivity of recombination detection would be 252/300*100 = 84% (Equation 3-3 
A). However, this could be reduced by variables such as biases in the fragmentation 
of the amplicon with regard to the location of junctions in the amplicon. 
To further investigate this, ViReMa was used to analyse Dataset I in Table 3-1. The 
fragmentation of this dataset was set to precisely 500 nts, so the effect of the DNA 
shearing could be clearly monitored. The sensitivity of ViReMa for detection each 
junction was calculated by dividing the number of reported reads on the number of 
unreported reads that spanned the junction (Figure 3-15), and confirmed with the 
theoretical sensitivity equation (Equation 3-3). The variability in sensitivity is due to 
two factors, the distance between the junction and the terminals of the amplicon and 
the fragmentation length. For example, the junction in recombinant 5’-768 can be 
calculated by subtracting the seed lengths from the length of the read and dividing 
the resulting length on the original length of the read (Equation 3-3 A). The forward 
and reverse reads will have the chance to reach the maximum sensitivity (84%) by 
both reads equally, as it is located in the middle of the amplicon; away from any 
possible physical restriction caused by the fragmentation (Figure 3-15). 
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However, the case is different in recombinant 5’-1176. Since the junction in 
recombinant 5’-1176 is only 124 nts away from the 3’ end of the amplicon, and the 
fragmentation length is 500 nts, only 124 unique reverse reads can represent the 
junctions. This because the fragmentation that happened at any of those 124 
positions would result in a fragment that contains the junction. Of those 124 unique 
reads only 124 – (seed length 24) = 100 positions could be detected by ViReMa. The 
forward reads would never have the chance to reach this junction if all the resulted 
fragments are exactly 500 nts (which is the case in this analysis) (Figure 3-16 A). 
However, this can deviate in the real experiment, resulting in slightly shorter or 
longer fragments (controlled by the standard deviation of the fragmentation method). 
Theoretically, this would allow a few forward reads to reach the junctions in the 
shorter fragments. A little modification of Equation 3-3 A is needed to calculate the 
theoretical sensitivity in for recombinant 5’-1176. As only the reverse reads would 
span the junction in this case, thus, the seed does not need to be multiplied by 2 
anymore. In addition, two new variables are considered, ‘r2’, which is the maximum 
distance the reverse reads can reach when they start at the 3’ end, and the distance 
between the junction location and the 3’ end  “Jd” (Equation 3-3 B). Thus, the 
theoretical sensitivity of ViReMa to detect the junction of recombinant 5’-1176 is 
32% for the reverse reads, and not applicable for the forward reads. However, based 
on the fact that the read and fragment length can be variable in the real experiment, 
this equation can be modified to include the variability, which was not investigated 
in this study. Rather it is based on the assumption that the majority of the fragments 
and reads would be 500 nts and 300 nts length respectively.  
Examining recombinant 5’-330 on the other hand, the forward reads would have 
different sensitivity from the reverse reads. The physical space in this situation is 
enough for the forward reads to cover the junction with 84% sensitivity while the 
reverse reads will be limited by the fragmentation fragment size (500 nts) (Figure 
3-16, B). This will allow 130 nts of the reverse read to extend beyond the junction 
and of these only 130 - (seed length 24) = 106 nucleotides would be detectable by 
ViReMa. This can be reflected by another modification on Equation 3-3 A by adding 
the fragmentation factor “f1” (Equation 3-3 C) and the junction location ‘J’. Thus, 
ViReMa theoretical rate sensitivity will be ~35% for the reverse reads (Figure 3-15).  
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Equation 3-3 ViReMa theoretical sensitivity 
A) TSVt= Major Theoretical Sensitivity of ViReMa, B) TSVr = Theoretical Sensitivity of ViReMa when the 
junction is located at the 3’ end of the amplicon, r means a factor related to the reverse read was added to the 
equation C) TSVf= Theoretical Sensitivity of ViReMa, when the junction detectability is partially limited by the 
fragmentation, f means fragmentation factor was added to equation A to become equation C. S = seed length. J = 
junction’s location. f1 = the largest fragment size possible. r = read length, S = seed length. r2 = the limit of the 
reverse read starts at 3’ location. Jd = the distance from the junction location to the 3’ end. 
 
Figure 3-15 Measuring ViReMa theoretical sensitivity of the synthetic recombinants 
From the reported reads and by using  Equation 3-3 ViReMa theoretical sensitivity was calculated for both read 
orientations in the three synthetic recombinants (Figure 3-3). The y-axis represents the percentage of theoretical 
sensitivity and the x-axis represents the name of the recombinants. The labels at the top denote the read 
orientation, fw = forward read, rv = reverse read. 
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A) 𝑇𝑆𝑉𝑡 = 𝑟 − (𝑆 ∗ 2)𝑟 ∗ 100 
 
 
B) 
𝑇𝑆𝑉𝑟 =  !𝑟 − (𝑟2 − 𝐽𝑑)!− 𝑆𝑟 ∗ 100  
 
C) 𝑇𝑆𝑉𝑓 =  !𝑟 − (𝑓1 − 𝐽)!− 𝑆𝑟 ∗ 100  
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Figure 3-16 Schematic drawing showing the effect of the junction's location in the NGS reads over the 
ViReMa theoretical sensitivity  
The physical space of the reads covering the junction is affected by fragmentation and their closeness to the ends. 
The bright blue lines represent the possible fragments resulting from fragmentation. To facilitate the presentation 
these were reduced to three; however, in the real experiment the possibilities can be all the nucleotides before 
junction. For example there are 124 possible fragmentation sites that can result fragments within which the 
junction is included in the case of 5’-1176 (upper panel) and 130 sites in the case of 5’-330 (the lower panel). The 
locations of these possible sites are depicted by the black boxes.  The arrows indicate the reads, forward (red) and 
reverse (dark blue). The circles refer to the junction. The main recombinants are depicted by the long horizontal 
lines; composed of two parts (grey, dashed-black) reflecting the parent. A) Recombinant 5'-1176. B) 
Recombinant 5'-330. 
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3.7.3 Analysing the effect of identical sequences on the sensitivity of 
ViReMa  
The exact site of recombination may be located in a region that has identical 
nucleotides between the two parents (so-called ambiguous regions). These 
ambiguous regions happen when nucleotides immediately upstream of the junction in 
the acceptor virus are identical to the nucleotides immediately upstream of the 
junction in the donor virus. When junction falls into an ambiguous region, it will be 
impossible to decide where the actual recombination could have occurred.  
Poliovirus type 1 and type 3 are 78% similar within the 1.3kb targeted fragment 
(from nt 3235 to nt 4548) analysed within this study. To gain a general insight into 
the ambiguous regions shared by both viruses, Jdotter (Brodie et al., 2004) was used 
to plot the similarities of the targeted region between the two viruses in a dotplot 
presentation using the default setting of sliding widow, 8 nts (Figure 3-17). The plot 
showed some ambiguous regions between the genomes, appearing as a continuous 
diagonal line when the two viruses share the same sequence and discontinuous over 
the divergent regions. From the dotplot it could be observed that the diagonal line 
mostly continuous in the 2A- and 2C-encoding region, which reflects the presence of 
long similar stretches over these regions. The junction location would not be 
identifiable if it lies within these ambiguous regions. Instead, ViReMa would push 
the potential junction towards the 3’ end of that ambiguous region (this can be set to 
5’ of the ambiguous region). By doing this, ViReMa may report several reads, which 
could have originally derived from different junctions, for one recombination 
junction (Figure 3-18). Note: the expressions ‘ambiguous regions’ and ‘identical 
sequence’ are used interchangeably hereafter as they refer to the same concept. 
Analysing the presence of identical sequences in more detail, it was found that these 
regions are distributed as short regions of identities between 2 and 21 nts in length in 
the P2 region and they exist in different frequencies. For example, there are 99 
identical sequences with 2 nts length (dinucleotide) scattered over the targeted region 
while only one identical sequence with 21 nts length lives in the 2C-coding region. 
In contrast, there are ~284 divergent nucleotides between poliovirus type 1 and type 
3 within the same region.  
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To investigate how these short identical sequences would affect ViReMa detection 
power, simulated libraries – composed of precise and imprecise recombinants at 
every possible location of the amplicon - were used. Precise recombinants are those 
recombinants that occurred at a comparable site between the parental genomes i.e. 
the resulted recombinant retain the same genome length of the parental genomes. On 
the other hand, the imprecise recombinants are those that occur at unrelated site, as a 
result; the recombinant virus will contain sequence duplication or deletion (see 
sections 1.3.5) 
The libraries were simulated by a custom-written Perl script (Appendix 1) that uses 
the junctions’ locations from both parents to generate the recombination read without 
any mutation (Table 3-1 Datasets J1, K1), or with 1% random mutation (Table 3-1, 
J2, K2) to study the effect of mutation in the context of the short identical sequences. 
The libraries contained 1252 unique junction reads as the 24 undetectable 
nucleotides from the terminals were removed. ViReMa was then used to find the 
recombination junctions in all libraries using N0X5 mode.  
In the case of precise recombinants, the results showed that ViReMa could detect 
~23% junctions from the 1252 total junctions when no mutations were applied on the 
library. The percentage of detectable junctions were reduced from ~23% to ~20% 
when 1% mutation was applied to the library (Figure 3-19) Analysing the results, it 
was found that ViReMa found the recombination junction in all the reads. However, 
because it was not possible to allocate the exact junction location if it occurred 
within an identical stretch, ViReMa reported several unique junctions as a junction at 
a single location. For example, ViReMa reported 22 unique junctions within a 
21mers identical sequence as one unique junction. Interestingly, the reported 
junctions constituted 23% of the total junctions, which is the same divergence ratio 
between the two viruses. This reflects the critical role of these divergent locations in 
helping the algorithm detect the nearest location to the exact junction location.  
In the case of imprecise recombinants, ViReMa could detect more recombination 
junctions than in the precise recombinants case,  ~67% junctions from the 1252 total 
junctions when no mutations were applied on the library and  ~44% when 1% 
mutation was applied to the library (Figure 3-19). As these recombinants are 
imprecise, they occurred at unrelated sites, thereby decreasing the effect of the 
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identical sequence, which in its turn would increase the detectability of ViReMa. 
This is discussed further in Chapter 5 and the correlation between the numbers of 
recombination unique reads and the length of the identical sequence is demonstrated 
in detail in Figure 5-18. 
 
 
Figure 3-17 Dotplot shows the identical sequences between the two viruses graphically 
A dotplot presentation displaying the identities between PV1 and PV3 within the targeted region; the PV3 
sequence runs along the x-axis and the PV1 along the y-axis. They are demonstrated as drawing genomes within 
which the protein encoding regions are indicated (the white colour refers to the PV1 genome and the grey to the 
PV3 genome). In regions where the two viral sequences are similar to each other, a row of high scores will run 
diagonally across the dot matrix.  
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Figure 3-18 schematic illustration of reporting junction location within an identical sequence 
When ViReMa encounters a junction located in an ambiguous region, it pushes the junction location towards the 
3’ end of the ambiguous regions. The long horizontal lines represent three different recombinants which have 
their junctions located within an identical sequence; the grey and dashed-black lines indicate the parental 
genomes of each recombinant. The red thick lines denote 10 nts ambiguous regions (i.e. a stretch of identical 
nucleotides between the two viruses), where the circles represent the actual junctions. The numbers above the 
ambiguous regions refer to the location at which the polymerase switched from the first virus (black-dashed line) 
to the other virus (grey line). If the three recombinants occurred in a real co-infection reaction, ViReMa would 
not be able to differentiate between the three types of junctions; thus, will report them all as one junction, using 
the 3' end of the ambiguous region as a reference location. In the case above ViReMa would report the three 
junctions with the location 90_to_92. 
 
 
Figure 3-19 Identical sequence effect on ViReMa (precise and imprecise) 
The sensitivity of ViReMa in detecting unique junction across the whole targeted genome within different NGS 
datasets. The x-axis shows the total recombination junctions and the detected ones while the y-axis refers to the 
percentage of recombination events. The colours refer to the results of ViReMa, either detectable reads (black), or 
undetectable (grey).  
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3.8  Mathematical function to calculate the theoretical sensitivity 
Depending on the ViReMa theoretical sensitivity, a function that can predict the 
sensitivity over the amplicon was established. The function calculates, for a 
particular junction at a particular location, the percentage of how many detectable 
junction sites in the NGS reads are available for ViReMa to detect, taking into 
consideration the factors that affect the physical space, such as fragmentation and 
distance from the ends of the amplicon.  
The function (Equation 3-4) was established based on four different locations that are 
important in defining the physical space of the reads to reach the junctions. The first 
location (termed r1) equals 300 which is defined by the maximum location the 
forward read can reach, the second location (termed f1) equals 500, and is defined by 
the first 500 fragments generated by the fragmentation process with respect to the 5' 
end of the amplicon. The remaining two locations, which were termed f2 and r2, 
follow the same concept from the other side of the amplicon (Figure 3-20- black 
circles). Because the theoretical sensitivity of the reverse reads is a mirror profile of 
the forward reads, they can both be calculated from the same functions by 
normalising the former to the latter. This can be done by subtracting the junction 
location (J) from the length of the amplicon (Amp - J = normalised reverse reads). 
For example, if the junction is located at nucleotide 1000 on the amplicon, then the 
criteria of the third component in the function is satisfied, thus it can be used to 
calculate the theoretical sensitivity of the forward reads. As for the reverse reads, this 
needs to be normalised to become 1300 – 1000 = 300, which will fulfil the criteria of 
the second component of the function.  
With the assumption that the coverage of reads is sufficiently high, this function can 
be used to determine the location on the amplicon at which ViReMa can start and 
stop detecting. In addition to that, it can predict the theoretical sensitivity at any 
location, which can be used as a reference profile to interpret the distribution of 
recombination reads from the real experiment.   
The results in Figure 3-20 demonstrate the ViReMa theoretical sensitivity calculated 
by the function (Equation 3-4) with an amplicon size of 1300, read length of 300 nts, 
fragmentation length of 500 nts, and a seed length of 25 nts. It can be observed that 
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ViReMa will start detecting more than one unique read for the forward reads at 
nucleotide 26 (0.3%), and will increase to reach the highest achievable sensitivity 
~84% at nucleotide 274.  This happens because the junction at this location can be 
spanned by all the nucleotides of the reads, and ViReMa can detect it in all the 
nucleotides except in the last and first 25 nucleotides. The sensitivity will remain 
constant till the junction reaches nucleotide 826, where the effect of fragmentation 
starts to appear. From this point onwards the sensitivity will decrease until it reaches 
the 0.3% again at nucleotide 1074. Based on the read and fragment length, the 
forward reads cannot cross any junction located after this position (Figure 3-20, red 
line). The same scenario applies to the reverse reads, but from the other side of the 
amplicon (Figure 3-20, blue line). The first and last 25 nts of the amplicon will 
remain undetectable.  
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Equation 3-4 Mathematical function to calculate ViReMa theoretical sensitivity 
The function is composed of three components; the first calculates the sensitivity if the junction lies in the first 
300 nts of the amplicon. The second component specialises in calculating the sensitivity of the junctions when 
they are located in the middle of the amplicon, and the third calculates the sensitivity for junctions located at the 
last part of the amplicon. The function is plotted in (Figure 3-20 - red line). The forward reads can't span any 
junction after nucleotides 1075 because of the physical restrictions imposed by the fragmentation and the 
closeness to the 3' end. r =  the read length. r1 = The furthest location the forward read can reach is when it starts 
from the 5' end of the amplicon. J = the junction location. S = The seed length. f2 = the furthest location from the 
3’ end  at which the fragmentation process could cut. r and r1 are both 300, but they are referred to as such to 
differentiate between their technical implications, r1 is a distance, r is a length. Jd = the distance from the 
junction location to the 3’ end. 
 
 
Figure 3-20 Diagram shows ViReMa theoretical sensitivity calculated by the function for the whole 
amplicon 
The function (Equation 3-4) created two patterns of sensitivity; one for the forward reads (red line), and the other 
for the reverse reads (blue line). The black circles indicate the major locations the function used to generate the 
sensitivity. X- axis represents the location over the amplicon and the y-axis refers to the theoretical sensitivity 
(%) 
𝑓(𝐽) =
⎩⎪⎨
⎪⎧𝑟 − (𝑟1 − 𝐽𝑑) − 𝑆𝑟 ∗ 100                        𝑖𝑓 𝑆 ≤ 𝐽 ≤ 𝑟1 − 𝑆𝑟 − (2𝑠)𝑟 ∗ 100                                   𝑖𝑓   𝑟1 − 𝑆 ≤ 𝐽 ≤ 𝑓2𝑟 − (𝐽 − 𝑓2) − 𝑆𝑟 ∗ 100   𝑖𝑓 𝑓2 + 𝑆 ≤ 𝐽 ≤ 𝑓2+ (𝑟 − 𝑆)
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3.9  Discussion 
A bioinformatics analysis system was developed to identify the recombinants from a 
co-infection between two serotypes of poliovirus. The major hurdle in analysing the 
NGS datasets that derived from viral recombination pool lies in mapping the reads 
that spanned the recombination junctions of either parental genome. To overcome 
this, the Python application ViReMa (Routh and Johnson, 2014) was used to identify 
recombination junctions within different simulated NGS datasets.  
NGS factors were optimised through data simulation – which would be considered 
later for the sequencing of the real samples - to guarantee high-resolution output that 
allows ViReMa to perform at its best. This includes the number and length of NGS 
reads, the type of NGS sequencing used, and the types of reads whether paired-end 
or single-end. The conditions were decided upon based on the aim and resources of 
this project, and more importantly on the knowledge of recombination occurrence in 
polioviruses. For instance, the region of interest was chosen based on a previous 
study from our lab using an artificial system (termed the CRE-REP assay) to isolate 
recombinants between poliovirus type 1 and type 3 (Lowry et al., 2014). Moreover, 
this region is characterised by being 23% divergent between the two viruses, which 
would facilitate the identification of the actual recombination junctions.  
However, the judgement of the location at which the recombination events occurred 
is highly correlated with the amount and type of mutations that could present in the 
final datasets. Therefore different types and rates of mutations (Figure 3-5) were 
applied onto the datasets (Table 3-1) and ViReMa with different settings (modes - 
Table 3-2) used against each in order to identify the recombination reads. 
Subsequently, the sensitivity and specificity of ViReMa performance was measured 
by the ROC curve (Figure 3-10). These results in the ROC curve were produced 
from three different simulated datasets with different rates of mutations. Nonetheless, 
the analysis in later stages was focused on the datasets that contained 1% mutation, 
as this is the closet one in nature to the dataset produced by the real experiment. The 
other datasets were used for the sake of comparison to improve the analysis pipeline.  
When analysing the results of dataset C (1% mutation) from the ROC curve, it was 
found that the best performance for ViReMa was achieved through the mode N0X5 
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(~64%). This mode does not allow any mismatch to happen either in the seed or in 
the remaining part of the read. Additionally, it does not depend on the length of 
similarities around the junction (‘X parameter’). Even though the ‘X’ is set to 5 in 
this mode, it will be disallowed by adjusting the ‘N parameter’ to 0. On the contrary, 
mode N1X5, which was found to perform slightly better regarding the sensitivity, 
does depend on the similarities around the junction. The reason of this increase in 
sensitivity can be explained by the fact that N1X5 mode allows 1 mismatch when 
aligning the reads. This would lessen the chance of rejecting the recombination read 
based on the presence of mismatch. However, this would happen at the expense of 
specificity; as mode N1X5 depends on the length of similarities around the junction, 
it would report some false positive junctions. Particularly when the algorithm 
encounters a far longer identical stretch than 5 nts, as illustrated in Figure 3-9. 
Because one of the main goals of this study is to understand the molecular 
determinants of recombination, the specificity was favoured and accordingly, mode 
N0X5 was chosen for the rest of the analysis.  
Using ViReMa with mode N0X5 to search recombination reads in a dataset with 1% 
mutation would be able to detect ~64% of the recombination reads (those spanning 
the recombination junction) and ~36% would be undetectable. These 36% reads were 
found to be either reads with mutation within 25 nucleotides of the junction or reads 
that spanned the junction at their first or last 25 nucleotides. In addition to this, a 
small proportion (~0.1%) of reads containing incorrect junctions were reported by 
ViReMa (Type 3, section 3.6.1 and read D, Figure 3-11). These ~0.1% reads were 
scrutinised and found to have a mutation right next to the identical sequence where 
the exact junction had occurred. Consequently, this would cause ViReMa to skip the 
exact junction and report a junction that was separated by an identical sequence from 
the exact one. The ability to detect these reads in the simulated dataset stems from 
that fact that the number of simulated recombinants is limited (three recombinants), 
thus any reported junction apart from the original three is recognisable. However, 
this is not the case in the experimental data as the identity and the number of 
recombinants are not known.  
The mutation that caused the third type of erroneous reads can be inherited from one 
of three possible sources throughout the experiment, either during the virus 
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replication in the cell, during the PCR amplification, or during the sequencing. 
Although with the presence of three sources of mutation, the probability of the 
occurrence of such a mutation is very low based on the mutation rate 5.2*10-4, and 
therefore it can be speculated that this sort of error would not have a drastic effect on 
the specificity.  It can be argued that the mutation may happen at an early cycle 
during the PCR, which might give it a chance to be amplified in the dataset. 
Nonetheless, these mutations should happen near to an identical sequence to be able 
to mislead the ViReMa, and the vast majority of identical sequences between the two 
viruses are of 2 nucleotides long. This means that the shift caused by this mutation 
between the correct and incorrect junctions would not be greater than 3 nucleotides 
for the most part, which can still be considered very close to the correct junction site. 
Therefore, this would not change the sequence composition of the surrounding area 
of the junction, which would be studied as an influential factor for recombination in 
chapter 5.   
Having determined the specificity and sensitivity of ViReMa in finding 
recombination reads, the sensitivity of ViReMa in finding the recombination 
junctions across the whole amplicon was tested. That is, if the recombination 
junctions could occur at every nucleotide in the 1.3kb amplicon, how many of those 
could the ViReMa detect? Using a library containing unique reads of all the possible 
precise and imprecise junctions ViReMa was able to detect 23% of all the precise 
junctions in comparison to ~67% of the imprecise junctions. Although it recognised 
all reads in these dataset as potential recombinants, ViReMa could not report the 
exact location for all the reads as most of them lie within sequences identical in the 
aligned parental genomes. Accordingly, it pushes the location towards the 3’ end of 
the identical sequence as illustrated in Figure 3-18, which can generate a bias 
towards the long identical stretch. The ability of ViReMa to detect more imprecise 
recombinants reads can be explained by the fact that these molecules are imprecise. 
That is, the 5’ and 3’ side of the junction would include sequences from unrelated 
regions in the genomes, thus creating more distinguishable sites. In the real 
experiment, the number of reads of each junction can be considered a reflection of 
the replicative nature of the recombinants. However, this should be analysed 
carefully to differentiate between high representations of reads caused by viable fit 
recombinants, and those caused by systematic bias (see chapter 5). 
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On the other hand, the location of the junction in the amplicon and the NGS read was 
found to be a major player in determining the sensitivity. It was found that the closer 
the junction to the amplicon's termini the less coverage it received (Figure 3-14). 
Based on this, the theoretical sensitivity of ViReMa would decrease as the physical 
space available for the reads to span the junction is limited at the termini (Figure 
3-16). This can be used in the data produced by the real experiment to differentiate 
between rare recombinants occurring in regions unfavourable for recombination 
from those likely underrepresented in the data analysis. 
ViReMa was found to perform efficiently in identifying recombination junctions 
amongst NGS simulated datasets. Although the bioinformatics analysis demonstrated 
here is efficient in detecting recombination junctions in the P2 region of poliovirus, 
with a few modifications it can be accommodated to study recombination in the rest 
of the poliovirus genome and other viruses. 
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4 Poliovirus in vitro intertypic recombination 
4.1  Introduction 
Many recombinants have been isolated and characterised from field samples 
following outbreaks of infection (Dedepsidis et al., 2010, Zhang et al., 2010, Kew et 
al., 2002). Previous studies suggested potential factors that could influence 
recombination such as RNA secondary structure and specific sequence motifs 
(section 1.3.3). Nevertheless, the mechanism by which recombination occurs is still 
poorly understood.  
Recombination is a rare biological event as it occurs at a low frequency within the 
virus population. The frequency of intertypic recombination between poliovirus 
type1 and type3 recombinants was found to from 2*10-4 – 1*10-5 recombinants 
molecules from the total virus progeny (Tolskaya et al., 1983). In contrast, intratypic 
recombination was found to occur 10-100-fold more frequently (Kirkegaard and 
Baltimore, 1986, Lowry et al., 2014). This rarity of recombination coupled with the 
inevitable competition of recombinants with parental viruses has been the major 
difficulty in isolating recombinants from a population after mixed infection.  
Early in vitro studies have largely relied on using viruses possessing different 
selectable markers. The main approach used in these methods is to carry out the co-
infection under permissive conditions with two different parental viruses bearing 
genetic markers such as drug resistance or temperature sensitivity. Those that escape 
the selection process would be recombinants virus (Kirkegaard and Baltimore, 1986). 
Although these methods have largely contributed to the understanding of 
recombination, their success is conditioned by the production of recombinants at a 
higher frequencies than the reversion rate which was found to be 10-3-10-4 (Holland 
et al., 1982). Recently, several methods have been proposed to study recombination 
in a more efficient way. Nonetheless, the vast majority of this study focused on 
intratypic recombination. For example Jarvis & Kirkegaard suggested a system to 
study intratypic recombinants in the absence of genetic selection markers (Jarvis and 
Kirkegaard, 1992). The system they proposed uses PCR-based technique not 
dependent on the viability of recombinants. Furthermore, Runckel et al developed a 
more inclusive experimental system to study intratypic recombination with a higher 
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resolution map, i.e., isolate recombinants from all the genome rather than from a 
particular region. In their method, they have utilised a synthetic poliovirus genome 
(type 1) and next generation sequencing to obtain a wide range of recombinants. 
However, due to the reliance on serial passage, specific PCR, and amplicon size 
selection, the system could detect precise viable recombinants only (Runckel et al., 
2013).  
In an attempt to study intertypic recombination, Lowry et al. have developed a novel 
reverse genetic approach with the parental genomes being incapable of producing 
any viable progeny but recombinants (Lowry et al., 2014). Upon co-transfection into 
permissive cell line the recombination should occur within the region between the 
beginning of VP1 and the CRE to produce a viable recombinant virus. The absence 
of CD155 receptors on the permissive cell would prevent the recovered virus from 
re-infecting new cells. This can be translated into two important features. Firstly, it 
ensures that recombinant viruses are isolated and characterised as near to the 
recombination event as possible. Secondly, as the produced viruses cannot go back to 
the cells; therefore no competition is allowed apart from the one that took place 
inside the cells during the replication. By minimising the selection, the CRE-REP 
allows the isolation of a range of possible recombinant viruses could be recovered 
regardless of their growth advantages.  
The CRE-REP system demonstrated that recombination is a biphasic process in 
which an initial recombinant is followed by a resolution process, deleting insertion 
sequences and optimising virus fitness. The initial recombinants were found to 
contain insertions which were  described as ‘imprecise’ recombinants whereas the 
resolved products were described as ‘precise’ recombinants. Despite the fact that 
only imprecise recombinants with insertions were detectable in the CRE-REP assay, 
recombinants could also theoretically contain deletion as would be discussed later in 
this chapter and the following ones. In this study the same names suggested by 
Lowry et al. were used with little modifications (see section 2.5 ); the recombinants 
with insertion were called ‘imprecise-insertion’, and ‘imprecise-deletion’ if they 
contained a deletion. If no insertion or deletion – relative to the parental genomes - 
were involved they were termed ‘precise’ recombinants (Figure 4-1). Since the CRE-
REP assay involved harvesting virus progeny 24-48 hours post infection and 
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isolating by limit dilution in HeLa cells, it was hypothesized that isolating 
recombinants at an even earlier stage would decrease the selection and allow 
detection of a wider range of recombinants. Therefore, a viability-independent assay 
involving PCR and NGS sequencing was developed in this study to amplify 
intertypic recombinants between wild-type poliovirus type 1 and type 3 in the 
absence of selection pressure. For the sake of comparison the targeted region in this 
study was the same that was targeted by the CRE-REP assay.  
 
 
Aim  
Based on the findings from the CRE-REP assay, the main aim was to develop a more 
natural and inclusive PCR-based screening strategy that a) uses co-infection strategy 
rather than co-transfection, which would allow for the natural virus infection to take 
place, rather than bypassing this by introducing a naked virus RNA into cells b) uses 
wild-type viruses rather than mutants contain non-virus sequence d) can detect 
recombinants regardless of their viability. This was planned with the intention of 
then using this assay as the basis for an NGS study 
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Figure 4-1 Schematic drawing illustrates the types of recombinants (precise, imprecise-deletion, 
imprecise-insertion) 
Intertypic recombination between poliovirus type 1 and type 3 produces two types of recombinants, precise, and 
imprecise. The latter is further divided into imprecise-deletion and imprecise-insertion. The rectangles represent 
the viral genomes while the colours denote the type of the virus. The arrows between the parental genomes 
rectangles represent the RdRp path, if the RdRp switched template as the dotted-line path then imprecise-
deletion would be generated, the solid-line path would generate precise recombinant, and the dashed-line path 
would result in an imprecise-insertion recombinant.   
 
 
4.2 Proposed experimental system  
A replication-dependent experimental method was developed to isolate and analyse 
recombinants 5 hours post infection to minimise the effect of selection pressure. The 
proposed system was based on three essential elements: 
A) Increasing the virus progeny to enhance the opportunities for recombination 
detection. As recombinants exist at a low frequency; increasing the scale of 
the infection increases the absolute number of recombinants in the sample, 
hence the recombinants are more likely e to be detectable.  
B) Optimising the time to harvest the virus progeny in order to detect a wide 
range of recombinants. 
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C) Efficient extraction of the viral RNA in order to enhance recombinants’ 
representation in the samples by preventing any possible loss happening in 
the extraction method.  
One of the biggest challenges was the low frequency at which intertypic 
recombination exists. Increasing the yield of the co-infection experiment was vital in 
bringing the absolute number of recombinants into the detectable range of the PCR 
assay used in this study. To achieve this, four T175 flasks were co-infected in 
parallel at a high multiplicity of infection (10 MOI), the cells were then pooled 
together (7.6*10 7 cells in total), which was followed by RNA extraction, cDNA 
synthesis, and PCR amplification.  
The next step was to optimise the harvest time of virus progeny to ensure the 
detection of the recombinants that were present. Because recombinants can be 
formed as early as 2.5h post infection (Egger and Bienz, 2002) and the virus is 
released from the cells 6h post infection (Kew et al., 2005) it was reasoned that 5h 
post infection would be the peak moment to capture recombinants while they were 
inside the cells. At this stage, the recombinant viruses had a maximum opportunity to 
be formed in the cell before they were released to the media. Additionally, after 5 
hours the virus did not have time to go through another round of infection. Therefore 
the selection pressure was limited to the ability of some recombinants to replicate 
while they were inside the cells. This situation maximised the chance to analyse a 
wide range of recombinants that were present at the time of infection - these can be 
categorised into five different types. 
1. Encapsidated precise recombinants. Some precise recombinants maintaining 
protein-protein compatibility that were capable of being both translated and 
replicated.  
2. Free RNA of precise recombinants. These recombinant molecules - with no 
deletions or insertions - either did not have time to be encapsidated or are of a 
size or junction type that was incompatible with encapsidation.  
3. In-frame imprecise recombinants. These recombinants maintain the open 
reading frame and could carry either deletions or insertions. The 
recombinants with the former would be shorter and most probably would not 
be able to replicate any further as they had lost part of their genome (see 
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section 6.2.3) while the genomes of the latter might be able to replicate and 
resolve into precise recombinants (Lowry et al., 2014).  
4. Out-of-frame imprecise recombinants. These recombinants did not maintain 
the open reading frame and could carry either deletions or insertions. In both 
cases these recombinants could not be translated or replicated.   
Finally, in order to extract the viral RNA without any critical loss that would 
undermine the presence of any of the above-mentioned molecules, an efficient 
concentrating step was required. This was achieved by collecting the pooled cells in 
a minimal amount of media, followed by three freeze-thaw cycles to rupture the 
cells. Subsequently, the cells’ debris was removed, and the supernatant, which 
contained the virus, was filtered. The pooling of virus progeny, from the four large 
flasks, into a minimal amount of media, concentrated the amount of virus in the 
sample. At this time during the infection, the viruses would still be inside the cells, 
and therefore they could be concentrated in the sample by concentrating the cells. 
That is, the cells served as cushions to save the virus from being diluted by the 
media.  
A schematic drawing showing the experimental steps is demonstrated in Figure 4-2. 
Briefly, poliovirus type 1 and type 3 were used to co-infect four T175 flasks at MOI 
of 10 (to ensure that the vast majority of the cells were dually infected (see section 
6.2.1)). The cells were incubated for 30 minutes at 37ºC before the virus was 
removed and the cells were washed with PBS. Fresh media was added and the flasks 
were incubated at 37ºC for 5h. Subsequently, cells were pooled in 2ml of the same 
media to be ruptured by freeze-thaw, the cells’ debris was removed and the 
supernatant containing the viral RNA was filtered through 0.2µm filters. Finally, 
from the filtrate, the RNA was extracted, followed by cDNA synthesis, PCR 
amplification, and sequencing.  
 
4.3 Optimisation of the PCR reaction 
The next step was to optimise the PCR conditions in order to improve the detection 
of recombinants. Before reaching the final optimised PCR protocol, which 
demonstrated a high sensitivity in amplifying a low number of cDNA copies (see 
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section 4.3.2), several elements were examined (Table 4-1). The final PCR protocol 
used throughout this study is described in section 2.2.11. Briefly, Promega PCR 
Master Mix containing Taq DNA polymerase was used in 50µl reactions and the 
PCR thermocycler was set to 40 cycles. Unless otherwise mentioned, the quantity of 
template used was ~0.1-0.3ng in 5µl volume of distilled water, which equalled ~107 
copies of either the plasmids containing the full-length of the viruses or the cDNA. 
The copy number was calculated using an online calculator developed by the 
Genomic & Sequencing Centre of the University of Rhode Island 
(http://cels.uri.edu/gsc/cndna.html).  
Optimising the PCR assay was a crucial step for enhancing detection; optimisation 
included both specificity and sensitivity. The former – in the context of this study - is 
the ability of the primers under certain PCR conditions to specifically amplify 
recombinants from wild-type poliovirus co-infection while the latter is the lowest 
number of cDNA copies the system can detect. Wide ranges of conditions were 
investigated during the optimisation of these PCR reactions. These included different 
primer pairs, different annealing temperatures, and different PCR reactants 
concentrations such as primers, templates and Mg++ (Table 4-1). Additionally, 
emulsion PCR was tested as a potential method to increase the sensitivity and specify 
of recombinants amplification. However, the attempt failed, as this was tried earlier 
in the project on a smaller-scale infection. For the sake of abbreviation and clarity, 
the final optimised conditions were discussed in this chapter.   
4.1.1 Designing specific primers to amplify recombinants  
One of the crucial steps for the experiment was to design primer-pairs specific for 
amplifying the recombinants that resulted from the co-infection experiment without 
any significant cross-reaction with the parental genomes. Since this non-specific 
reaction would produce artefactual products that would look like products from 
recombinants, the presence of these in the PCR product would confound subsequent 
analysis. The region of interest within which recombination was targeted to occur 
was located between the end of the capsid coding region (nucleotide 3235 in the 
poliovirus genome) and the CRE (nucleotide 4548) (Figure 4-3). 
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Initially, the population of recombinants that occurred within the P2 region and 
characterised by involving the dissociation of RdRp from PV1-Mahoney (Donor) 
and re-association to PV3-Leon (Recipient) was investigated; hence it was termed 
‘recP2-RLDM’ (Table 2-3). Hereafter, this abbreviation will be used to refer to this 
recombinants’ population and its corresponding primers pair will be referred to as 
‘primP2-RLDM’ (Table 2-3). The analysis of this population would verify the 
reliability of the current system, which is comparable to what was analysed in the 
CRE-REP assay (Lowry et al., 2014). It was reasoned that if precise and imprecise 
recombinants were successfully detected and analysed from this population then the 
experiment would be considered successful. As a consequence, it could then be 
expanded to encompass different regions and populations. (Note: the words 
‘acceptor’ and ‘recipient’ were used interchangeably in this report to refer to the 
genome on which the RdRp would re-associate.)  
The primer pair primP2-RLDM (PV3-3235F, PV1-4548R, Figure 4-3), which 
generated a product of 1313bp, was carefully designed. To assure the sensitivity and 
enhance the efficiency particular care was given to the 3’ end of the primers as they 
were considered specificity determinant regions (Miura et al., 2005, Onodera, 2007). 
As the two viruses were ~78% similar (within the targeted region) the primers were 
designed with their 3’ end to include as much non-identical nucleotide as possible, 
thereby assuring variant anchoring sites to prevent mispriming.  Additionally, 
priority was given to allow nucleotide C’ or ‘G’ to be encompassed within the 3’ end 
to promote binding. Finally, to avoid the formation of primer-dimers the 3’ ends of 
both of the primers were not complementary. The properties of the final designed 
primers including the melting temperature, the percentage of GC content, and the 
PCR suitability were tested by The PCR Primer Stats software, part of the Sequence 
Manipulation Suite (Stothard, 2000). Several primer pairs were designed and the 
ones that passed all the tests were used in this experiment (Table 2-3).  
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Condition optimised Purpose  Optimisation 
Templates’ concentration  A) This was considered to 
increase the PCR 
products. Increasing the 
number of the DNA 
template copies would 
create more chance for the 
recombinant molecules to 
be amplified. B) On the 
other hand, decreasing the 
template would allow for 
optimisation of the 
sensitivity (see section 
4.3.2). 
In the case of A, this was 
achieved by increasing the 
concentration of the DNA. 
The optimal situation was 
in the appearance of a 
high-intensity band with 
the absence of non-
specific product. As for B, 
this was carried out by 
using a serial dilution to 
determine the sensitivity 
of the detection. 
Primers’ concentration.  This was adjusted in order 
to minimise the primer-
dimer and the non-specific 
reactions. 
This was achieved by 
applying different 
concentrations of the 
primers. The optimal 
situation was the highest 
primer concentration with 
no appearance of the 
primer-dimer.  
Annealing temperature  This was optimised to 
increase the specificity. 
This was achieved by 
using a temperature 
gradient programme in the 
PCR machine. The best 
annealing temperature was 
the one at which the PCR 
reaction produced the 
highest intensity specific 
band with no non-specific 
products (Figure 4-4).    
Elongation time  This was adjusted to be as 
inclusive as possible i.e. 
imprecise recombinants 
with insertion could have 
a chance of being 
amplified. 
This was achieved by 
increasing the elongation 
time without affecting 
either the specificity or 
sensitivity. 
MG2+ This was adjusted to 
optimise the specificity. 
MG2+ can enhance the 
activity of the Taq 
polymerase, which can 
reflect on the specificity. 
Serial dilution of MG2+ 
was used. The optimal 
situation was for the 
specific band to appear 
with no extra non-specific 
products.  
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PCR cycle number  This was optimised to 
allow enough PCR cycles 
to increase the number of 
recombinants without 
producing non-specific 
products. 
This was achieved by 
trying several cycle 
numbers between 30-40. 
Table 4-1 Description of the conditions optimised for the PCR reaction 
 
 
 
 
 
Figure 4-2 Schematic drawing of the virus co-infection experiment 
The co-infection experiment was carried out in four T175 in parallel, and after 5 hours the infected cells were 
pooled together in 2ml media. The pool of the cells was lysed to extract the virus and the debris was discarded. 
The supernatant contained the viruses and the cellular molecules were filtered through 0.2µm filters. The resulted 
2ml filtrate was used for RNA extraction, subsequent RT-PCR and sequencing 
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4.3.1 Optimising the annealing temperature of the specific-recombinants 
primers   
To guarantee the efficient and specific amplification of recombinants, the annealing 
temperature for primP2-RLDM was optimised using a temperature gradients PCR. 
The ideal situation would be the ability of primP2-RLDM to amplify a product of 
1313bp when the PCR template was a recombinant molecule (positive control) and 
no products when the template was either PV1 or PV3 genome (negative control). A 
plasmid that contained a molecular clone of an imprecise-insertion recombinant, 
which contained 249 nts insertion, was used as a PCR template. This was constructed 
by Dr. Jonathon Cook and based on an isolate from the recP2-RLDM found by Lowry 
et al. (henceforward known as construct JC105B). It is worth highlighting that as this 
molecule included 249 extra nucleotides, the expected band would become 1565bp 
rather than 1313bp. 
At the beginning of this project, PCR gradient reactions were performed between 
54.1ºC and 61.1ºC, an example of which is given in Figure 4-4. However, as most of 
the tested primers showed the best performance between 57.1ºC and 60.1ºC, based 
on the intensity of the specific band and the absence of non-specific products, the 
range 57.1ºC to 60.1ºC was used to optimise the primers at a later stage of the 
project. The primP2-RLDM was found to amplify correctly within this range, without 
any non-specific priming on the parental genomes (Figure 4-5). The Primers 
generated a band of the expected size when ~0.3 ng of JC105B DNA was included in 
the reaction, and no products were observed when either full-length PV1 pPV1FLC 
plasmid or PV3 full-length pT7FLC with the same concentration was used as a 
template (henceforth referred to as PV1 and PV3 plasmids). Due to the lack of 
differences in amplification between the temperatures, any of them could be used as 
an optimised annealing temperature. Nevertheless, for the sake of consistency, 
58.1ºC was used for primP2-RLDM throughout this study. This was repeated several 
times before being adopted. 
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4.3.2 Measuring the PCR sensitivity and testing for artefacts using plasmid DNA 
Having determined the annealing temperature, which showed a specific amplification 
for recombinants molecules at 58.1ºC, it was important to test the efficiency and the 
sensitivity using this temperature under the same PCR conditions (see previous 
section). Therefore, three different conditions were analysed: 
1. The presence of artefacts (false positive recombinants). 
2. The sensitivity of the PCR reaction in amplifying recombinants alone. 
3. The sensitivity of the PCR reaction in amplifying recombinants in the 
presence of the parental genome.  
All the above-mentioned cases were optimised by using the PV1, PV3, and JC105B 
plasmids. In the first case, the formation of artefacts was tested. It is known that 
when PCR amplification is carried out using a mixture of two or more non-identical 
but similar genotype target sequences as a template, it can lead to a formation of 
chimeric artifacts by template switching (Lahr and Katz, 2009). This is important, 
because the designed experiment (Figure 4-2) would generate samples contain both 
parental and recombinant genomes. Therefore, the formation of these chimeric 
molecules was possible, which – if occurred - could have underrepresented the 
presence of recombinants formed between the viruses inside the cells. To test this, a 
PCR reaction containing primP2-RLDM with ~0.3ng of an equimolar mixture 
composed of PV1 and PV3 plasmids was prepared as a template.  
The second case, because recombination is a rare event that can exist at a low 
frequency, it was important to measure the analytical sensitivity of the PCR assay i.e. 
the lowest number of DNA copies that the assay could amplify. Determining its 
sensitivity would help in deciding the scale of the experiment later. This was 
measured by carrying out a serial 10-fold dilution of the JC105B plasmid, which 
contained a full-length imprecise-insertion recombination with 249 nts insertion. The 
dilution series – diluted in nuclease free water - started with ~107 copies of JC105B 
and was diluted down to reach ~10 copies at the final dilution.   
The third case was related to the second one, but differed in that it measured the PCR 
assay sensitivity of detecting recombinants in the presence of parental genomes. The 
importance of this stems from the fact that the primers could be used up by binding 
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to one of the parental genomes before reaching the targeted recombinants. Thus, 
adjusting the quantity and the specificity of the primers was crucial in this context. 
This was tested by spiking a mix of ~107 copies of each of the two parental virus 
plasmids with each of the dilutions in the JC105B dilution series. 
The prepared samples of all of the cases above were PCR amplified in parallel under 
the same conditions (see previous sectionS). When a mixture of both viruses was 
used as a template, no PCR product was observed, which showed that no artefacts 
were detected (Figure 4-6 A). On the contrary, a band of the expected size was 
formed when the template used was JC105B (Figure 4-6 B, ‘+’), which confirmed 
that the absence of artefacts in the previous sample was not due to a technical error.  
When the concentration of the template was serially diluted, the PCR assay 
demonstrated high sensitivity as it could detect down to ~10 copies of the DNA 
(Figure 4-6, B). The intensity of the bands started to decrease gradually when ~1000 
copies of DNA were used as a template, and was barely seen with ~10 DNA copies. 
However, the fact that the band could still be seen on the gel suggested a successful 
detection. Comparably, when JC105B was spiked into a fixed concentration of 
parental viruses DNA, the PCR assay could detect down to the presence of 100 DNA 
copies (Figure 4-6, C). This suggested a 10-fold decrease in the PCR sensitivity of 
detection in the presence of parental viruses. In both cases, small visible bands could 
be observed at the bottom of the gel. These could be clearly seen when ~104 copies 
of DNA were used as a template and their intensity increased with the decrease of 
the templates’ copy number (Figure 4-6, B & C). Based on their small size (below 
the smallest band in the ladder) these bands could have possibly resulted from excess 
primers left over after the PCR amplification. Additionally, they did not appear when 
the DNA copy number was higher than ~104 copies. The rationale is that the primer 
concentration had become higher than the targeted template concentration. On the 
other hand, the fact that artefacts did not appear on the gel did not rule out their 
presence at <10 copies. Nevertheless, this could be tackled during the NGS analysis 
by running a control sample that contained a mixture of both viruses (see section 5.4 
). 
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Figure 4-3 Poliovirus genome map with the PCR targeted regions indicated  
Two possible recombinants genomes are illustrated to highlight the locations of the targeted regions considered in 
this project. The grey colour refers to the PV3 genome and the white colour to the PV1. The dashed line denotes 
the region of interest. The small arrows represent the primers with their 3’ position indicated. The black, blue, 
and red lines at the bottom refer to the P1, P2, and P3 regions of polioviruses genome respectively. The non-
translated regions are represented by NTR. The CRE and the coding regions are indicated. A) Example 
recombinant demonstrates the primP2-RLDM. B) Example recombinant demonstrates the primP3-RLDM. The 
locations were located on the genome drawings using poliovirus complete genome with NCBI Reference 
Sequence: NC_002058.3. The CRE extends from nucleotide 4435 to 4495 based on the PV3 genome 
(Goodfellow et al., 2000)  
 
 
 
 
 
 
Figure 4-4 An example of PCR annealing temperature optimisation 
The figure shows an optimisation of the annealing temperature using another pair of primers than primP2-RLDM 
earlier on in the project. The amplicons in the figure belong to the construct JC105B amplified with a pair of 
primers that produced a product of ~1100bp. However, as JC105B contains an insertion of 249 nts, the bands 
appear at the size of ~1349bp. The triangle refers to a gradual increase in the annealing temperature. The black 
arrow shows the lane that corresponds to the optimal amplification where the band intensity is the highest in the 
absence of the non-specific band. Most of the tested primers showed their best performance between 57.1ºC and 
60.1ºC (the black horizontal line). Therefore this range was adopted for the rest of the optimizations carried out 
throughout the project. 
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Figure 4-5 The specificity of the detection at different annealing temperature using primP2-RLDM (primers 
within the P2 region) 
The construct JC105B and the plasmids of the parental viruses were amplified individually using primP2-RLDM at 
different annealing temperatures starting from 57ºC to 60.1ºC. The PCR products run on 1% agarose gel and 
were stained with ethidium bromide. The triangle refers to a gradual increase in the annealing temperature. When 
JC105B was used as a template, the band of the expected size was observed in all the considered annealing 
temperatures (the gel on the top). When either PV1 (the gel in the middle) or PV3 (the gel at the bottom) were 
used as templates no products were observed at any annealing temperature. The red rectangle indicates the lane 
where the annealing temperature was set to 58.1, the one that was chosen to be used throughout this project.  
 
 
 
Figure 4-6 Sensitivity and artefacts optimisation of PCR with primP2-RLDM (primers within the P2 region) 
Products from PCR reactions were separated by agarose gel electrophoresis, stained with ethidium bromide, 
visualised on a transillluminator and photographed. (A) Shows negative control, a mixture of PV1 and PV3 
plasmids, (B) shows PCR products amplified from the JC105B dilutions and C) shows PCR products from 
JC105B dilutions spiked into a fixed concentration of parental viruses. The sign + represents the line of the 
positive control, before starting the dilution. The amplification of the JC105B in the ‘+’ lane is the same 
amplification of the first dilution in the series, hence it appears in one lane. 
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4.3.3 cDNA synthesis sensitivity 
Based on the PCR sensitivity results, the samples generated by the co-infection 
experiment (Figure 4-2) should contain at least 100 recombinant molecules to be 
detected in the PCR assay in the presence of parental genomes. However, as these 
samples would contain RNA, which had to be reverse transcribed into cDNA before 
PCR amplified, the sensitivity of cDNA synthesis should be at the same level or 
higher so as to synthesise enough cDNA to be detectable by the PCR reactions. Thus, 
it was important to measure the cDNA synthesis sensitivity. The detection sensitivity 
of the cDNA synthesis was performed at an early stage in the project by using the 
PV3 full-length pT7FLC. The plasmid was linearized with SalI, followed by RNA 
transcription using T7 polymerase. The resulting reactions that contained RNA were 
DNAse treated by TURBO DNAse to remove any residual cDNA. Subsequently, the 
RNA was diluted in serial 10-fold increments starting from ~5*105 RNA copies 
moving down to ~5 RNA copies, and cDNA was synthesised using Superscript III 
Reverse Transcriptase (RT) and oligo dT primers (see section 2.2.9). Eventually, 5µl 
of the resulted cDNA were PCR amplified using PV3-specific primers (PV3-3235F 
and PV3-4521R) that generated a product of 1.3kb (Table 2-3).  
When the plasmid was omitted from the RNA transcription reaction (negative 
control), the PCR amplification did not produce any product that reflected the 
absence of contamination (Figure 4-7, A). On the other hand, the PCR amplification 
demonstrated a high sensitivity by being able to detect as low as ~5 copies of cDNA 
synthesised using RT (Figure 4-7, B). This means that the cDNA synthesis reaction 
could reverse transcribe down to ~5 copies of RNA. To rule out that these products 
resulted from amplifying leftover DNA from the RNA transcription reaction, a 
negative (no-Reverse Transcriptase) reaction was considered for each dilution from 
5*105 to 5 DNA copies (Figure 4-7, C). Clearly, no bands of the expected size were 
observed. This, together with the fact that DNAse treatment was carried out, 
confirms that PCR products of the dilution series samples resulted from RNA that 
had been reverse transcribed (Figure 4-7, B). Finally, the small visible bands 
observed at the bottom of the gel most probably represented leftover reactants.  
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4.3.4 Quantitative estimation of the recombinants generated by the experiment 
One of the key issues in the proposed method was to generate a sufficient amount of 
recombinants within the detectable limit of the subsequent cDNA synthesis and the 
PCR amplification. Based on the sensitivity results (see sections 4.3.1, 4.3.2), which 
demonstrated that the PCR assay could detect down to 100 recombinant copies in the 
presence of parental viruses, a large-scale experiment was decided to ensure 
obtaining more than 100 recombinants in the final samples. This section explains the 
basic calculations used to estimate the number of recombinants molecules in the 
samples. 
Four T175 flasks, each containing 18.6*106 cells, were co-infected with poliovirus 
type 1 and type 3. To assure that the vast majority of the cells would be infected with 
at least two viruses the infection was carried out at MOI of 10 using 0.2ml of each 
parental virus stock with concentration of 109 Plaque Forming Unit (PFU)/ml (0.2 * 
109 / 18.6 * 106  = ~ 10 MOI), which means that there were 109 PFU * 0.2ml = ~ 
2*108 viruses from each type. In four flasks there were (2 * 108 * 2) * 4 = 1.6 * 109 
viruses from both types. After five hours, as measured by the plaque assay, the virus 
titer would increase by around ~ 4 logs (Figure 4-8), which translates into 1.6 * 1013 
viruses. These viruses were then collected in 2ml media, in which – based on the 
recombination ration 1/100000 - the number of recombinants was estimated to be 1.6 
* 108.  From this, only 140µl was used to extract the viral RNA, which means the 
number of recombinants would become 1.1 * 10 7.  In 40µg total RNA extracted, the 
recombinants would constitute 0.1ng from the total. From the total RNA, 3µg was 
used to synthesize the cDNA, which would have 4000 copies of recombinants. The 
copy number was calculated by the previously mentioned calculator 
(http://cels.uri.edu/gsc/cndna.html). However the calculation above was based on the 
assumption that no loss happened during the collecting and the extracting steps.  
Because it is hard – within the context of this project – to be certain of how many 
particles were infectious, or how many recombinants were losses, or how many 
particles invaded each cell this was not explored any further.   
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Figure 4-7 cDNA synthesis sensitivity (primP2-RLDM)  
Products from PCR reactions were separated by agarose gel electrophoresis, stained with ethidium bromide, 
visualised on a transilluminator and photographed. PV3 full-length pT7FLC was used with PV3-specific primers 
A) Negative (no-plasmid) control. B) PCR amplification of the RNA dilutions that had reverse transcribed. C) 
PCR amplification of the negative (no-RT) reactions. 
 
 
Figure 4-8 Single-step growth analysis over 12 hours of parental viruses 
Comparison between the growth characteristics of parental viruses (PV3 and PV1) was measured by the plaque 
assay. The y-axis refers to the virus titer (pfu/ml) and the x-axis to time post infection.   
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4.4 Amplification and Sanger sequencing of the recombinant amplicons 
4.4.1 Amplification of recombinants within the P2 region of the virus (recP2-
RLDM)  
The next step was to amplify, sequence and analyse the recP2-RLDM which resulted 
from the co-infection of HeLa cells with wild-type poliovirus type 1 and type 3  
(Figure 4-2). The four T175 flasks, in which HeLa cells were co-infected with both 
viruses, were pooled together in 2ml media (co-infection-sample), the viral RNA was 
then extracted, and the cDNA was synthesised using Superscript III and oligo dT 
primers, followed by PCR amplification. In addition to that, two “no co-infection” 
control samples (PV1-sample and PV3-sample), where HeLa cells were infected 
with each virus in separate cultures, and one mock infection control (mock-sample) 
were generated in the same way. In order to verify the recombination products, three 
different controls were analysed in parallel.  
Firstly, to test if the infection experiment and PCR amplification had worked as 
expected, PV1-specific and PV3-specific primers (Table 2-3) were used to amplify 
cDNA from PV1-sample and PV3-sample respectively (Figure 4-9, A, lane 1 & 2).  
Products of the expected size (1.3kb) were observed, which indicated that PV1 and 
PV3 viruses existed and the targeted genomes were successfully amplified. The 
identity of each product was further verified by Sanger sequencing to ensure that 
they were not derived from the same virus (data not shown). 
Secondly, to verify the absence of the artefacts an equimolar mixture of viral RNA 
was prepared and used to make the cDNA. Subsequently the cDNA of the mixture 
was used as a template in a PCR reaction using primP2-RLDM (Figure 4-9, A, lane 
3). In agreement with the optimisation results (Figure 4-6), no products of any size 
could be seen, which ensured the absence of artefacts. It was important in this control 
to mix the viruses before synthesising the cDNA, as there was a possibility that 
during the cDNA synthesis, rather than during the PCR reaction, artefacts could have 
formed. 
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Thirdly, PV3-specific and PV1-specific primers were used to verify the presence of 
both viruses in the co-infection-sample (Figure 4-9, B, lane 4 & 5). The appearance 
of both products with the expected size proved that both viruses existed in the sample 
and took part in the infection. Eventually, primP2-RLDM was used to amplify 
recombinants in the co-infection sample. (Figure 4-9, B, lane 6). A band of the 
expected size with low intensity was observed. Depending on the control results, this 
band was interpreted as representing one ore more recombination products. To test 
whether the amplification of recombinants from this sample was reproducible, 
another cDNA were synthesised from the co-infection-sample, PCR amplified, and 
run simultaneously on the gel (Figure 4-9, B, lane 7); here the same product was 
observed. To further analyse these products, the camera was zoomed-in and the gel 
was photographed again (Figure 4-9, C, lane 6’& 7’). This revealed an extra ~1kb 
band with a smear above and below the major band, which seemed to be a reflection 
of imprecise recombinants (deletion and insertion).  
4.4.2 Increasing the yield of recombinants’ amplicons within the P2 region 
by pooling 8 PCR reactions  
To this end, as the main aim of this study was to identify and characterise 
recombinants by next-generation sequencing, it was necessary to confirm the 
recombination products in Figure 4-9 by cloning and Sanger sequencing. The main 
goal of this was to test whether the amplified recombinants were derived from a 
diverse recombination population, thus eliminating the possibility of ending up 
sequencing one or two amplified molecules. 
The first preparation step was to increase the yield of amplified recombinants, which 
would provide a sufficient amount to guarantee an efficient cloning and subsequent 
sequencings. To do this, 8 PCR reactions using the cDNA from the co-infection-
sample were performed in parallel, in which primP2-RLDM were used to amplify 
recP2-RLDM. After amplification, all the reactions were pooled in one tube and 
treated as one sample, the PCR products were purified and separated by agarose gel. 
Concurrently, two control samples were considered and prepared in the same way. 
The first one was to test for any contamination that may have developed during the 
process; the mock-sample was used for this purpose (Figure 4-10, lane 1). The 
second was to test for any artefacts formation; as the scale of the PCR reaction was 
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enlarged, thus it was more likely to see artefacts than in the case of one PCR reaction 
if there were any (Figure 4-10, lane 2). Nevertheless, neither artefacts nor 
contamination were observed. On the contrary, a band with high intensity of the 
expected size was observed in the co-infection-sample (Figure 4-10, lane 3), 
indicating that recombinants were successfully amplified with a high yield.  
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Figure 4-9 Recombinants amplification within the region of P2 (recP2-RMDL) from the Co-infection sample  
The viral RNA - extracted from the PV1-sample, PV3-sample, and the co-infection-sample – was cDNA 
synthesised and amplified with different primers before running on 1% agarose gel and being stained with 
ethidium bromide. The ‘Primers’ in the table above the gel refers to the primer pairs used while the ‘Templates’ 
indicates the cDNA used. Mix = RNA mixture of both viruses used to synthesise the cDNA, which then 
amplified A) Control reactions were used to confirm the absence of any cross-reactivity, and to ensure that the 
infection had worked. B) Different primers were used to amplify the cDNA from the co-infection-samples C) 
Zoom in on Lane 6 and 7 to show the presence of an extra band and smears within the recombination PCR 
products.  
 
 
 
  
Figure 4-10 Increasing the yield of recP2-RMDL by pooling 8 PCR reactions 
To increase the yield of the PCR amplification, the products of 8 reactions were pooled in one tube, purified and 
then screened on agarose gel, stained with ethidium bromide and photographed. Lane 1 and 2 are negative 
controls. Lane 3 is the co-infection sample. 
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4.4.3 Cloning and Sanger sequencing of recombinants within the P2 region 
(recP2-RLDM) 
From the recombinants products on the gel (Figure 4-10), three separate regions were 
excised, purified, and cloned into pGEM-T Easy Vector separately. The region above 
the major band was named ‘insertion’ indicating the imprecise-insertion 
recombinants. The region of the major band (1.3kb) was named ‘precise’, signifying 
precise recombinants with no insertion or deletion. The region below the major band 
was named deletion representing the imprecise-deletion recombinants (Figure 4-11 
A). The cloned vectors of the three regions were transformed into competent 
Escherichia coli, plated onto the LB agar plate and incubated overnight at 37ºC. The 
next day, several clones from each region were picked, lysed in distilled water, PCR 
amplified using primP2-RLDM, and photographed. This process was repeated several 
times to pick as many colonies as the time allowed.  
Several clones were successfully isolated from the ‘precise’ and ‘deletion’ regions. 
In contrast, successful cloning and amplification was limited regarding the 
‘insertion’ region, possibly due to the length of recombinants in this region, which 
might lessen the efficiency of cloning. This could explain the fact that the only 
successfully isolated clone with insertion had only 2 extra nucleotides. Examples of 
the clones that were successfully amplified from the three regions are shown in 
Figure 4-11 B. The insertion and precise products appeared to be the same length 
(Figure 4-11, lane 2’and 3’), as they only differed by 2 nucleotides and were both 
clearly shorter than the control JC105B. Right to the ladder, the shorter band (~700 
nts) reflected a recombinant that had lost part of its genome (Figure 4-11, lane 4’). 
These PCR amplicons, in addition to another 12 amplicons, were prepared for Sanger 
sequencing (see section 2.2.7) and sequenced by the University of Warwick 
Genomics Facility.  
The resulted sequences were analysed by ViReMa – the algorithm described in 
section 3.5  – to detect the junction locations and were then visualised on the Parallel 
Coordinates, a visualisation tool (see section 2.8.14) that was developed for this 
purpose (Figure 4-12). The lines within the map show the connection between the 
location from where the RdRp had disassociated from the donor and re-associated to 
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the acceptor. The lines are horizontal (slop = 0) if the recombinants did not contain 
any insertion or deletion. 
From the 15 analysed recombinants, 11 were precise recombinants with 6 unique 
recombination junctions, as some of them were found in multiple copies. Precise 
recombinants are, by definition, in-frame; therefore all of these recombinants were 
represented by horizontal blue lines (slope = 0). However, if insertion or deletion 
was involved, the slope would change, unless the inserted or deleted fragments were 
~10 nts length, in which case the line would appear horizontal as with the precise 
recombinant line. In fact, this is the case of the isolated imprecise-insertion 
recombinant, which contains insertion with 2 nts length (the line is marked with a 
star in Figure 4-12). Although the line looks horizontal in the map its colour is red, 
which makes it easier to tell that it is not precise. If the length of the insertion 
fragment increased, the lines’ slope would then increase; as a result, the lines would 
point up towards the 3’ end of the recipient genome. On the contrary, the lines would 
point down towards the 5’ end of the recipient genome if the recombinants had part 
of their genomes deleted. This was the case for the three analysed imprecise-deletion 
recombinants, two of which were found to occur within the 2C-coding region, and 
one within the 2A-coding region. 
Interestingly, the lengths of deleted fragments were found to vary. For example the 
in-frame imprecise-deletion recombinant occurred at the 2C-encoding region in the 
donor strand that had resulted from the RdRp switching to the 2A-encoding region in 
the recipient strand. This was represented by a fragment of ~1100 nts length being 
deleted from the recombinant sequence and, thus, represented by a line being pointed 
down towards the 5’ end of the acceptor (negative slope). However, the slope was 
increased for the line which represents imprecise-deletion recombinants occurring 
between the 2A- and VP1-encoding regions as the deleted fragment length decreased 
to ~89 nts (Figure 4-12). These findings show that the isolated recombinants were 
diverse and suggest that they were not derived from over-amplification of one 
recombinant molecule.  
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Figure 4-11 Gel extraction of the PCR products that corresponded to precise and imprecise recombination 
within the P2 region (recP2-RLDM) 
A) A pool of 8 PCR products was amplified by primP2-RLDM run on 1% agarose gel and stained with ethidium 
bromide. Mock-sample and Mix are negative controls. The red rectangles demonstrate the regions that were 
excised from the gel for the cloning step, while the blue arrows indicate the names (types) of recombination of 
each region. B) PCR products of three colonies amplified by primP2-RLDM represent precise and imprecise 
recombinants. Lane 1’ is the amplification product of JC105B (positive control).  
 
 
Figure 4-12 Parallel Coordinates map of recombinants amplified from the P2 region (recP2-RLDM) 
The amplified recombinants were cloned, sequenced, and analysed by the algorithm ViReMa (see section 3.5). 
The detected junction locations were visualized using the Parallel Coordinates tool, which was developed for this 
project. The PV1 genome (the donor strand) is in white on the left side. The recipient genome is on the right side. 
The genomes are represented by cartoon drawings referring to the regions of interest (within the P2 region) with 
the coding regions indicated. The lines between the genomes represent recombinants and connect between the 
junction locations in both genomes. The red lines denote out-of-frame recombinants, and blue lines indicate in-
frame recombinants. The slope of the line reflects the size of inserted or deleted fragments, while the direction of 
the line refers to the type of recombinants (horizontal line = precise, negative-slope line = deletion, positive-slope 
line = insertion). The 10 analysed recombinants from recP2-RLDM are demonstrated. The star highlights the 
imprecise-insertion recombinant. 
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4.4.4 Amplification of the reciprocal recombinants’ population within the P2 
region (recP2-RMDL) 
The analysis results of recP2-RLDM populations made it worth expanding the search 
for other recombinants populations. From the same P2 region, recombinants that 
happened in the opposite direction (reciprocal) were analysed. In this population, the 
PV3 virus would become the donor and the PV1 the recipient, hence the name 
(recP2-RMDL). The primers used to amplify this recombinant population were 
designed from the same area in the genome (PV1-3241F and PV3-4521R and Table 
2-3). Using the same annealing temperature (58.1ºC) and the same PCR conditions, 
the primers worked successfully in amplifying the recombinants without any 
evidence of artefacts when tested with the RNA mixture of both viruses (Figure 4-13 
A). 
The same strategy was used to analyse this population. The primers were used to 
amplify 8 PCR reactions in parallel. Subsequently, they were pooled in one tube, 
separated by agarose gel, cloned into pGEM-T Easy Vector, sequenced, and 
visualised on the Parallel Coordinates (Figure 4-13 B). From the total of 7 
recombinants sequenced, 6 were precise recombinants with 5 unique junctions. The 
remaining recombinant was imprecise-deletion out-of-frame with ~20 nts deletion. 
Of the five recombinants, two were found in the 2C-coding region, two in the 2B-
coding region, and one in the 2A-coding region. On the other hand the imprecise-
deletion was located at the beginning of the 2C-coding region. No colonies were 
isolated containing plasmids carrying imprecise-insertion recombinants. 
 
 
 
 
 
129 
 
Figure 4-13 recP2-RMDL; recombinants’ population (Reciprocal population)  
A) PCR products amplified with primP2-RMDL, screened on 1% agarose gel, and stained with ethidium bromide. 
Mix = cDNA from RNA mixture of both viruses. B) Parallel Coordinates visualisation of recombinants isolated 
from recP2-RLDM population.  
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4.4.5 Amplification of the recombinant populations within the P2-P3 region 
(recP3-RLDM and recP3-RMDL) 
After succeeding in isolating several different recombinants from the P2 region, the 
search process was further expanded to the region downstream of the CRE until the 
first part of the 3C-coding region, which encompasses the 3A- and the 3B-coding 
sequences from the P3 region in the genome (Figure 4-3 B). Therefore the P2 was 
replaced by P3 in the names. Primers for recombinants populations were designed in 
the same way in the P2 region (see section 4.1.1); the populations of the two possible 
directions (recP3-RLDM & recP3-RMDL) were targeted. When testing the designed 
premiers (PV3-4552F - PV15610R & PV1-4579F - PV3-5647R, Table 2-3) on the 
co-infection sample, a product of the expected size (~1.1kb) was observed for both 
directions (Figure 4-14, lane 2, 4), which suggested that recombination occurred in 
this region of the genome. Nonetheless, when using an equimolar mixture of viral 
RNA as a control, a band of the expected size was observed (Figure 4-14, lane 1, 3), 
which indicated a non-specific priming event had taken place in the reaction. 
Additionally, an extra smaller band was observed in the mixture reaction (~250 nts) 
using primP3-RMDL (Figure 4-14, lane 1 with red rectangle). Sequencing these 
products revealed that they were derived from either PV3 or PV1 genomes, which 
suggested a mispriming event rather than a formation of artefacts. Probably, this non-
specific priming happened because of the high similarities in this region (~85%) 
represented by long identical stretches (~25-30 nts) between the two genomes at this 
part of the genome. 
Having a defined recombinant construct (JC105B) in hand helped to optimise the 
primers for the P2 region. However, this was not the case for this region of the 
genome, as no such a recombinant control was available to optimise the reaction. 
Therefore, advantage was taken of the co-infection-sample, which was used as a 
positive control. The yield of amplifying the viral RNA mixture of both parents by 
primP3-RMDL and primP3-RLDM (Figure 4-14, Lane1 & 3) appeared to be lower than 
the yield of the PCR products which resulted from amplifying the co-infection-
sample with the same primers (Figure 4-14, Lane2 & 4). This observation is 
evidence that both specific and non-specific priming happened in the co-infection-
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sample. Accordingly, the annealing temperature was increased by one degree to be 
59.1ºC and 8 PCR amplifications were performed again and screened on agarose gel. 
It was reasoned that increasing the annealing temperature would decrease the non-
specific priming within the co-infection-sample and provide purer recombinants 
amplicons for cloning. Increasing the annealing temperature had, in fact, succeeded 
in lowering the amount of the non-specific products (Figure 4-15 A).  
 
 
Figure 4-14 Optimisation of recombinants’ amplification within the P2-P3 region (recP3-RMDL and recP3-
RLDM ) 
PCR products were amplified with primP3-RMDL and primP3-RLDM at 58.1ºC annealing temperature, separated 
by 1% agarose gel, and stained with ethidium bromide. Mixture = cDNA from RNA mixture of both viruses. The 
red rectangle highlights the lane where more than one non-specific product was observed. The products in lane 1 
and 3 represent non-specific products which resulted from amplifying the viral RNA mixture. The remaining 
lanes represent amplification from the co-infection-sample. The lines above the gel categorise the lanes into their 
corresponding population. 
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Figure 4-15  Amplification of recombinants within the P2-P3 region (recP3-RMDL and recP3-RLDM) 
A) PCR products amplified with primP3-RMDL and primP3-RLDM at 59.1ºC annealing temperature, run on 1% 
agarose gel, and stained with ethidium bromide. Mix = cDNA from RNA mixture of both viruses. B) Parallel 
Coordinates visualization of recombinants which wer amplified from the recP3-RLDM. The left line above the gel 
categorises the lanes where primP3-RMDL was used. The right line is categorising the lanes wherein primP3-
RLDM was used and correlating them to the Parallel Coordinates visualisation map.  
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Although non-specific bands were observed at the bottom of the gel (Figure 4-15 A), 
the recombinants amplicons of the expected size was now much clearer for analysis. 
These small products could have been formed due to a cross reaction between the 
primers (cross-dimers), which is likely to have happened in this part of the genome 
where the similarity is high. Nevertheless, these products were removed when 
preparing the samples for NGS.  
As the time started to become very limited, only three molecules from recP3-RLDM 
were cloned and sequenced to verify the presence of recombinants in this region. Of 
those, two unique precise junctions were identified at the end of region encoding 3A 
protein (Figure 4-15 B).  
 
4.5 Preparing samples for next generation sequencing (NGS) 
Based on the success in identifying recombinants from different locations and of 
different types, the use of next-generation sequencing was valid and justified to 
identify a wider range of recombinants. In order to achieve this, 7 major samples 
were prepared by purifying the recombinants amplicons and sent off to GATC Ltd. 
(www.gatc-biotech.com)  for sequencing by Illumina MiSeq. Four of them 
represented the four recombinants’ populations described in this chapter, and two 
samples were negative controls composed of viral RNA mixture treated with the 
same primers used to amplify the co-infection. The remaining sample was a known 
concentration of recombinant JC105B spiked into known concentrations of the 
parental viruses to establish a method to quantify recombinants based on the NGS 
reads.    
All the samples were prepared to meet the requirements of the company, in terms of 
quantity and quality. The agreement was to fragment the amplicons in each sample 
(~1.3kb & ~1kb) into ~550 nts and sequence them with 300 nts paired-end reads by 
Illumina technology. The company guaranteed the feasibility of the project, and 
assured us that they would provide us with high-quality results.  
Unfortunately, after receiving the samples, the company – after much further delay – 
came back to us indicating that they could not complete the sequencing due to the 
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way the samples had been prepared. GATC Ltd. subsequently admitted liability for 
providing incorrect information and for destroying the material submitted to them. 
As the time had become very narrow, the only solution was to repeat the experiment 
or part of it in order to generate the NGS dataset. My supervisor Professor David 
Evans contacted Dr. Andrew Macadam at National Institute for Biological Standards 
and Control (NIBSC) and arranged a two-week visit for me to Macadam’s lab to 
repeat this work, the results of which are discussed in the next chapter. 
 
. 
4.6 Discussion 
An experimental system involving large-scale infection and PCR amplification was 
optimised and successfully used to amplify and characterise poliovirus intertypic 
recombinants. Different recombinant populations were amplified from two different 
regions in the genome. The first region extended from the end of the VP1-coding 
sequence to the CRE, thereby including the last part of the P1 region and the first 
part of the P2 region (Figure 4-3 A). The second region was located downstream of 
the CRE, encompassing the last part of the P2 region and the first part of P3 region 
(Figure 4-3 B). The two possible reciprocal occurrences of recombination were 
studied from both regions (recP2-RMDL, recP2-RLDM, recP3-RLDM, and, recP3-
RMDL).  
Different recombinants of different types were isolated from both regions. Within the     
recP2-RLDM, 6 different unique precise recombinants were detected. Moreover, 4 
different unique imprecise recombinants were found. Three of these were imprecise-
deletion recombinants and one was imprecise-insertion. The deleted fragments, 
among the imprecise-deletion molecules, were found to be varied in their lengths 
between ~20 – 1100 nts. Interestingly, the imprecise-deletion recombinant with 
~1100 nts deletion was found to be in-frame while the remaining 3 imprecise 
recombinants were all out-of-frame. No correlation, however, was noticed between 
the location (either on the acceptor or the donor), the type of recombinants (precise 
or imprecise), and the maintenance of reading frame  (in-frame or out-of-frame). 
This was reflected by the absence of clustering of any of these features in one or near 
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one region in the genome, rather recombinants seemed to be distributed randomly, 
though it is acknowledged that the sample size was too small to conduct any 
statistical analysis of this. Furthermore, the ratio of imprecise recombinants was 
found to be 1 molecule in-frame to 4 out-of-frame, which when compared to the 
random expected ratio (1:3) based on the multiple of 3 codon, did not show a 
significant difference (Chi-Square P = 0.1). These findings suggested that 
recombination is a random event at this stage of infection. In contrast, the same 
recP2-RLDM was studied by Tolskaya E.A.et al., who concluded that the distribution 
is nonrandom within this region of the genome (Tolskaya et al., 1987). They 
suggested that there is a selection against the coding sequence of polypeptide 2A and 
in favour of the 2B-coding region. In fact, looking at Figure 4-12, there seems to be 
more recombinants within the 2B-coding region and less within the sequence of the 
polypeptide 2A. Nonetheless, as only few a recombinants were analyzed, this was 
further analyzed in the next chapter where several hundreds of recombinants were 
obtained. 
Similarly, imprecise and precise recombinants were also successfully analysed from 
the recP2-RMDL (the reciprocal population). Less recombinants were isolated due to 
the time limitation, from those, 5 recombinants were found to be precise, and one 
imprecise-deletion recombinant with 20 nts deletion (Figure 4-13). No special 
clustering was observed; rather recombinants were detected within all the coding 
regions except the VP1-coding region. The lack of recombination occurrences within 
the VP1-coding sequence was also observed in the recP2-RLDM (Figure 4-12). This 
region is part of the capsid region where recombination had rarely been observed to 
occur (Cao et al., 1993). This stems from the fact that the capsid sequences are the 
most divergent region between the two viruses used in this study, and folding of 
capsid polypeptides are extremely sensitive to the change of amino acid sequence  
(Murray et al., 1988a). At this stage, it was thought that this underrepresentation at 
the VP1-coding region was perhaps due to the small number of analysed 
recombinants. Nonetheless, this appeared not to be case when the analysis involved a 
greater number of recombinants (see the next chapter). 
Intriguingly, the PCR products of recombinants that have their 5’ part derived from 
PV1   (recP2-RMDL) were found to be higher than when the 5’ part derived from PV3 
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(recP2-RLDM). This can be seen by the more intense band, which resulted from the 
former in comparison to the latter (Figure 4-16). This could be explained by the 
copy-choice mechanism, which is widely regarded as being operative in poliovirus 
(Kirkegaard and Baltimore, 1986, Lowry et al., 2014). If the cells were co-infected 
with wild-type viruses that replicated at the same rate, the probability of switching in 
either reciprocal sense should also be the same. However, the PV3 virus used in this 
experiment was found to be ~1 log slower than the PV1 in the growth kinetics curve 
(Figure 4-8), which made the PV1 viruses more available to act as acceptors. 
Therefore the frequency (reflected by the thickness and intensity of the band on 1% 
agarose gel) of recP2-RLDM was found to be lower than recP2-RMDL. The results are 
consistent with findings by Jarvis and Kirkegaard, who suggested a correlation 
between recombination events and the replication activity of the recipient genome 
(Jarvis and Kirkegaard, 1992). Moreover, this was also observed among recP3-RLDM 
and recP3-RMDL (Figure 4-14 and Figure 4-15). Nonetheless, it was not as clear as 
the P2 region, which could be down to the presence of the nonspecific products. 
Unfortunately, because of the time restrictions, this was not investigated any further. 
On the other hand, precise recombinants were found to be predominant within the 
analysed populations, i.e. they occurred at much higher frequency than the imprecise. 
The ratio of precise to imprecise within recP2-RLDM was 11/4 while it was 6/1 within 
recP2-RMDL and 3/0 in the recP3-RLDM. The apparent preponderance of precise 
recombinants was reported in several previous studies (Romanova et al., 1986, 
Kirkegaard and Baltimore, 1986, King, 1988). The explanation of such an 
observation may be the selective advantage of the precise recombinants, based on the 
fact that they possess the same genome length of the parental viruses, hence they 
may replicate faster than the imprecise. Alternatively, it could be speculated that the 
high number of precise recombinants may have resulted from a resolution process of 
early imprecise recombinants (see section 6.2.3). 
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Figure 4-16 Comparison between the two possible reciprocal populations within the P2 region (recP2-
RMDL & recP2-RLDM).  
PCR products amplified with primP2-RLDM (lane 1, 2) and primP2-RMDL, screened on 1% agarose gel, and 
stained with ethidium bromide. Mix = cDNA from RNA mixture of both viruses 
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5 Analysis of recombinants by NGS 
5.1  Introduction 
Chapter four demonstrated and described a new approach for studying recombinants 
in wild-type poliovirus in the absence of any external pressure. The results gained 
from cloning and sequencing revealed 18 unique junction sites within an area of 
1.3kb (nucleotides 3235-4548), of those, one imprecise-insertion out-of-frame 
molecule, three imprecise-deletion out-of-frame molecules, and one imprecise 
deletion in-frame recombinants were found. These findings imply that there were 
probably many potential recombination sites within the amplified products. It also 
suggests that 5 hours post-infection – before completion of a full replication cycle – 
there was already some selection on the virus population. 
Recombinants within the targeted region were PCR amplified and NGS technology 
was used to sequence the amplicons. The amplicons were isolated and sequenced by 
Illumina MiSeq. Subsequently, the generated reads were analysed by the optimised 
bioinformatics system discussed in Chapter 3. Because of the time limitation, only 
the analysis of recP2-RLDM (recombination product in which the PV1 (Mahoney) is 
the donor genome and the PV3 (Leon) is the recipient genome) is demonstrated in 
this chapter.  
This chapter demonstrates the analysis of several hundreds of recombinants analysed 
5 hours post infection between two serotypes of poliovirus. The analysis was 
developed to examine:  
a) The randomness.  
b) The influence of the secondary structure of RNA on junction position  
c) Similarities and sequence identity between both viruses and how they can 
influence the recombination process.  
d) The primary sequence compositions around the junction site, e.g. GC-
content, homopolymer, mononucleotides and dinucleotides.   
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Aims 
After succeeding in identifying several different recombinants as outlined in chapter 
four, the aim was to detect more recombinants by using NGS technology to generate 
an extensive population of recombination. It was planned to use the optimized 
bioinformatics described in chapter three to identify the recombinant, coupled with 
some other bioinformatics software and custom Perl code to characterize the 
identified recombinants.  By performing this detailed analysis, the purpose was to 
understand the nature of the recombination process at an early stage of the virus 
cycle. Moreover, such explanatory data would help to differentiate between precise 
and imprecise recombination and whether they were derived by different 
mechanisms. The ultimate goal was to determine the factors that could influence a 
recombination population after five hours of co-infection before the virus was 
assembled or packaged. 
5.2  Generating recombinants samples for the NGS sequencing 
As mentioned in chapter 4, GATC Ltd. failed to sequence the samples that were 
generated at the University of Warwick. Moreover, their preliminary analysis 
resulted in the destruction of all samples meaning that the experiment had to be 
repeated. Therefore my supervisor Professor David Evans had arranged a visit for me 
to Dr. Andrew Macadam’s laboratory at National Institute for Biological Standards 
and Control (NIBSC) institution to repeat the experiment. The same experimental 
conditions were used at NIBSC (Figure 4-2) 
The primers (primP2-RLDM) that specific to amplify recP2-RLDM  were used to 
amplify recombinants and a band of the expected size was observed (1.3kb) in 
addition to smears and two secondary bands that presumably corresponded to 
imprecise recombinants (Figure 5-1). The band below the major one corresponded to 
imprecise-deletion and the one above the major band reflected the imprecise-
insertion recombinants (as found in the data analysis – see below). No band was 
observed for the control sample wherein an equimolar mixture of parental viral RNA 
was used as a template for the cDNA synthesis and PCR reactions (see section 
4.4.1). The PCR products of both the co-infection sample and the control were then 
purified to be sequenced by Illumina MiSeq NGS.  
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Figure 5-1 Amplicons of precise and imprecise recombinants within recP2-RLDM (P2 reagion) generated 
for NGS sequencing  
Viral RNA was extracted 5h post infection, reverse transcribed, cDNA synthesised, and PCR amplified using 
primP2-RLDM. The resulting products were analysed by 1% agarose gel electrophoresis after staining with 
ethidium bromide. The major band of expected size (~1.3kb) reflects precise recombinants, while the smears and 
secondary bands represent imprecise recombinants (as found in the analysis). The control lane reflects the 
absence of artefact wherein an equimolar viral RNA mixture was used as a template for PCR.  
5.3  Description of NGS dataset and the analysis methods  
NGS data 
Library preparation for Illumina MiSeq was performed according to the 
manufacturer’s instructions. Briefly, 1ng was used from the amplicons, 
simultaneously fragmented and tagged with unique adapter sequences, followed by 
10 cycles of PCR, before being loaded into the MiSeq instrument. The generated 
reads were uploaded to Illumina BaseSpace, a cloud-based genomics analysis and 
storage platform that directly integrates with all Illumina sequencers. 
Duplicates 
Duplicates are NGS reads with identical sequence; these reads can be generated 
during the library preparation, specifically in the PCR step after adding the adaptor 
sequences. Counting these reads would inflate the proportion of the NGS reads for 
some recombinants in the dataset. Therefore, they were removed from the 
recombination dataset, so that we increase the chance that every recombination read 
observed in the dataset is in fact driven from an independent recombination event.  
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Flattened vs. Unflattened 
The data was divided into flattened and unflattened groups. The former took into 
consideration the number of unique recombination junctions regardless of their NGS-
read representation and the latter accounted for the number of NGS reads. The 
flattened data could be used to study the presence of any favoured or disfavoured 
sites for the recombination mechanism across the genome. On the other hand, 
considering the unflattened data would help in studying the replicative nature of 
recombinants and/or the bias towards generating a recombination junction 
independently from the same site. Using the NGS reads to reflect the fitness of the 
recombinants could be misleading in the presence of duplicates. However, removing 
the duplicates would render the dataset unable to inform about the replication 
competent recombinants, since what will remain after excluding the duplicates are 
unique independent reads and not necessarily derived from the same recombination 
event.  
Differentiating between the technical and biological duplicates would need further 
verification steps as discussed later in this chapter. Therefore, the analysis described 
in this chapter informs about either preferred sites (flattened data) and or preferred 
recombination junctions, that can be independently generated several times 
(unflattened data).  
Junction definition 
The junction location reflects the point at which the polymerase switched from donor 
(PV1) to recipient (PV3) template. In most cases, the junction cannot be 
unambiguously determined due to local sequence identity between the parental 
genomes. Therefore, the position of each junction site was assigned to either the 3’ or 
the 5’ end of the identical sequence. Because no significant difference (in 
preliminary analysis) was observed between the two locations, the 5’ end of the 
sequence identity was considered as the junction location and described in this 
chapter.   
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5.4  Filtering the reads 
Using the BaseSpace software analysis, FastQC and FASTQ ToolKit, the low-
quality reads and the reads less than 150 nts were removed from the dataset. 
Additionally, the regions of low-quality sequence were trimmed from both ends of 
the reads if they existed. The numbers of remaining reads were 792,437 and 
1,484,341 for the control and the sample respectively. The length of the majority of 
remaining reads was 250 nts (Figure 5-2). 
The next step was to filter out the parental reads, which can impose a source of noise 
when analysing the recombination reads. These exist in the dataset as they were 
derived from a fragmented 1.3 kb PCR product, the majority of which would 
generate reads identical throughout their length to the donor or recipient molecules. 
Using Bowtie aligner (Langmead and Salzberg, 2012), the reads from both the 
control and the sample were first aligned against PV1, the unmapped reads were then 
re-aligned to PV3, and the remaining unmapped were kept for recombination 
analysis (Illustration of the filtration process is in Figure 5-3). A further step to 
ensure the uniqueness of the NGS reads was performed by removing the duplicates 
from the recombination reads found in the co-infection sample. Recombination reads 
left in the dataset constitute 1.21% of total reads and almost zero for the control 
sample (Figure 5-4). These findings are indicators of the specificity of the PCR 
approach that was used in this project.  
 
 
Figure 5-2 Read length distribution after removing short and unqualified reads 
The short and unqualified reads were filtered out from the total NGS reads generated by Illumina MiSeq. The 
remaining reads were binned based on their number (y-axis) and their length (x-axis) The figure was generated by 
Illumina BaseSpace built-in software (https://basespace.illumina.com/home/index). 
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Figure 5-3 The pipeline of removing parental NGS reads from the dataset 
An illustrative drawing explaining the steps of generating and removing the parental reads from the dataset. A 
two-halves line depicts the recombinant amplicon; the solid-grey represents the acceptor while the dashed-black 
represents the donor. The horizontal arrows refer to the NGS reads whereas the thick vertical arrows refer to the 
steps of the pipeline. The lines ending with filled circles denote the 500 nts fragments. The PV3 acceptor genome 
is represented by a solid grey complete line, and the dashed black complete line represents the PV1 donor strand 
A) The recombinant amplicon is fragmented into 500 nts during the library preparation. B) The majority of 
resulted reads are derived from parental genomes. C) Filter out the reads that derived from the acceptor strand by 
aligning all the reads against the PV3 strand, and keep the unmapped reads for the next step. D) Filter out the 
reads that derived from the donor strand by aligning all the reads against the PV1 strand, and keep the unmapped 
reads. E) What is left are the reads derived from recombinants. 
 
 
 
 
 
 
Figure 5-4 Recombination NGS reads percentage in comparison to parental genome read  
The grey bars represent the number of reads, and the numbers above them refer to the percentage of the reads. 
The left panel corresponds to the coinfection sample, while the right panel corresponds to the control no-
coinfection sample. 
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5.5  Finding Recombinants 
The 1.12% recombination reads were analysed by ViReMa algorithm at mode N0 X5 
as described in Chapter 3.  Subsequently, the recombination reads were manually 
securitized by extracting the reads represented at each junction and searching for 
recombinants by either BLAST or Bowtie2. As for BLAST, reads from several 
recombination junctions were extracted, and used in BLAST search via the NCBI 
website. The reads would be accepted as reads derived from a recombinant molecule 
if the resulting alignment showed a clear pattern of mismatches when aligned to one 
of the parental genome.  
On the other hand, reads represent several recombination junctions were aligned by 
Bowtie2 against one of the parental genomes using Bowtie2 with configurations that 
increased the mismatch tolerance (see section 2.8.6). Because the recombinant 
molecule genome has two parts, each derived from either parent, the part that does 
not belong to the reference parental genome in use will demonstrate a pattern of 
mismatch when visualised in a genome viewer (Figure 5-5).  The recombination 
junction was accepted if a clear pattern of mismatch was observed.  
Furthermore, to be included in the subsequent analysis, the observed recombination 
event should have forward and reverse reads if it lies towards the middle of the 
amplicon, and either forward or reverse reads if it is located towards the ends of the 
amplicons as it was verified by the bioinformatics system. Finally, the recombination 
events that were represented by less than 3 reads were excluded from the dataset. 
This to increase the confidence that the recombination event was not mistakenly 
reported based on mismatches (the cut-off number was arbitrarily chosen). 
The number of the unique recombination events that passed all the criteria is 313 
represented by 16860 unique reads; two-thirds of the recombinants were found to be 
precise recombinants, with the rest imprecise (Figure 5-6). Among the imprecise 
recombination junctions, the imprecise-deletion recombinants were found to be 2.4 
fold higher than the imprecise-insertion recombinants (Figure 5-6). It is clear that the 
precise recombination is occurring at a higher frequency than the imprecise and the 
imprecise-deletion overshadows the imprecise-insertion. Whether these variations 
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are influenced by biological factors will be further investigated in the following 
sections.	
 
 
 
Figure 5-5 Bowtie local alignment of recombinant’s reads against PV1 parent 
Alignment carried out by Bowtie2 using settings that allow mapping in the presence of mismatches, then 
visualised by Tablet (see section 2.8.13). The figure represents a screen-shot for an example recombination 
alignment generated by Tablet. The vertical red lines represent mismatches, which correspond to PV3 parent, and 
the grey part is the PV1.   
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Figure 5-6 Precice and imprecise NGS reads percentages 
The grey bars represent the percentage of unique recombinants found in the dataset for each type of 
recombination. The X-axis defines the type of recombination tested and the y-axis demonstrates the percentage of 
the unique junction in the total 313 recombination junctions found in the database. 
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5.6  Visualising recombinants found by NGS on the Parallel Coordinates 
visualisation tool 
To screen the locations and the features of the 313 identified recombinants, the 
Parallel Coordinates visualisation tool (see section 2.8.14) was further developed and 
manipulated to fit all the recombinants generated from the NGS sequencing. In this 
visualisation method, recombinants are represented by lines that connect the 
switching location of RdRp on the donor strand with its corresponding landing 
location on the acceptor strand.  
This visualisation tool allows for tracing recombinants between the two genomes and 
links each recombinant with its related features such as the number of NGS reads, 
being in-frame or out-frame, and the length of the inserted and deleted fragment 
among the imprecise recombinants. Using Parallel Coordinates visualisation tool, 
three different recombination maps were established, precise, imprecise-deletion, and 
imprecise-insertion (Figure 5-7).  
Precise Recombination Map 
In this map all the lines are horizontal (no slope) and because the blue colour was 
assigned for the in-frame recombinants, all the lines in this map appeared in blue 
colour; this because all the precise recombinants by definition are in-frame. Purple 
colour was assigned for the recombinants that were found in the laboratory at the 
University of Warwick via the cloning and Sanger sequencing (see section 4.4.3), 
and was found again among the NGS sequencing reads that were generated at 
NIBSC. This finding verifies the reproducibility of the method used in this research.  
The number of NGS reads that represent each recombinant is demonstrated on the 
last vertical bar on the right, which is termed ‘frequency’. The vast majority of the 
recombinants are represented by 3-300 NGS reads while fewer were found between 
300-500 reads and one recombinant was observed at a frequency of 823 reads (see 
5.7.2.)  
In a previous study targeting the same region of the genome, it was suggested that 
intertypic precise recombination was nonrandomly distributed (Murray et al., 1988b, 
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Freistadt et al., 2007b). Moreover, a study by Lowry et al , in which the same region 
was analyse, showed distinct clustering for recombinants (Lowry et al., 2014).  
However, apart from the VP1-coding region, identified precise recombinants in this 
project appeared to occur everywhere across the whole targeted region without any 
apparent clustering.  
This discrepancy may be due to the differences in methods used to isolate 
recombinants; they selected for viable recombinants - that had time to be packaged - 
with mutant markers. In contrast, the virus progeny was harvested early in the 
infection and no selection of any kind was used in this project and no viability was 
required.  
Imprecise-deletion Map  
Imprecise-deletion, by definition, can be either in-frame or out-of-frame. In this map, 
many red lines can be observed representing the out-of-frame imprecise-deletion 
recombinants (Figure 5-7, B). The recombination lines between the parental genome 
are not horizontal anymore; they became diagonal, moving downward from the 
donor to the acceptor genome reflecting the path of RdRp. In imprecise-deletion 
recombinants the RdRp should move towards the 5’ end of the acceptor genome to 
skip part of the genome, the slope of the line reflects the length of the deleted 
fragment i.e. the greater the slope, the larger the deleted fragment. Some lines look 
like horizontal lines because of the scale of chart, but they are not. In fact, these lines 
represent recombinants with small deleted fragments between 1-10 nts. The third 
vertical bar from the left, which is called ‘length’, represents the length of the deleted 
fragment, over which a clustering at a short-length deleted fragment can be observed. 
Finally, as before, the last vertical bar on the right of the chart represents the number 
of NGS reads that represent each recombinant. It is worth noting that imprecise-
deletion recombinants are occurring cross the whole targeted genome apart from a 
~350 nts region in the 2A coding region, which seems to be a “cold spot” (see 
section 5.8  & 5.12 ) 
 
 
149 
Imprecise deletion recombinants are historically referred to as defective interference 
particles (DI) in the literature (see section 1.3.6). These particles have deletion 
located in the capsid-encoding region (Cole and Baltimore, 1973b) and still they can 
replicate. However, because they don’t synthesise virus proteins they cannot produce 
virions, and rather compete for the wild-type (helper virus) structural protein (Cole et 
al., 1971). DIs are proposed to be an imprecise recombination mediated either by the 
copy-choice mechanism (Lundquist et al., 1979), or the loop-out mechanism (Kuge 
et al., 1986). In all cases, DI genomes have always been studied as a result of 
intratypic recombination, and have never been reported in the P2 or P3 region. The 
results demonstrated in this chapter are strong evidence that deletion can happen in 
the middle of the polyprotein region (P2), and more importantly that it can result 
from an intertypic recombination.   
Imprecise-insertion recombination map  
The lines are moving diagonally in the opposite direction to the imprecise-deletion 
map, this because the RdRp in this situation duplicates part of the genome, thus it 
switches towards the 3’ end of the acceptor (Figure 5-7, C). Three recombinants 
were detected have their acceptor strand locations after the CRE, which is outside of 
the PCR range of this project. Although, the RdRp switched templates outside the 
PCR-region range in these three molecules, the primer sites remained preserved. This 
is not the case with imprecise-deletions where switching templates outside the range 
would result in losing the 3’ primer site. Interestingly, the first half of 2A (~220 nts) 
region in the donor strand seems to be selected against, which also was observed in 
the imprecise-deletion (Figure 5-7, B). The lack of recombination at this region 
would imply a particular feature(s) retained by this region that would affect the 
formation of recombination. The fact that this was not found among the precise 
recombinants (Figure 5-7. A) suggests that it is specific for imprecise recombination.     
Imprecise-insertion recombinants are rarely reported in the literature, either in 
natural isolates or cell culture. The difficulty of isolating recombinants stems from 
the fact that they occur at a low frequency. Together with being less fit than the 
precise recombinants, the imprecise-insertion recombinants - as they possess longer 
genomes than the wild type - disappear after several hours (within the host) or serial 
passage due to the inevitable competition with the parental viruses and the precise 
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recombinant viruses.  However, Lowry et. al were able to isolate viable imprecise-
insertion recombinants at the same region of the genome (P2). The insert was deleted 
upon serial passage and restored the original wild-type genome length. This 
occurrence was also observed in an engineered virus carrying an insert (Alexander et 
al., 1994). The results in Figure 5-7, C show that imprecise-recombination does in 
fact occur at an early stage of infection in a random manner, regardless of their 
viability.   
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B) 
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Figure 5-7 Precise and Imprecise recombination maps (Parallel Coordinates Visualisation)  
The identified recombinants and their corresponding features were plotted between the two parental genomes as 
coloured lines in a parallel coordinates style. Each line represents an individual recombinant. The targeted 
genome of the PV1 (donor) strand is represented by a vertical white cartoon drawing with protein coding region 
indicated while the targeted genome of the PV3 (Acceptor) strand is represented by a vertical transparent-grey 
cartoon drawing. The locations of the lines on the PV1 strand are the positions where the RdRp has switched 
template whereas the locations on the PV3 strand are where the RdRp has re-associated. A name was assigned for 
each vertical bar; ‘frequency’ = the number of unique NGS reads, ‘length’= the inserted or deleted fragment 
length. The direction of the lines indicates the path of the RdRp. In the precise recombinants, the lines are 
horizontal with no slope as no deletion or insertion are involved. In the imprecise-deletion, the lines are diagonal 
pointing downward as the RdRp will jump towards the 5’ end on the acceptor whilst in the imprecise-insertion 
the lines are pointing up indicating the move of RdRp that will create an insertion in the resulted recombinant 
molecule. As the effect of the scaling view, the short insertion or deletion lines appear as horizontal as the precise 
ones. The red lines refer to out-of-frame recombinants and the blue lines indicate the in-frame recombinants. A) 
Precise recombination map. The purple lines are recombinants identified previously by cloning and Sanger 
sequencing and were found again by NGS. B) Imprecise-Deletion map C) Imprecise-Insertion map.   
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5.7  Test of randomness of recombination  
In this test the overall distribution of recombination junctions was studied to examine 
if what was observed in the maps were random events. The findings were divided 
into three samples: precise, imprecise-deletion and imprecise-insertion, and each of 
these were analysed as both flattened and unflattened data, then different statistical 
methods were used to compare the distribution with a random model (see section 2.6 
). The tests in this section studied the randomness of the recombination based on 
their locations on both viruses, the donor and the acceptor. However, as no 
significant difference was found between both locations in terms of randomness, the 
locations on PV1 was described in this section as a representative aspect for the 
randomness.  
5.7.1 Precise recombination randomness (flattened data) 
A random model was established by simulating random precise recombination reads 
with the same length (250 nts) in the same-targeted region (this randomisation was 
done by Excel), and ViReMa was used to find the junctions of the simulated reads. 
This was treated as a random-control model against which the sample was compared. 
This test ignores the number of NGS reads for each event, and rather focuses on the 
recombination event at each location. Starting the counting of recombination events 
from the beginning of the amplicon where no event was observed (zero), moving 
towards the 3’ end of the targeted region, the first encountered event at the next 
location would be counted as 1. Moving to the next location with the counter set to 1, 
which will remain 1 as long as no recombination event is encountered. Once a 
recombination is met then the counter will become 2. The same counting process 
continues until reaching the end of the amplicon. The resulting numbers from the 
counting process - for both the sample and control - were then normalised to 100% 
and plotted on a chart (Figure 5-8, A).   
The null hypothesis (H0) is that the precise recombination sample and the random-
control sample come from the same distribution, and the alternative hypothesis (Ha) 
is that they come from different distributions. Testing the goodness of fit by Mann-
Whitney U test resulted in a significantly small P value (P<0.01), which meant that 
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the chance that both samples come from the same distribution is very low; therefore 
the null hypothesis was rejected. Looking at the chart in Figure 5-8, A, the 
distributions of both samples are deviating at the beginning of the amplicon, 
specifically over the VP1 region and then moving towards each other until they meet 
at the end of amplicon.  
This significant absence of recombination over the VP1-encoding region among the 
precise recombination could be due to the physical location of the VP1 being at the 
3’ end of the amplicon, rather than being selected against for a biological reason; as a 
result it is underrepresented in the data (see section 3.7.1). To test this, the closest 
recombination occurrences to both ends were compared using Equation 3-3. The first 
detected recombinant from the 3’ end is at location 4499, which is 49 nts away from 
the 3’ end of the region amplified. Whereas, the first detected recombinants from the 
5’ end (the location of the VP1) is at 3366, which is 131 nts away from the beginning 
of the amplicon. Using the equations the theoretical sensitivity for ViReMa was 
found to be  29.6% and 62.4% at location 4499 and 3366 respectively. If the physical 
location were the reason behind the underrepresentation, then ViReMa should have 
had detected a sign of recombination at location ~3297 where the sensitivity is equal 
to 29.6% from the 5’ end. The fact that ViReMa needed a 1.1-fold increase in 
theoretical sensitivity to detect a sign of recombination at the 5’ end in comparison to 
the 3’ end suggests that this underrepresentation is due to a biological reason. The 
selection against the VP1 region is not surprising, as it is part of capsid-encoding 
regions, within which recombination has rarely been observed in previous studies 
(Heath et al., 2006). 
The test was repeated after removing the VP1 region (Figure 5-8, B) and the two 
samples were found to be derived from the same population; the (H0) was accepted 
(P=0.17, Mann Whitney U test). These findings suggest a strong selection against the 
VP1 region. Moreover, it demonstrates that the distribution of the precise 
recombinants occurs randomly cross the P2 region if the VP1 is excluded.  
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Figure 5-8 Randomness of precise recombination flattened data  
The occurrence of recombination was given a score 1 while no occurrence is 0, therefore the number of 
recombination occurences was calculated in a cumulative way i.e. the occurrence of recombination at each 
postion is added to the occurrence at the previous postion. This was applied on two populations; the precise 
recombiantion sample and a random recombination model generated by Excel. The findings (y-axis) were plotted 
against the locations on the PV1 (donor) amplicon (x-axis). The blue line represents the precise recombination 
random model and the black one for the sample (observed). A) Comparison between both populations over the 
whole targeted region. B) Comparison between both populations in the absence of VP1-encoding region.  
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5.7.2 Precise recombination (unflattened) 
The number of NGS reads - without the duplicates - for each recombinant can be 
used to test if there is any preference towards a specific recombination junction over 
the others. However, based on the fact that it is not possible to unambiguously 
determine the exact location for many recombinants due to the presence of identical 
sequence stretches between the two viruses (so-called ambiguous junctions), it is 
important to test how safe it is to consider the number of NGS reads as an indicator 
for preference occurrences for some recombinants. If two recombination junctions 
happened to occur over two different places in the middle of an identical sequence, 
ViReMa will push the findings towards the 3’ end of the identical sequence and 
report them both as one recombination event (Figure 3-18). To test this, a random 
model was created by simulating random recombination events, taking into 
consideration the number of NGS reads into account this time (this was performed 
by the Perl code Appendix 1). Subsequently ViReMa was used to find the 
recombinants and their corresponding NGS reads. The normalised results were then 
compared between the random model and the sample (Figure 5-9).  
Looking at the results, it is visually clear that the distributions are similar for the 
random-model and the precise-sample, apart from the VP1 region and the primers 
sites at the end. The null hypothesis was rejected (P<0.001 Mann Whitney Test) 
without any modification. While after removing the primer sites and the VP1, the 
null hypothesis can be accepted (P = 0.08 Mann Whitney Test).  
After examining some of the recombination events, it was found that the number of 
reads is actually reflective of a systematic bias rather than a biological indicator. For 
example, the highest number of reads over the 2C encoding region corresponded to a 
recombination event that occurred within a 21nt identical sequence, which implies 
that possibly this is a representation of several events occurring at this region (see 
section 5.10 ). Based on these findings it was decided not to consider the number of 
NGS reads as an indicator of a favoured situation for recombination.  
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Figure 5-9 Randomness of precise recombination unflattened data 
Comparing the number of NGS reads (frequency) for each recombinant found in the precise recombination 
sample and in the random recombination model. Blue refers to the random model and black to the precise 
recombination sample.  The x-axis label is placed on the top of the graph as a cartoon representing the PV1 
genome placed in a position that corresponds to the scale. The y-axis is the percentage of the NGS of each 
recombinant in regards to the total number of reads. 
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5.7.3 Imprecise Recombinants (flattened) 
The imprecise recombination in the case of flattened data was tested based on their 
ability to maintain the open reading frame. If these molecules occur randomly, then it 
is expected to see two-thirds of the molecules in each category out-of-frame, based 
on the fact that the first two nucleotides –within a codon - if disrupted will generate 
out-of-frame recombinants. The recombinants were divided into two categories, 
imprecise-deletion and imprecise-insertion, then a goodness of fit was tested by Chi-
Square Test between the expected and observed. The results in Figure 5-10 show that 
the imprecise-insertion is occurring randomly (P=0.88) while, surprisingly, the 
imprecise-deletion is biased towards the out-of-frame molecules (P=0.0004). The 
(H0) is accepted in the former case and rejected in latter case. This is also reflected 
by the overwhelming presence of the red lines over the blue lines in the imprecise-
deletion map (Figure 5-7, B) in comparison to the imprecise-insertion map (Figure 
5-7, C). It is not clear if this bias among the imprecise-deletion is due to a selection 
mechanism, or it is an effect resulting from the sequencing technology or the random 
sampling. This can be verified by repeating the experiment and comparing the 
results.  
5.7.4 Imprecise Recombinants (unflattened) 
In the case of the unflattened data, a random model was established by simulating 
random imprecise-deletion and insertion reads (by Perl code Appendix 1). The 
number of simulated reads for both populations is equal to the number of reads found 
in the sample. ViReMa was used to find the simulated junctions in both cases. The 
random-control sample and the imprecise sample were then plotted against each 
other.  
The junctions (the location is based on the PV1 genome) from the random-control 
found by ViReMa were distributed equally throughout the genome in comparison to 
the imprecise samples (Figure 5-11), which implies the absence of the systematic 
bias. Based on this, and on the fact that all the duplicates were removed from the 
dataset, it seems that some other factors contribute to the high number of NGS reads 
at some locations in the imprecise sample (see next section). A high number of NGS 
reads was detected at the VP1 region among the imprecise-insertion, the same region 
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that was found to be selected against in the precise recombinants. Interestingly, the 
vast majority of these are in-frame (7/10) with a short insert, which may suggest a 
preferable site for the imprecise-insertion (Figure 5-7, C). 
 
 
Figure 5-10 Randomness of imprecise-insertion and imprecise-deletion (flattened data)  
Blue bars = expected, dark-grey= observed. The dotted line between the bars reflects the difference between the 
findings with the P value calculated by Chi-Square. X-axis defines the population while y-axis represents the 
number of recombinants found for each population. The legends and the titles are at the top of each figure. The 
left panel compares the number of the observed out-of-frame/in-frame recombinants in imprecise-insertion with 
the expected value, which was calculated based on the whole position (2/3 expected to be out-of-frame). The 
right panel compares the number of the observed out-of-frame/in-frame recombinants in imprecise-deletion with 
the expected.  
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Figure 5-11 Randomness of imprecise-insertion and imprecise-deltion (unflattened data)  
Comparing the number of NGS reads (frequency) for each recombinant found in the imprecise recombination 
(deletion and insertion)  sample with the random recombination model. Blue refers to the random model and 
black to the imprecise recombination sample.  The graph is divided into two parts sharing the same x-axis label 
which is placed on the top of the graph as a cartoon representing the PV1 genome placed in a position that 
corresponds to the scale. The y-axis is the percentage of the NGS of each recombinant in regards to the total 
number of reads. The sharped bins refere to the recombination events. As there was no clustering among the 
control samples the bins are appearing small and scattering all over the targeted region. 
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5.8  RNA Secondary Structure analysis of recombinants found by NGS 
Previous studies have implicated local RNA secondary structure as an influencing 
recombination (Freistadt et al., 2007b, Dedepsidis et al., 2010, Runckel et al., 2013). 
To further investigate this, the amount of RNA structure on the positive sense 
genome was defined in the acceptor and donor genomes. This was achieved by 
calculating the mean folding energy difference (MFED) - a measure of sequence-
independent localized RNA structure - between the native sequence and the sequence 
order randomised control over a sliding 100nts window (stepped by 30 nts) spanning 
the region within which recombination could occur (this was done by Prof. David 
Evans). The MFED values - positive indicates sequence order dependent structure, 
negative values the absence of structure - then were plotted against either the number 
of recombination junctions within the same sliding window (flattened data) or the 
number of unique NGS reads (unflattened data). Since the widely accepted model of 
recombination in RNA viruses suggests that recombination occurs during the 
negative strand synthesis, the analysis was focused on the structure formed in 
positive-sense RNA. Recombinants were divided into precise, imprecise-deletion and 
imprecise-insertion. The Spearman’s Rank Correlation test was used to study any 
correlation with RNA secondary structure for each category individually.  
The flattened data of precise recombinants showed a significantly weak negative 
correlation with the RNA secondary structure in the acceptor strand (r = - 0.328, P = 
0.03) (Figure 5-12, B) while no correlation was found in the donor strand (Figure 
5-12, A). From section 5.7.2, the unflattened data for precise recombinants was 
demonstrated to be a reflection of a systematic bias due to the presence of identical 
short sequences between the two viruses. Nonetheless, this was also examined for 
any correlation with the RNA secondary structure, and the results did not show any 
significant association with either genome (data not shown). The negative correlation 
found with the acceptor strand may imply that a minimal RNA secondary structure 
can influence the sites of recombination, and cast more importance on the RNA 
structure of the acceptor strand than the donor strand within the process of 
recombination.  Nonetheless, as the correlation is weak (r = - 0.328), this might be 
reflective of the analysis method rather than a biological correlation. Therefore, more 
analysis of further recombinants is needed to verify this.    
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On the other hand, neither flattened nor unflattened data has shown any correlation 
when the imprecise-deletion and imprecise-insertion were treated as one sample. 
When analysed separately, imprecise insertion also did not show any correlation 
(Figure 5-13) while a weak negative correlation in the donor strand was found in the 
imprecise-deletion recombinants for both flattened and unflattened data (Figure 5-14, 
A and C). The negative correlation is attributable to the absence of a recombination 
junction in the first half of the 2A coding-region, which was found to be a highly 
structured region; in fact, this region demonstrates the highest MFED value in the 
targeted genome of PV1 (donor) genome. This is coupled with the notable high 
occurrence of recombination over the region with low structure within the 2C-
encoding region in both cases. 
Some sort of detectable limitation of the assay being used might have caused the gap 
in the 2A-encoding region. For imprecise-deletion recombinants to be generated, the 
RdRp must move towards the 5’ end of the acceptor strand, thereby skipping part of 
the genome. This means if the polymerase happens to switch template at this area, it 
may re-associate on a region outside of the PCR detectable range used in this project. 
In addition to this, the correlations are not strong in either the flattened (r = -0.365) 
and the unflattened (r = -0.388) data. Therefore it is difficult to prove that the 
mechanism of imprecise-deletion is influenced by RNA structure in the donor strand, 
or that the high frequency of imprecise-deletion over 2C-encoding region is caused 
by a preferable site defined by the RNA-secondary structure.  
At this stage, it appears more convincing that there is no difference between the 
recombination mechanisms of the imprecise-deletion, and imprecise-insertion, 
especially that there is no obvious relation between the locations and the occurrences 
of recombination (Figure 5-7, B and C). The blue and red lines seem to scatter 
randomly over the genome, apart from the 2A-encoding region in imprecise-deletion 
(cold spot) and VP1-encoding region in imprecise-insertion (hot spot). However, 
these exceptions are likely to be a bias caused by the detectable-range effect of the 
assay, particularly in the case of deletion. Additionally, no special relation between 
maintaining the open reading frame and the frequency was found, some of the out-
of-frame are occurring at a higher frequency than the in-frame molecules, which may 
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rule out the replication ability as a factor influencing the frequency, which in its turn 
is more likely to be excluded as the duplicates were removed from the data. 
Therefore, the imprecise-deletion and insertion were merged into one sample for 
subsequent analysis, unless mentioned otherwise.  
 
 
 
Figure 5-12 Precise Recombination RNA secondary structure analysis (flattened data).  
The mean folding energy difference (MFED) was measured within 100 nts sliding window (in 30 nts increments) 
in the sense strand of parental genomes indicated in dotted line and represented at the secondary y-axis. The 
solid-marked line represents the recombination junctions count within the same window represented by the 
primary y-axis. The x-axis was replaced by targeted genome calibrated to the scale. White genome = PV1 
(donor),  grey genome = PV3 (acceptor). The title above each figure refers to the population’s name in its first 
half, and to the Sperman’s Rank Correlation Test results in its second half.  
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Figure 5-13 Imprecise-insertion Recombination RNA secondary structure analysis (flattened and 
unflattened data) 
The mean folding energy difference (MFED) was measured within 100 nts sliding window (in 30 nts increments) 
in the sense strand of parental genomes indicated in dotted line and represented at the secondary y-axis. The solid 
line - marked with circles for flattened data and with diamonds for unflattened data - represents recombination 
junctions count within the same window represented by the primary y-axis (flattened) or the number of NGS 
reads (unflattened) . The x-axis was replaced by a targeted genome calibrated to the scale. White genome = PV1 
(donor),  grey genome = PV3 (acceptor). The title above each figure refers to the population name in its first half, 
and to the Sperman’s Rank Correlation Test results in its second half. 
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Figure 5-14 Imprecise-Deletion Recombination RNA secondary structure analysis (flattened and 
unflattened data) 
The figure is highlighted red for the significant correlation findings. The remaining schematic features as in the 
previous figure. 
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5.9  Sequence similarities analysis of recombinants found by NGS 
Sequence similarity between the parental genomes was suggested to be a key factor 
for recombination. This stems from the fact that the yield of intra-serotype 
recombinants was found to be 10 to 100-fold higher than intertypic recombinants 
(Molla et al., 1991, Lowry et al., 2014). To investigate this, the sequences similarities 
between the targeted regions of both viruses were measured within a 25 nts sliding 
window advanced by 1 nt (by Prof. David Evans), and then plotted against the 
number of observed recombination junction within the same window in the flattened 
data, and against the number of unique NGS reads in the unflattened data. The 
recombinants were divided into two samples, precise and imprecise. The imprecise 
recombinants were studied in both cases, flattened and unflattened data, while only 
flattened was studied for the precise recombination. The evidence of any correlation 
was determined by Spearman’s test.  
A very weak negative correlation was observed for the precise recombination (r = - 
0.1, P<0.01) in both genomes (Figure 5-15) PV1 and PV3 (represented as one line in 
the chart as the location is precise and would not change between the viruses). The 
correlation is very close to zero, which makes it negligible, and possibly it is an 
effect of the analysis method. This indicates a random distribution of the 
recombination sites over the genome with no significant preference towards regions 
with high similarities. Visually, there is no clear pattern among the precise 
recombinants (Figure 5-15). The line of recombination occurrences is moving up and 
down regardless of the sequence similarities.  The same thing is awhen looking at the 
imprecise. 
Previous studies suggested that imprecise recombination may exist adjacent to RNA 
similar segment between the two parental genomes (Kuge et al., 1986), or may not 
(Pilipenko et al., 1995). The results show no correlation with the similarity regarding 
the donor strand, and slightly stronger negative correlation than precise in terms of 
the acceptor strand in both cases, flattened (r = -0.35) and unflattened (r = -0.25) 
(Figure 5-16). This may indicate that imprecise recombination may favour the 
occurrence within divergent regions on the acceptor strand. Alternatively, as the 
correlation is not strong, similarities may not be a determinant factor for the 
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imprecise recombination, and the slight negative correlation with the acceptor strand 
may reflect the imprecise and random mechanism of the polymerase to re-associate, 
which is likely to end up on a divergent site.  
 
Figure 5-15 Sequence similarity analysis for precise recombination (flattened Data)  
The sequence similarities (%) between the two viruses was measured within a 25 nts window advanced by 1 nts. 
(primary y-axis) represented by a solid blue line. The number of recombination events were counted within the 
same window (secondary y-axis). The the black line describes the relation between PV3 and PV1 and sequence 
similrities. The title contains the name of the population as well as the Spearman's Rank Correlation Test results 
for both viruses. The x-axis was replaced by the targeted genome with protein coding regions indicated. To 
reflect the correct location, it was calibrated to the scale. As each figure contains data for both PV1 and PV3, the 
colour of the genome is a gradient between grey (PV1) and black (PV3). 
 
 
Figure 5-16 Sequence similarity analysis for imprecise recombination (flattened & unflattend data) 
See Figure 5-15 for legend 
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5.10  Identical sequence analysis of recombinants found by NGS 
The overall similarity between the two viruses (PV1 and PV3) does not seem to be a 
major influencing factor for recombination. To further investigate this, the 
correlation between the length of the identical regions and the occurrence of 
recombination was studied in flattened and unflattened data for both populations, 
precise and imprecise. Sequence identity between poliovirus type 1 and 3 is ~78% 
within the targeted region (P2), distributed as short identical sequences between 1 
and 21 nts interspersed with variant nucleotides. The number of each identical length 
was counted across the targeted genome (Figure 5-17, Exp) and plotted against the 
observed recombinants at that particular length (Figure 5-17, Obs). Sequence identity 
of 1 nt length and the divergent sites were also included.   
The results from precise recombination in Figure 5-17 show no significant difference 
between the length of identical sequence frequencies (1 – 21 mers) and the 
recombination junctions observed at these sequences (Figure 5-17). For example in 
the aligned sequences there were 98 different conserved dinucleotides, and 35 
positions with an identity of 5 nts. Of the precise junctions characterised, 87 occurred 
at positions within identical dinucleotide and 32 occurred within identical sequences 
of 5 nts length. These findings go in line with results from previous studies (Lowry et 
al., 2014, Kirkegaard and Baltimore, 1986). However, looking at position 0 
(divergent locations) between the two viruses, the observed precise recombinants are 
notably lower than the expected number.  
On the other hand, the imprecise recombination does not show the same correlation. 
For example only 27 recombinants were observed within the identical sequence of 2 
nts length, which is remarkably lower than the expected 89 recombinants. 
Nonetheless, it is also worth noting that imprecise recombination does not appear to 
favour the divergent sites either, as only a small number of recombinants were 
observed (24) in comparison to what was expected (228).  
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Figure 5-17 The occurrence of precise and imprecise recombination in regions of maximum sequence 
identity (flattened data) 
Short identical sequences between 1 and 21 nts interspersed with variant nucleotides (x-axis), the 0 represents 
variant nucleotides. Individual counts of short lengths are represented by the grey bars (the primary y-axis). The 
red and blue bars represent the counts of recombinants found within the identical sequences of all possible 
lengths available in this region of the virus (the secondary y-axis). 
 
 
Figure 5-18 Correlation between the precise recombination frequences and the lengths of the identical 
sequences (unflattened data)  
The same visualisation logic of the recombination map (Figure 5-7) is applied here. A vertical bar corresponding 
to the length of identical sequences was added. This links together the locations of each recombinant on the 
genome, the identical sequence within which it occurred, and the frequency. Blue lines = in-frame. 
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On the other hand, by analysing the correlation between the precise recombination 
from the unflattened data and the identical sequences length, it was found that the 
number of NGS reads corresponded to the length of the identical sequence rather 
than to a biological preference towards the identity (Figure 5-18). The longer the 
length of the identical sequences the higher the frequency. It is clear that the highest 
number of NGS reads was located at the identical sequence of 21 nts in the 2C-
encoding region, which occurs only once within the targeted region. Therefore 
recombinants at this region are represented by one line. This systematic bias may be 
caused by the inability to report the exact location of the junction (see 5.7.2 and 
3.7.3). It is worth mentioning that the presentation of the recombination occurrences 
on the third axis (the length of sequence identity) in Figure 5-18 is actually a close-
up look into the findings in Figure 5-17; the source of each recombinant occurring at 
a particular sequence identity length can be traced to the genomes.   
In contrast, there seemed to be an inverse relationship in the imprecise recombination 
between the frequency and the sequence identity length. It could be observed that the 
number of NGS reads was reduced when the length of sequence identity increased 
(Figure 5-19). Interestingly, comparing the two maps together (Figure 5-18 and 
Figure 5-19), the region extends from the end of VP1 to the first half of 2A was 
found to be crowded with long identical sequence stretches and lack of imprecise 
recombinants occurrence. The crowdedness of identical sequences within this region 
(VP1-2A) is noticeable in Figure 5-18 as the blue lines (precise recombinants) in this 
region are pointing upwards towards several long identical sequences, 
8,9,12,13,14,15. This observation possibly suggests that sequence identity has an 
important role in influencing recombination. 
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Figure 5-19 The frequency of imprecise recombination in regions of maximum sequence identity 
(unflattened data) 
For the legand see Figure 5-18. This demonstrates imprecise-insertion and deletion together. Red lines = out-of-
frame 
 
 
 
 
 
 
 
 
 
 
172 
5.11  Sequence Composition  
The randomness, RNA structure and sequence similarities analysis did not show a 
robust involvement in determining the junction site. It was speculated that 
recombination occurs via a copy-choice mechanism in which RdRp paused for some 
reason during RNA synthesis and removes itself with the incomplete nascent RNA 
from the donor and resumes elongation on the acceptor (Kirkegaard and Baltimore, 
1986, Nagy and Simon, 1997). Therefore, the primary objective of this section is to 
determine whether there were features of the nucleotide composition at the junction 
that might influence recombination.  
Analysis of the sequence composition surrounding the junction sites in both parents 
was performed. These surrounding sequences were divided into four zones and are 
symbolised in a diagram in Figure 5-20 for precise recombination and Figure 5-21 
for imprecise recombination. A specific name was assigned to each region based on 
its parental genome and its location regarding the junction site (Figure 5-20, A). For 
example R3 means the sequence located to the 3’ side of the junction location on the 
recipient strand (PV3) and D5 corresponds to the sequence 5’ to the junction on the 
donor strand (PV1). This naming system can be used to refer to specific nucleotide(s) 
within a particular region. For instance the last nucleotide transcribed by the 
polymerase is referred to as N-D3; the first nucleotide of the sequence located 3’ to 
the junction site on the donor strand. Whilst the nucleotide where the polymerase re-
associates is R5-N; the last nucleotide of the sequence located 5’ to the junction site 
on the recipient strand. Based on this, the nucleotide upstream to R5-N is R5-N-1, 
whereas the nucleotide downstream to N-D3 would be N-D3+1. Using the same 
logic, NN-D3 would refer to the first dinucleotide of the sequence located 3’ to the 
junction site on the donor strand.  
The analysis method used is based on comparing the expected versus the observed 
for several sequence features. The recombinants were divided into two samples, 
precise and imprecise. Based on the fact that the number of NGS reads ‘frequency’ 
was found to be biased towards the long identical sequence stretches (see section 
5.7.2) only the flattened data of the precise recombination was included in this 
analysis. In the case of imprecise recombination, the unflattened and flattened data 
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were considered for analysis. However, as the results did not show any difference, 
the flattened data only is explained in this section. Several Perl scripts (Appendix 5-
9) were written to extract the desired mononucleotide, dinucleotide, homopolymer 
around the recombination junction by using the locations of every recombinant on 
both strands as reference points. 
Five major analyses were performed: 
1. G+C and A+T content within 50 nts of each sequence around the junction. 
These sequences are referred to as D3, D5, R3, R5 in Figure 5-20, A.  
2. Mononucleotides. This was divided into two analyses; mononucleotides 
within a 50 nts window of the surrounding sequences and mononucleotides at 
the junction site. The nucleotides analysed by the latter are illustrated in 
Figure 5-20, B. They are highlighted either red or blue depending on which 
genome they belong to. They have different names indicating that they were 
analysed individually.  
3. Dinucleotides at the junction site. These targeted dinucleotides are 
demonstrated in Figure 5-20, C. 
4. Homopolymer within a window of 50 nts around the junction location.  
5. Exit and entry nucleotides. The exit nucleotide (referred to as Z) is the one 
upstream to where the polymerase dissociates   from the donor strand while 
the entry nucleotide (referred to as Y) is where the polymerase re-associates 
on the acceptor strand. They are highlighted in blue and red respectively in 
Figure 5-20, D.  
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Figure 5-20 Sequences surround the junction site considered for sequence composition analysis (precise 
recombination) 
The sequences that encompass the junction location were divided into four zones and named based on their 
location to the junction. R5 = 5’ end to the junction on recipient strand, R3= 3’ end to the junction on recipient 
strand, D5 = 5’ end to the junction on donor strand, and D3 = 3’ end to the junction on donor strand. The N’s 
refer to any possible nucleotide. Red refers to the donor strand and blue to the recipient strand. The black arrow 
denotes the path of the RdRp A) General overview of the four zones. B) Demonstration of the nucleotides that 
were nominated for the mononucleotide test. C) The dinucleotide nominated for the dinucleotide test. D) 
Defining the entry and the exit sites for the RdRp, Z = Exist site, Y = Entry site. The grey N’s refer to nucleotides 
located at a far distance from the junction, and were thus excluded from this analysis. 
 
Figure 5-21 Sequences surround the junction site considered for sequence composition analysis (Imprecise 
recombination) 
The same type of nomenclature used in the precise recombination is applicable on the imprecise recombination 
for all the analyses. This figure illustrates the entry and the exit sites analysis in the imprecise recombination as 
an example.   
 
 
175 
5.11.1 G+C and A+T content (GC-Content, AT-content) 
It was reported that G+C and A+C content are associated with bias in the 
recombination mechanism (Runckel et al., 2013). The rational is that if the RNA 
incomplete strand dissociated at G+C-rich sequences, it could be predicted to anneal 
to the acceptor strand more robustly than A+U-rich sequences. To investigate this, a 
comparison between the frequency of G+C and A+T within 50 nts window from the 
four zones (D3, D5, R3, R5) with the frequency of G+C and A+T in the targeted 
region (the region between nucleotides 3235 and 4548 in the virus genome) was 
performed. The expected ratio was calculated as (G+C/A+T+G+C)*100 for GC and 
(A+T/A+T+G+C)*100 for AT. The denominator equals 1300, which is the length of 
the targeted sequence. The GC-content – within this region 3235-4548 - was found to 
be 45.3% and 44.6% for donor and acceptor respectively and 54.6% and 55.3% for 
AT-contents. This was compared with the observed, which was calculated by 
calculating the GC-content within a 50 nts window as (G+C/50)*100 for each region. 
The statistical significance was tested by Chi-Square. None of the 50 nt sequences 
flanking the recombination junction in the donor or acceptor had shown any bias 
with either content in both populations, precise and imprecise (Figure 5-22).  
 
Figure 5-22 G+C and A+T contents analysis (within 50 nts window) in precise and imprecise 
recombination 
The frequencies of the expected GC or AT contents (black bars) were binned side by side with the observed 
frequencies (grey bars) in all the four zones for both populations, precise and imprecise. Y-axis represents the 
frequency (%) for GC and AT contents; the upper side belongs to precise recombination, and the lower one for 
imprecise recombination. X-axis shows the test in question (GC or AT) and the zone within which they were 
analysed.    
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5.11.2  Mononucleotides  
The high number of distinct recombinants identified in this project implies that, if a 
specific nucleotide sequence is required for recombination, it must be a very short 
one. It was speculated that A-rich sequences would influence RdRp slippage 
facilitating its dissociation (Pilipenko et al., 1995, King, 1988). To inspect if there is 
any nucleotide(s) bias, mono and dinucleotide were analysed. In regards to 
mononucleotides the test was split into two analyses. First, a comparison between 
each nucleotide frequency within 50 nts of the four zones (D3, D5, R3, R5) with the 
frequency of each nucleotide within the targeted region of the genome (P2 region). 
The same method as in GC-content test was used to calculate the frequency; no 
evidence for any bias was detected (Figure 5-23).  
Secondly, a study of the mononucleotides at the junction site was carried out. To do 
this, three nominated nucleotides were picked from each strand; these represent the 
nucleotide where the junction occurs (N-D3 and R5-N), the nucleotide upstream (N-
D3-1 and R5-N-1) and the nucleotide downstream (N-D3+1 and R5-N+1). The 
rational of picking these particular three nucleotides is to study if there is any 
preferred nucleotide for recombination either at the junction site or at the border. For 
the sake of simplicity in demonstrating the findings in a graph they were given 
different names. Those corresponding to donor strand are N1, N2 and N3, while for 
the acceptor strand they were called Na, Nb, Nc Figure 5-20, B. The comparison is 
based on the difference between the number of observed recombinants with a certain 
nucleotide and the frequency of that nucleotide in either parent (expected). For 
example, nucleotide ‘G’ was found with 23% frequency in the donor strand targeted 
region, thus if the recombination is random we expect to see ~23 recombinants of 
100 have ‘G’ at their N1, N2 or N3 positions. The statistical significance was tested 
by the Binomial Distribution test.   
The results (Figure 5-24) show some noticeable biases; nucleotide ‘C’ was found to 
be selected against in both populations (precise and imprecise) at N2 site where the 
RdRp dissociates. Additionally, ‘A’ nucleotide was favoured at N2, N3 and NC. It is 
also worth noting that ‘T’ nucleotide was found lower than expected at two sites in 
the imprecise recombination (N2, N3), which probably may suggest a significant role 
for this nucleotide in the imprecise recombination. 
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The different biases observed between the two populations may reflect the presence 
of two different mechanisms for imprecise and precise. Nucleotides NC and N3 
correspond to each other by their locations (right before the dissociation and re-
association sites) were found to be significantly high among the imprecise 
recombinants. Interestingly, separating the imprecise into insertion and deletions 
(Figure 5-25) revealed the presence of such correlation in the imprecise-insertion 
only. This suggests that the mechanisms underlining imprecise-insertion and –
deletion may differ from each other. Nevertheless, as there is more than one pattern, 
it is difficult to conclude from these findings alone how these nucleotides correlate 
and interact with each other. These patterns can be verified by repeating the 
experiments and by considering some more experiments including sequence 
manipulation. 
 
 
Figure 5-23 Mononucleotide analysis (within 50 nts window) in precise and imprecise recombination  
For the legends see Figure 5-22 
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Figure 5-24 Mononucleotide analysis (at the junction site) in precise and imprecise recombination. 
The six nucleotides which were picked for this analysis are illustrated in Figure 5-20, B. N1, N2, N3 are located 
on the donor strand while Na, Nb, Nc are located in the recipient strand. The significant difference between the 
observed and expected is highlighted in red (calculated by Binomial Distributing test). X-axis demonstrates the 
mononucleotide in question and its corresponding name as defined in in Figure 5-20, B.   
 
Figure 5-25 Comparative analysis of mononucleotide at the junction site between imprecise insertion and 
deletion.  
Analysis of mononucleotides Nc and N3 from Figure 5-20, B at the junction site. The Nc is located on the 
acceptor and the N3 on the donor strand. The significant difference between the observed and expected is 
highlighted in red (calculated by Binomial Distributing test). X-axis demonstrates the mononucleotides and their 
corresponding names as defined in in Figure 5-20, B.   
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5.11.3  Dinucleotides  
Dinucleotide ‘AA’ was noticed by King to be significantly higher than the random 
model in the area of the junction site (King, 1988). To further investigate this and 
any other bias towards any of the potential dinucleotides, the same method of 
studying the mononucleotides at the junction site was used, with the focus on 
dinucleotide this time. The locations of the dinucleotides in regards to the junction 
site are illustrated in Figure 5-20, C. Unlike the mononucleotide around the junctions 
where six different nucleotides were tested and every nucleotide was given a specific 
name, dinucleotide exists with one possibility at the junction site, and therefore they 
are referred to by the zone’s name.  
The frequency of all the 16 dinucleotides was determined in the targeted genome 
individually. The expected values were calculated by the same method used in the 
mononulcutide (see previous section). The four zones around the junction were 
tested and the statistical significance was measured by the Binomial Distribution test.  
The results (Figure 5-26) of all the four zones showed some desirable dinucleotide 
for the recombination mechanism. As for the precise recombination, several 
dinucleotide patterns can be observed at the four zones. For example, ‘GA’ occurred 
significantly higher than expected at the R3 and D3 zones, which are corresponding 
to each other in terms of location. Similarly, ‘TC’ was found to be significantly high 
at the R5 and D5. It could be speculated that this arrangement might play a role in 
facilitating the recombination by aligning the two parental viruses. However, it is 
difficult to interpret the bias found as precise recombination occurred majorly within 
identical sequences.  
On the other hand, different other significant patterns were found among the 
imprecise recombination. In consistent with previous studies (King, 1988, Nagy and 
Simon, 1997), dinuclutides ‘AA’ was found to be significantly rich at the 
dissociation site (D3 zone). Moreover, another dipurines – such as ‘AG’ and ‘GG’- 
were found to be significantly high at this site, which is in agreement with previous 
results found in Evans lab. More biases were observed at different zones for the 
imprecise recombination, which might also play a role in facilitating recombination 
(see Figure 5-26).   
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5.11.4  Homopolymer (50 nts window) 
In addition to looking for potential biases in mono or di-nucleotide distributions and 
recombination junctions the presence of short homopolymeric sequences was 
investigated. To study whether homopolymer is a recombination influencing factor, 
all possible homopymers of 3-6nts were identified in the targeted genome in both 
genomes (donor and acceptor) and compared to the observed homopolymers within 
50nts sequences of all the zones (D3, D5, R3, R5). As no correlation was found in 
any of them, only the results of the 3nts hompolymers were demonstrated in this 
chapter (Figure 5-27).  
 
 
Figure 5-26 Dinucleotide analysis (at the junction site) in precise and imprecise recombination for zones 
R5 and D3 
The upper panel belongs to R5 zones and the lower for D3. X-axis indicates the dinucleotide in question. See  
Figure 5-24 for the rest of the legends 
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Figure 5-27 Homopolymer analysis (within 50 nts window) in precise and imprecise recombination 
The figure demonstrates the analysis of 3mer homopolymers. X-axis demonstrates the homopolymer in question 
with its corresponding zone. The rest of the variables as in previous figures of section 5.11. 
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5.11.5  Sequence compositions of the identical regions 
The analysis of precise recombination sequence compositions within 50 nts of the 
surrounding sequence at the junction location did not show any significant role of 
sequence in influencing recombination. To further study this, the sequence 
compositions within the shared identical sequences between the two parents at the 
recombination site were analysed in the case of precise recombinants (see Figure 
5-28). The recombinants within the precise recombination population were divided 
into sub-samples based on the length of the identical sequences near the junction 
location. Subsequently, the sequence composition in question was measured for each 
recombinant in a particular sub-sample and the average was calculated. Finally the 
average of all the averages from the sub-samples was calculated and compared with 
the expected values - for both parents - using Chi-Square.  
The expected values were calculated in terms of the targeted sequence length; 1300 
nts - the region between nucleotides 3235 and 4548 in the virus genome. For 
example, the equation ‘(G+C/1300)*100’ was used to calculate the expected ratio for 
GC. Additionally, the calculation of the percentage of the sequence composition was 
modified according to the length of the identical sequence in question. For example, 
the dinucleotide ‘AT’ would constitute 100% of the sequence if the identical 
sequence was composed of two nucleotides and happened to be ‘AT’. However, this 
will decrease to 50% if the AT was found within an identical sequence of three 
nucleotides and 33.3% within four nucleotides and so on. Custom Perl codes were 
used to calculate the percentages of sequence compositions (appendix 10-13).  
The results of the analysis (Figure 5-29) did not show any significant correlation in 
all the studied sequence compositions. This would increase the importance of the 
sequence identity rather than the sequence composition in influencing precise 
recombination.   
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Figure 5-28 Demonstration of the identical sequences picked for sequence composition analysis in precise 
recombination  
The figure demonstrates an example of an identical sequence of 12 nts, within which the recombination was 
occurred; the sequence represented in red. The black and blue represent PV1 and PV3 viruses respectively. 
ViReMa (depending on the configurations of the algorithm) would report the resulted recombinants at the 3’ of 
the identical sequence (the red arrow), which means that the red sequence would be considered as a PV1 
sequence. Based on this, the Perl codes were written to extract the red sequence and analyse its sequence 
composition.  
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C) 
 
D) 
 
Figure 5-29 Analysis of sequence composition within the identical sequences 
The expected and the observed values for each sequence composition were compared in both viruses; represented 
in the figures as PV1 at the upper side and the PV3 at the lower side of the charts. The chi-square p value is 
written for each test near the y-axis and below the viruses’ names. The grey bars denote the observed values and 
the black for the expected values. A) Analysis of GC and AT contents. B) Analysis of the mononucleotides. C) 
Analysis of the dinucleotides. D) Analysis of the homopolymers.  
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5.11.6 Exit (Z) and entry (Y) nucleotides 
In the majority of the identified recombinants, it was not possible to unambiguously 
define the recombination junction due to local sequence identity between the two 
viruses. In this report, the junction was defined at the 5’ of the identical sequence 
(see section 5.3 ). In this test we examined the nucleotides combination between the 
Z and Y nucleotides (Figure 5-20, D and Figure 5-21) and compared them to the 
expected nucleotides combination. The expected ratio was calculated by multiplying 
the frequency of each nucleotide at the Z location in the donor strand by the 
frequency of each nucleotide at the Y location in the acceptor strand. For example 
the frequency of nucleotide ‘A’ within the targeted region in the donor strand was 
found to be 32%, and ‘G’ in the acceptor strand was 24%. Thus, the expected value 
equalled 0.32 * 0.24 = 7%. If the combination of Z and Y is random, then we expect 
to see 7% of the recombinants with ‘A’ as an exit site and ‘G’ as an entry site.  
The results showed a significant increase in the transitions and decrees in the 
transversions of the precise recombination. To further investigate this, 90 nts from 
both sides of the precise recombinants were extracted. The analysis was done by 
Professor David Evans; the reading frame (RF) was divided into three possibilities: 
1. RF1 =.ACG.TAG.CTA.acg.tag.cta.  
2. RF2 = AC.GGA.TCG.Aac.gga.tgc.a    
3. RF3 = A.CGG.ATT.ACa.tta.tat.gt  
 
All the recombinants were then translated using Manipulation Suite 
(bioinformatics.org). If the recombinant had no stop codons, it meant that they were 
in frame, since there were 90nts before and after the recombination junction. 
Therefore those recombinants were categorized under the RF1. For anything that had 
stop codons, one or two nucleotides were added to the 5’ end of the recombinants 
and checked whether it restored the open reading frame. If 1 nt was needed then the 
recombinant would be categorized under RF2, while if 2 nts was needed then it was 
RF3. 
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The results in Figure 5-31, showed that RF1 existed with ~84%, while RF2 and RF3 
were  ~8 % and ~6% respectively. These findings suggest that the large number of 
transitions in precise junctions was in fact due to the way that the junction location 
was defined; at the 5’ of the identical sequence. The vast majority of the 
recombinants were in RF1, reflecting that Z and Y nucleotides were occupying the 
third base of the codon immediately preceding the recombination junction (Figure 
5-20, D), therefore, transitions were more common. This is because in previous 
studies, transitions were found to outnumber transversions (Kuge et al., 1989, 
Acevedo et al., 2014). Additionally, it was found that only 32% of the nucleotides at 
the third positions of the codons were conserved between poliovirus serotypes and 
around 98% at the first and second positions (Toyoda et al., 1984). This was 
reflected by the difference between RF1 and RF2 and RF3 found in this analysis. 
Due to the inability to precisely define the junction location, this was not pursued 
any further.  
On the other hand, studying the exit and entry sites among the imprecise 
recombination, a bias towards ‘A’ nucleotide as an entry site was observed (Figure 
5-30). This probably reflects the percentage of nucleotide ‘A’ within the targeted 
region, which is ~31% in comparison to around ~22% for ‘C’, ‘G’, ‘T’ individually. 
Nonetheless, this could be verified by investigating more data. 
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Figure 5-30 Exit and Entry nucleotides analysis 
The combinations of Z and Y nucleotides in 'Figure 5 20, D' were tested by comparing the expected (black bins) 
with the observed (grey bins). The x-axis demonstrates the possible combinations that can happen when Z 
changes to Y, divided into transitions and transversions for the precise recombination. The nucleotides below the 
arrows represent nucleotides from the donor strand. Above the arrows are nucleotides from the acceptor strands. 
(^) = 'change to'. The y-axis represents the count of recombinants (%) found for each combination.   
 
 
Figure 5-31 Reading Frame (RF) in Precise Recombination 
The 206 precise recombinants were tested for their RFs to determine at which position of the codon the 
recombination occurred. The x-axis represents the possible RF, which described in 5.11.6. The y-axis refers to the 
percentage of recombinants found for each possible reading frame.  
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5.12  Discussion  
In order to understand the mechanism that influences poliovirus recombination, an 
experimental system that can specifically amplify recombinant molecules from a 
wild type mixed infection was developed. This was accompanied by NGS 
technology to sequence and analyse recombinant RNA that was present 5h post 
infection before the virions were produced. Therefore, minimising the selection for 
increased fitness within the recombination population that on its turn would widen 
the range of obtained recombinants. To analyse the data, a bioinformatics system was 
created and optimised, through which high-resolution recombination maps were 
produced for both precise and imprecise recombinants (Figure 5-7). 
Using the bioinformatics pipeline to analyse the NGS reads, the total number of 
recombination junctions was found to be 313 distinct recombinants. Of those 206 
were precise and 107 were imprecise recombinants. Of the latter, 35 were imprecise-
insertions and 70 were imprecise-deletions. The results demonstrated that at this 
early stage of the infection and within an environment with minimised selection for 
fitness, precise and imprecise recombinants are detectable in the infected cells. In 
contrast to the results obtained by Jarvis & Kirkegaard, although they harvested the 
virus progeny early in the infection and the experimental system they used did not 
select for viability, no imprecise recombinants were detected (Jarvis and Kirkegaard, 
1992). This discrepancy in results can be attributed to two reasons. Firstly, they used 
a smaller infection scale, which might have undermined the presence of the 
imprecise recombination. Secondly, they studied intratypic recombination within 
which parental genomes are identical, which might have disfavoured the occurrence 
of imprecise recombination. In fact, in this study, imprecise recombination was 
found to be selected against in the presence of long identical sequences. This was 
reflected by the absence of imprecise recombinants within the region extended from 
the end of VP1-coding region to the middle of 2A-coding region, within which 
several long identical stretches were existed (Figure 5-18 & Figure 5-19). This 
finding was confirmed by the presence of a strong negative correlation (r = -0.915, P 
= 0.000079) between the occurrence of imprecise recombination and the length of 
the identical sequences (measured by Spearman test Figure 5-32). Based on this, the 
highest occurrence would be expected to happen at the divergent sites. However, the 
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highest occurrences were observed within the identical sequence of 2 nts long, and 
slightly lower when no identical sequence was present (0) i.e. between divergent 
nucleotides. This maybe a random sampling effect, and could not be confirmed 
without repeating the experiment and analyse more recombinants. 
 
 
Figure 5-32 Negative correlation between the imprecise recombination occurrence and the length of 
identical sequence  
The x-axis refers to the length of the identical sequences whereas the y-axis reflects the number of imprecise 
recombination occurrences. The diamonds indicate the relation between the recombination occurrences and the 
length of the identical sequences.  
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The tendency of imprecise recombination towards the shorter identical sequences can 
explain its lower frequency in intratypic in comparison to intertypic recombination, 
which was found in several studies (Molla et al., 1991, Lowry et al., 2014, Runckel 
et al., 2013, Tolskaya et al., 1983).  
In addition to the presence of long identical sequences within the segment from the 
end of VP1- the middle of 2A-coding region, a weak negative correlation with the 
RNA secondary structure was observed in the same region within the imprecise-
deletion recombination (r = -0.365, P = 0.019, see Figure 5-14). Although the 
correlation was not significant in the insertion but was still noticeable. These 
findings may imply the presence of a dynamic relation between the RNA secondary 
structure and sequence identity that can generate a disfavour environment for 
imprecise recombination (see next chapter).  
On the other hand, the presence of the identical sequences did not seem to affect the 
precise recombination, which was found to occur cross the whole targeted region. 
However, there did not seem to be a positive correlation between the precise 
recombination occurrences and the length of the identical sequences (Figure 5-18). 
Moreover, few precise recombination occurrences were observed at divergent sites 
between the two viruses. This may suggest that sequence identity is not essentially 
required for precise recombination to occur; rather it could be favoured by the 
recombination. Therefore, it is speculated that the role of sequence identity, if it 
exists, may stem from a need for a sort of alignment to bring the two genomes into 
the correct position, or for stabilising the structure at a different level and not 
necessarily adjacent to the junction site. In fact, this may explain the absence of 
precise recombination and the presence of imprecise occurrences within the VP1-
coding region part that included in the targeted region (see section 5.7.1 and 5.7.4). 
In both precise and imprecise recombination, two types of data were analysed 
namely flattened and unflattened. The unflattened data, which takes into 
consideration the number of NGS reads, showed a systematic bias amongst the 
precise recombination. This was considered a logical reason to refuse to interpret the 
number of the reads as a reflection of a preferable site (see section 5.7.2).  On the 
contrary, the imprecise did not show such a systematic bias in the unflattened data, 
therefore, the frequency was considered as an indicator for preferable sites. Based on 
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the NGS reads, the imprecise-insertion was found to prefer more locations than the 
imprecise-deletions (Figure 5-11). However, no special correlation was found 
between the NGS variations and the length of the deleted and inserted fragments or 
the ability to maintain the open reading frame.  Therefore, the consequences of these 
differences are not clear and open the door for many questions. For example are 
these molecules evolving in an integral way i.e. some of imprecise-deletion out-of-
frame recombinants were derived from imprecise-insertion? If this evolving occurs, 
does it occur in cis or trans? Furthermore, imprecise recombination flattened data 
showed that the number of imprecise-deletion recombinants occurred in a higher 
frequency than expected, which was not the case among the imprecise-insertion 
recombinants (Figure 5-10). These findings, in addition to the different biases 
observed within the mononuclutides at the junction site (see Figure 5-25),  may 
suggest that there are different mechanisms that drive the formation of these 
molecules. 
Upon the examination of imprecise recombination, it was observed that the length of 
deletions and insertions (indels), in the vast majority of recombinants, ranged 
between 2~10 nts. This is reflected by clustering of recombinant lines at the bottom 
of the ‘length’ axis in figure 5-7 B and C. Interestingly, it was noted that more 
imprecise- recombinants were associated with the dinucleotide identical regions 
(Figure 5-19). To test for any correlation between these two biases, figure 5-19 was 
adjusted to show the correlation between the length of deletions and insertions, and 
the length of the identical regions (Figure 5-33). The relation appeared to be random; 
the recombinants occurred at identical region of dinucleotide showed variations in 
the length of deletions and insertions. The lack of correlation was verified by 
Spearman test, which was carried out on all the imprecise recombinants (r = 0.185, P 
= 0.05). This was also applied on imprecise-deletion and -inserion individually (data 
not shown). Arguably, a possible explanation for observing more recombinants with 
small insertions would be a technical issue caused by the tendency of PCR to amplify 
shorter cDNA fragments (see section 6.5 ). However, this should not be the situation 
in the case of imprecise-deletion, as the longer the deletion the shorter the 
recombinant. Therefore, the bias towards the small deletions amongst the imprecise-
deletion recombinants was likely caused by the limitations of the PCR assay to detect 
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any recombinant caused by an RdRp re-association outside of the detectable range on 
the acceptor strand. Alternatively, it could be a reflection of a random sampling.  
Analysing the sequence composition near the junction site showed that RdRp - in the 
imprecise recombination - favours to switch template immediately after synthesising 
‘UU’ on the donor strand. No difference was observed when tested this on imprecise-
deletion and –insertion separately (data not shown). The same finding was observed 
by others (Nagy and Simon, 1997, King, 1988) and it is believed that the presence of 
such dinucleotide would promote RdRp slippage. This, in turn, contributes to an 
accidental incorporation of nontemplated nucleotides at the 3’ end of the growing 
strand.  Moreover, it was striking to find that the majority of the imprecise 
recombination junctions occur next to another dipurine sequences (AG, GG) (see 
Figure 5-26, D3). In this project, it is not feasible to study how this strong bias 
towards the dipurine would serve the RdRp to switch template. Further in vivo 
studies are required to place the frequencies of the dinucleotide into an evolutionary 
context.  
In this study, we analysed poliovirus intertypic recombination after 5 hours of the 
beginning of the infection. The results suggest that recombination at this stage could 
happen everywhere in the middle of the non-structural region of the viral genome. 
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Figure 5-33 Corrolation between the lengths of indels and lenghs of identical sequences  
The identified imprecise recombinants and their corresponding length of indels (third axis from the left) were 
plotted against the length of identical sequences associated with their occurrences (fourth axis from the left). The 
green lines represent the imprecise-insertion recombinants and the black ones are the imprecise-deletion 
recombinants. 
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6 General Discussion 
6.1  Current understanding  
RNA viruses have gained a reputation as Nature’s swiftest evolvers owing to their 
high mutation rate, high yields, and short replication cycles. Recombination has been 
shown to play a crucial evolutionary role in the life of RNA viruses. The 
implications of this are demonstrated by the emergence of modified viruses that have 
resulted from recombination and are associated with disease outbreaks. For instance, 
the 2001 outbreak of poliomyelitis in Hispaniola was due to a recombination event 
that occurred between OPV derived PVs and a non-polio species C enterovirus (Kew 
et al., 2002). Understanding recombination, and how to control it, would help to 
develop safer vaccines composed of recombination-deficient and genetically stable 
strains. 
This study has benefited from previous recombination studies including the CRE-
REP assay, which uses two defective partners that should recombine (at the region 
between the VP1 and the CRE) to produce viable progeny (Lowry et al., 2014). This 
provided an insight into the underlying molecular requirements for recombination by 
distinguishing between the recombination event itself and the subsequent ‘resolution’ 
process. The assay was designed to minimise the competition between the generated 
recombinant viruses, therefore; reduce the selection to allow for the isolation of a 
wide range of recombinants regardless of the growth advantages. With this in mind, 
a more inclusive approach was designed so that in addition to the recombinants with 
disadvantageous alleles, it can provide an opportunity to characterise the nonviable 
recombinants. This was achieved by combining a specific RT-PCR amplification 
with NGS technology to sequence virus progeny. The infection was carried out in a 
large-scale culture of HeLa cells to increase the absolute number of recombinants to 
the detectable level (see section 4.3). In contrast to the CRE-REP assay - with which 
the recombinants were isolated 24-48h post-infection – virus progeny was harvested 
5h post-infection even before the virions were produced. Subsequently, whole cell 
RNA was extracted, cDNA synthesized and PCR amplified. The amplicons were 
purified and sequenced by Illumina MiSeq. The NGS reads were then analysed using 
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the ViReMa; a recombination-specialised algorithm that was extensively optimised 
for the purpose of this study (see section 3.4.3).  
Unlike the other proposed methods to study recombination, the method used in this 
project allows for the isolation of a wider range of recombinants that can occur 
within the targeted region 5h post infection. For example, viability of recombinants 
is not a prerequisite i.e. defective recombinants, which have lost a fundamental part 
(required for replication) from their genomes can also be detected. Related to this, 
recombinants don’t have to be in-frame; out-of-frame recombinants are also 
detectable. Accordingly the non-replicative recombinants, which either have 
deleterious mutation or are unable to maintain protein-protein compatibility, will also 
be included. Finally, some recombinants may replicate more efficiently than the 
others, probably because they have inherited an advantageous mutation. Thus, they 
can prosper at the expense of other recombinants in the population. The challenge in 
detecting the low abundant recombinants was overcome by utilising NGS 
sequencing. The main feature of this approach is that it can focus on recombination 
at the level of the virus genome, without a subsequent round of selection for 
viability. For example, if protein-protein compatibility resulted in a recombination 
junction between X and Y, the CRE-REP assay would only be able to detect those 
recombinants, which occurred between X and Y. In contrast, utilising NGS on 
recombinants populations generated at an early stage of infection would allow for the 
detection of a range of recombination junctions outside of X-Y. 
The work presented in this thesis has contributed to the understanding of 
recombination and its findings are broadly summarised below: 
• Precise-recombination appears to be a random event 
• Imprecise-recombination appears to be a site-specific event. Detailed 
analysis of the sequence composition around junction locations did show 
that imprecise-recombination most likely to occur adjacent to dipurines 
(AA, AG, GG).  
• In-frame and out-of frame imprecise-deletion and imprecise-insertion 
recombinants– with various deletion/insertion fragments length – can 
occur early in the infection within the non-structural region P2 (the target 
region).  
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• No correlation between the lengths of indel in imprecise recombination 
and the maintenance of the reading frame.   
• The majority of recombinants are precise. At 5h post infection, they 
appeared twice as much as imprecise recombinants. 
 
6.2  Recombination dynamics and possible recombinants   
The essential prerequisite for successful recombination between two viruses is that 
an individual host (animal or cell) must be infected with both viruses. Taking this 
into consideration, there are several constraints, which may prevent the 
recombination process from proceeding. The viruses that participate in forming 
recombination should pass through all of the stages presented in Figure 6-1 before 
producing viable recombinants. This section will discuss the assay and the findings 
of this project within the framework of these constraints 
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Figure 6-1 A model of the steps required for generating a viable recombinants and possible constraints. 
It is based on the copy-choice mechanism. Step 1 was not involved in this project; hence the colour of the 
illustrative boxes is white. This figure is adapted from Worobey M. et al. (Worobey and Holmes, 1999) 
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6.2.1 Dual infection of the same cell 
The major constraint viruses can face when entering the host cell is the difficulty in 
meeting each other at the right place and time (Figure 6-1 step 1). In the case of 
poliovirus, this restriction can readily be overcome, since recombination events 
between PV serotypes of OPV are routinely documented in vaccinees (Cammack et 
al., 1988). The other constraints that might operate at this level are the immune 
response of the host factors, which can be achieved by either blocking the 
superinfection or by clearing the virus, hence decreasing the chance of co-infection. 
Nonetheless, in the studies described here, to ensure the dual infection, this step was 
bypassed, and instead HeLa cells were infected with two serotypes of poliovirus PV1 
and PV3. The infection was carried out at a high multiplicity of infection (10)  to 
make sure that there are enough viruses from both strains to dually infect the vast 
majority of cells. This, however, does not necessarily imply that every cell will be 
dually infected with no cells will obtain one virion or none. In fact, this process can 
be described by Poisson distribution, and expressed by Equation 6-1. The equation 
can be simplified to calculate the fraction of uninfected cells (k=0), cells with a 
single infection (k=1), and cells with multiple infections (k>1). Using the equation, 
the number of cells that receive more than one virus in each flask can be determined. 
In a culture of 18.6*106 cells the probability of the number of cells that will receive > 
1 virus in each flask is p=0.995, which means that ~18.5*106 cells will receive >1 
virions. Clearly, in this large-scale culture, the few cells that do not receive a virus or 
receive only one virus is negligible, leaving the vast majority of cells with a high 
chance of receiving more than one virus. As a consequence, the chance for both 
viruses to meet in one cell is very high.  
 
 
 
 
 
Equation 6-1 Poission distribution describing the number of virions each cell recieves  
P(k) is the fraction of cells infected by k virus particles, at m MOI. The ‘e’ reflects the number 2.71828 (Euler’s 
number) 
 
 
𝑃(𝐾) = 𝑒!!𝑚!𝑘!  
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6.2.2 Switching template within replication complex inside the cell 
Once PV1 and PV3 are inside the cell, the two viruses have to replicate in the 
presence of each other for the replicative recombination to proceed. Based on a study 
by Egger et al., the two viruses would co-localize in a closed-off replication complex 
near the nuclear periphery, wherein the recombination occurs. In their study, they 
found a high percentage (85%) of replication complexes containing both viruses 
early on in the infection. Furthermore, they observed that the first detectable 
recombinant was 2.5h post infection and was interestingly accompanied by the onset 
of viral replication (Egger and Bienz, 2002), which may reflect the essential role of 
recombination for the virus to prosper. Within this locked environment of the 
replication complex, the two viruses would have an appropriate space to come close 
to each other, facilitating the RdRp switching template. Accordingly, it seems logical 
to assume that there are low physical constraints in order for the RdRp to switch 
templates (Figure 6-1 step 3,4). 
Taking Egger et al. into consideration, the two viruses were allowed 2.5 hours inside 
the replication complexes before being eventually harvested. The results from this 
work have shown that the RdRp can switch templates at related and unrelated sites in 
the presence or absence of nucleotide similarities producing all types of 
recombinants suggested by Lai (Figure 1-3). The analysis of the sequence similarities 
within all the produced recombinants in this project did not show an apparent 
influence of sequence similarities on recombination (see section 5.9 ). This may 
suggest that recombination occurs via the non-processive model (see section 1.3.4) 
of the copy-choice mechanism, where the RdRp dissociates from the donor strand 
but not from the incomplete nascent strand (Jarvis and Kirkegaard, 1991, Jarvis and 
Kirkegaard, 1992). Notably, the switching template process did not take into account 
the maintenance of an open reading frame reflected by the presence of out-of-frame 
and in-frame recombinants in the dataset (Figure 5-7). It seems conceivable that at 
this stage of infection recombination can occur without a strict selection reflected by 
the presence of all types of recombinants with various features.   
A further investigation including the identical sequences analysis, for both precise 
and imprecise recombination, was carried out (see section 5.10 ). Among the 
imprecise recombination, a negative correlation between long identical sequences 
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and the occurrence of recombination (see sections 5.10  and 5.12 ) was found. This 
was in stark contrast to the precise recombinants, which were found to occur across 
the whole targeted region regardless of the presence or the length of the identical 
sequence. This finding was supported by the occurrence of some precise 
recombination at divergent sites (Figure 5-17 & Figure 5-18). Based on this, it may 
be possible that the identical sequence per se is not essential for precise 
recombination, and their lengths rather facilitate the process of bringing the two 
viruses into an aligned position (Romanova et al., 1986). This alignment, by 
definition, would be a disfavoured environment for the imprecise recombination to 
occur. Moreover, since the targeted region (nucleotides 3235-4548) is 78% similar 
between the two viruses, the presence of such an aligning technique (based on the 
identical sequences) would help the virus to increase the production of the precise 
recombination at the expense of the imprecise. This, on its turn, can be translated 
into an evolutionary aspect by ensuring advantageous selection, as precise 
recombinants would have more chance to replicate (see next section). This is 
important as it may explain the absence, (or the very low frequency) of the imprecise 
recombination between two identical viruses (intratypic recombination), even at an 
early stage and in the absence of the selection pressure (Jarvis and Kirkegaard, 
1992).  
The question would become then, how recombination could occur at the divergent 
sites where no such aligning facility is available?  It has been hypothesised that 
RdRp switching may be promoted by a misincorporation event that can lead to stall 
the enzyme on the RNA template (Dulin et al., 2015). The misincorporation at the 3’ 
end of the nascent strand could anneal with its ‘perfect complement’ on the acceptor 
strand and may produce either precise or imprecise recombinants (Agol, 1997). The 
former will occur if the ‘perfect complement’ is located in the same position on the 
donor strand where the misincorporation has taken place on the acceptor stand, while 
the latter will occur if the nascent strand binds to a distant ‘perfect complement’ 
nucleotide. This type of misincorporation cannot be detected in the real dataset, as 
the misincorporated nucleotide would appear as a correct nucleotide within the 
recombinant sequence in the aligning process. Therefore, just for the sake of this 
discussion, this type of misincorporation will be referred to as ‘silent 
misincorporation’ (Figure 6-2, left panel, see also section 3.6.1and Read D in Figure 
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3-11). This is to differentiate it from the other type, where misincorporation may 
happen without the need for a ‘perfect complementation’. This is termed ‘non-silent 
misincorporation’ as some of the non-complement nucleotides (Figure 6-2, right 
panel) would appear as mismatches during the aligning process, and are hence 
detectable. Unfortunately, this analysis would require additional scripting to extract 
the relevant information, and due to the time restraints this was not possible. The test 
can be done by comparing the presence of mutation (non-silent misincorporation) 
around the junction in the real data and comparing it with a control simulated data.   
On the other hand, the analysis of sequence composition around the junction location 
did show that imprecise recombination favours to occur near dipurines (AA, AG, 
GG) (Figure 5-26). The significance of this is not clear and can be further 
investigated by different experiments that involve increasing (or decreasing) the ratio 
of these dinucleotides in both viruses and measure the outcome. In comparison, 
precise-recombination did not show any strong evidence for a correlation with either 
the RNA secondary structure and/or specific sequence motifs (see section 5.11 ). 
This was in contrast to other study which proposed that the presence of either an 
RNA structure  and/or sequence motifs (Runckel et al., 2013) was required for 
recombination to occur. Arguably, although there did not appear to be any 
correlation with the structure or sequence, the possibility of a combination between 
structures and/or sequence that serves momentarily to promote RdRp dissociation 
cannot be ruled out. Alternatively, it could be that the occurrence of precise 
recombination near identical sequence has masked the presence of specific sequence 
during the analysis. 
To conclude, it seems more conceivable that there is more than one mechanism that 
drive the recombination process either within the same type of recombination or 
between different types (precise, imprecise-deletion, and imprecise-insertion 
recombination).   
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6.2.3 Competition between recombinants for fitness selection 
It is clear that at this early stage of infection all types of recombinants can occur 
within the targeted region. Whether these recombinants persist, however, depends on 
the selective separation of the growth advantages and disadvantages among these 
recombinants (Figure 6-1 step 5). Although recombination can offer growth 
advantages in some cases (e.g. removing some deleterious mutations, or combining 
advantageous ones), it can - in a chaotic situation illustrated by the randomness of 
recombination found in this project - delete more good alleles than it creates. For 
example, many imprecise-deletion recombinants were detected in the NGS dataset 
(Figure 5-7 B). As the targeted region (nucleotides 3235-4548) encoded proteins 
critical for replication such as 2A, 2B, and 2C, any deletion would have a destructive 
effect on the survival of these molecules. Therefore, it is most likely that these 
imprecise-deletion molecules would be outcompeted if they were allowed any further 
inside the cell. i.e. if the virus progeny was harvested at a later stage than 5h post 
infection.  As a consequence, they would be degraded, and not be detected. In fact, 
this is the major reason for the lack of evidence for the existence of these molecules 
in recombination studies, and DIs molecules are the only imprecise-deletion 
recombinants that are published in the literature. Nonetheless, whether some of these 
defective molecules can restore the missing part of their genomes through a non-
replicative recombination (Gmyl et al., 1993) or perhaps replicate at a significantly 
reduced level (Collis et al., 1992) is unknown. In addition to the imprecise-deletion 
recombinants, many recombinants (imprecise-insertion recombinants) contained 
additional sequences (in-frame and out-of-frame) were detected within the targeted 
regions. The inserted sequence can be either a long insertion that duplicates part of 
the genome (duplication) or a few nucleotides (see section 1.3.7).  
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Figure 6-2 A model of RdRp switching recombinants involving a nucleotide misincorporation during the 
nascent strand synthesis  
The complementary between the 3’ of the nascent strand and the template is depicted by a key-lock manner. R1 
and R2 refer to the association and dissociation sites respectively. The misincorporated nucleotide is represented 
by a black symbol. A) Silent mutation would happen if the misincorporated nucleotide found a perfect match on 
the acceptor strand, and this could be either precise or imprecise. In both cases the mutation would not be 
detectable in the data analysis. B) Non-silent misincorporation would happen if the misincorporated nucleotide 
couldn’t find a perfect match on the acceptor strand. As a result, some nucleotides near the misincorporated one 
would appear as mismatches in the dataset, and would be therefore detectable. 
  
Unlike the imprecise-deletion recombinants, imprecise-insertion recombinants, as 
demonstrated by Lowry et al., can replicate, at least the ones that they tested. 
Although these recombinants are unfit, they can rapidly lose the inserted sequences 
and regain full fitness upon serial passage (Lowry et al., 2014). Those in CRE-REP 
assay were isolated in the absence of infective parental genomes, clonally selected 
and tested separately. However, they would have much lower chance to compete in 
the presence of infective parental viruses and with such a high MOI of 10 used in this 
experiment, particularly because they had to go through another step to resolve into 
the original size by losing the extra sequence. Nevertheless, even if they succeeded 
to resolve into the original size, and found a safe place to escape the competition 
with the parental viruses, they might face another constraint, namely protein-protein 
compatibility. Although these recombinants had a minimal chance to survive in an 
environment that was limited to a flask and full of competent viruses, it is not clear if 
this would still be the case in a natural infection environment. Presumably, 
imprecise-insertion recombinants can travel to a distant site in the same host, or 
another host, causing a founder effect. In this case, the recombinant can resolve, and 
its subsequent resolved product can thrive in the absence of the parental genomes.  
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The resolution of imprecise-insertion recombinants leads to the formation of precise 
recombinants, which were found to be the predominant recombinants among the 
results (Figure 5-7). Indeed, this may explain the fact that the frequency of the 
precise recombinants was found to be double the amount of the imprecise 
recombinants. This can be attributed to two facts. Firstly, within the allotted time 
frame of 2.5h (from the beginning of the replication) in the experiment, the 
recombinants had time to go through replication more than once based on the finding 
that poliovirus can replicate an average of 6 times before being released (Schulte et 
al., 2015). Therefore, it seems logical to assume that the obtained precise 
recombinants may have actually represented a generation that had already gone 
through the resolution process. Based on this, it can be theorised that the precise 
recombinants were increasing over time at the expense of the imprecise-insertion 
recombinants. In fact, this can be mathematically modelled by taking into 
consideration the generation rate of all recombinants and the resolution rate (Figure 
6-3). Simplistically, within a window of 5 hours, precise and imprecise recombinants 
will be generated, and those with growth advantages can go through a subsequent 
replication, and the defective ones will accumulate, and at a later stage of the 
infection they might degrade. This process will continue increasing until the reaction 
is stopped. Some of these generated recombinants will be imprecise-insertion; 
therefore, they will go through an additional resolution process, to finally resolve 
into precise recombinants. Based on the fact that these resolved recombinants might 
have more chance to replicate (at least by having the same size of the original 
genome) than other recombinants, they will keep growing constantly. At a certain 
point (threshold), due to their accumulation and replicative nature, their generation 
rate will overshadow the overall generation rate of recombinants. The time at which 
the resolution process would start is yet to be determined; it is logical to assume that 
this depends on when the imprecise-insertion recombinants would have been created 
in the population. Additionally, the proportion of these recombinants is an important 
factor in the process.  For example, if imprecise-insertion recombinants appeared at a 
low frequency in the beginning of the recombinants formation, then it would take 
more time for the resolved recombinants to establish their own production (Figure 
6-3 A). In this case the resolution process would stay part of the overall 
recombinants generation, and at some point – when enough resolve recombinants 
produced – the resolved recombinants would establish their own population. The 
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other scenario would be for the imprecise-insertion recombinants to appear 
concomitantly with the precise recombinants and at a relatively high frequency 
(Figure 6-3 B). In this case, the resolution process would establish its own 
production from the beginning of the recombinants’ formation. However, it won’t 
exceed the overall recombinants generation rate, till there are enough resolved 
recombinants. Finally, the last possible scenario would be for the resolution process 
to lag behind the overall recombinants generation process. In this situation, the 
imprecise-insertion recombinants would have been created after some times of the 
beginning of the recombinants generation (Figure 6-3 C).  
Alternatively, the reason for seeing more precise recombinants may simply be 
attributable to the ‘selective advantage’. These recombinants may replicate faster, 
thus they will appear sooner in the population regardless of the resolution process. 
This is supported by the finding that ~93% of the total recombination NGS reads 
belonged to the precise recombinants and only ~7% were derived from the 
imprecise-recombinants.   
 
Figure 6-3 Mathematical model representing the outnumbering of precise over the imprecise recombinants  
The x-axis represents the time point post infection while the y-axis reflects the possible recombination frequency 
(log scale). The solid black diagonal line represents the overall recombinants’ generation rate. The blue line 
represents the resolution rate of imprecise-insertion recombinants i.e. the resolved recombinant replication. A) 
Imprecise-insertion recombinants appeared simultaneously with the recombination onset at a low frequency. B) 
Imprecise-insertion recombinants appeared simultaneously with the recombination onset at a relatively high 
frequency C) Imprecise-insertion recombinants appeared later than the initial recombination onset at either high 
or low frequency.  
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6.3  Comparison of simulated and experimental data  
The bioinformatics pipeline to detect recombination junctions from the NGS dataset 
was optimised by using simulated datasets. The system, in the presence of 1% 
mutation within the NGS simulated datasets (Dataset C, Table 3-1), showed a 
sensitivity of detecting ~64% unique reads from the total number of reads 
representing recombinants. This was found in a dataset that contained only three 
different recombinants, and was covered with ~4 million reads. In theory that means 
that every recombinant has a chance to be covered with 1.3 million reads. By 
applying the Lander and Waterman equation on this (Equation 3-1) the average 
coverage for each recombinant was ~300000 reads. This means that every nucleotide 
had a chance to be seen by 300000 reads, at least once. With such a high coverage, 
taking into consideration the random nature of the amplicons’ fragmentation process, 
all the recombinants in the dataset would be detectable within the system’s 
sensitivity window of ~64%. Nonetheless, the system would not detect those 
recombinants that have their locations at the either end of the amplicon. For example, 
if a recombinant’s amplicon in the dataset had its junction location within the first or 
last 25nts, it would never be picked up by the system (see section 3.7.1 & 3.7.2). 
Accordingly, the detection of this recombinant is not included within the ~64% 
sensitivity window.  
Analysing the NGS reads from the real data, which was generated under similar 
conditions to the simulated data (high coverage and long reads), 313 unique 
recombinants were detected. That means ~64% of the total recombination reads 
represented 313 unique recombinants. It is possible that the system missed several 
recombinants because either they did not have the chance to be spanned at the 
detectable locations by the reads or they contained mutations that prevented the 
system from recovering them (erroneous reads type 1 and 2 section 3.6.1). 
Additionally, there is a small chance that the system reported some inaccurate 
recombinants caused by a mutation located immediately upstream or downstream to 
a junction that was situated next to an identical sequence (erroneous reads type 3 
section 3.6.1). The reported junction in this case would have shifted from the true 
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junction by the length of the identical sequence. The fact that there is no way to 
distinguish these reads in the real dataset – unlike in the simulation dataset – means 
that few inaccurate recombination junctions (if any) were dealt with as true junctions 
in the data analysis. Nevertheless, the effect of these reads can be considered 
negligible based on their minimal chance to appear.  
6.4  The reproducibility of the experiment  
The experiment developed in this project is a novel approach and has not been 
applied before to study recombination in the RNA viruses. This means that the 
results produced by each step were not always predictable and many optimisations 
were carried out to adjust both the in vitro and in silico systems. This, besides the 
large-scale characteristic of the experiments developed in this project, the use of 
NGS technology, and the large amount of data that could be produced made it 
difficult in terms of cost and time to repeat the whole experiment. However, the 
experiment was developed at the University of Warwick where the first successful 
recombinants’ amplification, isolation, and Sanger sequencing were carried out. 
Subsequently, new samples were produced and sequenced at NIBSC in Dr. Andrew 
Macadam’ laboratory, arranged by Professor David Evans. The experiment was 
repeated exactly in the same way with the following exceptions; HEp2c cell line 
(HeLa cells derivatives) was used instead of HeLa cell line, also the virus stock was 
different from the one used at the University of Warwick. Despite these minor 
changes The results obtained were similar to the ones obtained at the University of 
Warwick; a PCR product of the expected size was observed when amplifying 
recombinants, and no product was observed for the control sample (mixture of RNA 
viruses) (Figures 4-9 and 5-1). Moreover, the same recombinants found at the 
University of Warwick by Sanger sequencing were found again in the NGS dataset 
generated at NIBSC. The only difference was in the clear appearance of the bands 
that reflected the imprecise recombinants, where only a strong smear appeared at the 
University of Warwick. This probably can be explained by the fact that different 
equipment (such as PCR thermocycler, gel electrophoresis, transilluminator) were 
used, which may had different sensitivity. Nonetheless, the reproducibility could be 
confirmed by repeating the experiment with three different biological triplicates and 
compare the results 
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6.5  Limitations of the experimental and analytical systems 
Experiment  
The approach of enlarging the scale of infection and using a combination of a 
specific RT-PCR assay and NGS sequencing has been shown to be successful in 
amplifying and characterising recombinants that result from wild-type intertypic 
recombination in poliovirus. However, the cost of this method is high, which 
imposes some restrictions for applying it more widely, particularly if optimisation 
steps were needed, which would most probably be the case. Moreover, it is not clear 
yet if this approach can be used to study recombinants at a late stage of infection. 
This depends on the time at which all the recombinants would be outcompeted by the 
parental viruses. This can be measured by carrying out the experiment at diffident 
time point (see section 6.6.3).  
Another considerable drawback of the system is its dependence on the PCR assay, 
which is known to be biased towards shorter fragments. As a result, recombinants 
with long insertion may have less chance to be amplified, and hence detected. This 
could be overcome by using emulsion-PCR rather than the traditional PCR, which 
would allow uniform amplification of the recombinants’ population. This technique 
was used at an early stage of this project and failed to produce any results when 
applied on a smaller scale of infection. However, most probably that was a detection 
sensitivity problem, as the system was not fully optimised by then. The technique 
could be tried again, and an advantage could be taken from the results produced by 
this project to properly optimise the emulsion PCR conditions.   
Finally, the system is merely qualitative i.e. recombinants quantification is not 
included, which renders the system incapable of measuring the frequency of 
recombinants as this cannot be inferred from the number of reads (see section 5.3 ). 
However, this flaw can be overcome with real-time PCR (see section 6.6.5). 
Alternatively, a control sample that contains known concentrations of the parental 
viruses and a spiked-in recombinant can be run in parallel with the rest of the 
samples. This sample can inform about the relation between the NGS reads and the 
quantity of the recombinants, which can then be applied on the reset of the samples 
to estimate the quantity of recombinants. It is worth mentioning that this sample was 
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included in the initial samples prepared at the university of Warwick. Unfortunately, 
the construct JC105B was not available at NIBSC, therefore this sample was not 
included in this project.   
ViReMa 
The Python implemented algorithm ViReMa with the mode N0X5 was used 
successfully to detect recombinants from the NGS datasets. However, using this 
mode would not allow the algorithm to tolerate any mismatch within the 25 nts seed 
sequence the algorithm extracts from the beginning of the read to initiate the 
searching process (see section 3.5 ). As a result, those recombination junctions who 
were spanned by the ends of the reads could not be detected. To tackle this issue, the 
reads could be extracted from the unknown file and used as a new dataset for 
ViReMa to search recombinants within it. This time, the mode N1X5 or N2X5 could 
be used, as they allow for one or two mutations to happen respectively (see section 
3.6 ), therefore providing more flexibility in finding those reads which were rejected 
based on the location of the junction. Nonetheless, a care should be taken, as this 
would decrease the specificity of ViReMa. As a consequence, false positive 
recombination junctions are possible to be reported. Based on this, one more 
verification step should be considered. This can be achieved by pulling the reads that 
correspond to all the reported recombination junctions (see sections 2.8.8 and 2.8.9) 
and align them against synthetic reference recombinant sequences (see section 3.4.1). 
Another possibility could be by shortening the seed length and repeat the verification 
steps.     
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6.6  Future experiments:  
6.6.1 Extend the regions of the genome analysed 
Recombinants within the capsid region have rarely been observed, it was suggested 
that this could be due to the high divergence - at these regions -, the RNA structure, 
or protein incompatibility (Simmonds and Welch, 2006). Additionally, this region of 
the genome has been always associated with the occurrence of DIs (Kuge et al., 
1986). It would be of interest to apply the approach used in this project to study 
recombination within the (P1) region. This might help in understanding the 
mechanisms involved in the generation and evolution of DIs. For example, do 
imprecise-deletion recombinants occur more than precise or imprecise-insertion? If 
yes, is the proportion of in-frame higher than the out-of-frame? Is there any 
correlation between the recombination occurrence and RNA structures or sequence 
motifs? Studying this region can also be accompanied by studying the P3 region. 
This can provide a comparable platform through which, the role of some features 
such as sequence identity and RNA structure can be further investigated. For 
example the 3D coding region shares a high level of similarities between PV1 and 
PV3, how this affects the recombination frequency, and how the features of 
recombinants differ from the P2 and P3 recombinants. This also can provide an 
insight into the dissociation rate of the RdRp, is it consistent throughout the whole 
genome? 
This can be achieved by designing several specific pairs of primers to target the P1 
and P3 regions. Due to the high similarities within the P3 region between both 
viruses extra care should be taken in designing the P3 primers to maintain specificity. 
In contrast, designing specific primers for the P1 region should be less challenging. 
Subsequently, ViReMa can be optimised for these regions. For example, as the 3D 
coding region (5987-7369nts) contains more sequence identity; there are longer 
identical stretches here than there are in P2 that can reach 29nts. Based on this, the 
seed length used in the targeted region in this study (25nts) would not be as specific 
in this region. Increasing the specificity of the algorithm in this case can be achieved 
by setting the seed length to 30 or probably more. This should be tested on 
simulation data, as increasing the length of the seed would enhance the specificity 
within the 3D coding region, but can also affect the sensitivity. This balance can also 
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be controlled by the X value, which defines the length of the identical sequence 
around the junction location. This was set to 5 within the targeted region in this 
project as the majority of identical sequences ranged between 2 to 5nts in length. 
 
6.6.2 Serial passage of the recombinant population 
In a previous study on coronavirus using a specific PCR assay and Sanger 
sequencing, it was shown that recombinants appeared to be random at an early stage 
of infection, and after serial passages of the recombinants the recombination sites 
had clustered in a specific place (Banner and Lai, 1991). Applying this to the 
recombinant population identified in this study would be a valid experiment in order 
to study the ‘hot-spot’ regions. This would contribute to understanding the selection 
criteria of the fitness recombinants. Moreover, it would provide comparable data 
with the CRE-REP system, through which a clearer decision could be made if 
whether the clustering effect observed in CRE-REP was not due to the artificial 
nature of the assay. For example, would the imprecise-insertion recombinants cluster 
at VP1/2A and/or 2A/2B as it was found in CRE-REP? Would the imprecise 
recombinants disappear altogether? Answering these questions would allow for a 
wider understanding of the functional constraints that govern the selection of 
recombinants. This could be achieved by using the supernatant extracted from the 
four-pooled flasks, to re-infect more HeLa cells. As the sample would contain a large 
amount of recombinants, it would then be reasonable to carry out the reinfection on a 
smaller scale e.g. one T175 flask. To make it more inclusive, this could be performed 
over a time course and in different regions on the genome.  
6.6.3 Time course infection (to prove the origin of precise recombinants) 
The fact that recombination is a biphasic process (Lowry et al., 2014) which starts to 
occur simultaneously with the onset of replication (Onodera, 2007) means that, after 
5 hours, some recombinants would have been derived from an earlier ones. 
Therefore, repeating the experiment demonstrated in this study over a time course 
would be a useful tool to study the evolution of recombinants from the moment they 
start to appear. Would the vast majority of recombinants be imprecise at 3h post 
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infection for example? NGS sequencing of the recombinants generated at different 
time points would shed more light on the factors that govern the ratio of 
recombinants. This could be achieved by repeating the experiment and harvesting the 
virus progeny every hour, starting from 2.5h post infection. Although a shorter 
interval window would be more inclusive, 1h seems more applicable based on the 
large scale nature of the experiment.  
6.6.4 Resolution process (cis or trans) 
Based on the biphasic nature of recombination, the imprecise-insertion recombinants 
would resolve into precise recombinants with enhanced fitness. The mechanism by 
which the resolution process occurs is still to be determined. Does it occur in cis 
(part of the insertion is looped-out from the genome) or in trans (through another 
recombination event)? In theory, both mechanisms are possible. The construct 
JC105B, which was isolated from the CRE-REP assay, could be used as a model in 
this suggested experiment. It contains an imprecise-insertion recombinant, with 
249nts insertion, and was found to go through the resolution process upon serial 
passage when tested in cell culture (Lowry et al., 2014).  
JC105B could be transfected into HeLa cells, and the generated recombinants’ 
population could be sequenced at several passages. However, this would not allow 
tracing back the origin of the NGS recombination reads and would thus be no way to 
predict the mechanism by which the original recombinant was generated. To 
overcome this, a codon-barcode technique (Cho et al., 2015) could be used to insert 
degenerated nucleotides into JC105B that can serve as unique tags to trace back the 
molecules. The suggested tags would be unique combinations of synonymous 
mutations around the insert within JC105B (Figure 6-4). The length of the tag should 
not be more than 10 to 15nts; the shorter the better. The reason for this is that 
inserting long tags may increase the effort and the cost of the experiment, besides 
which it could affect the functionality. The synonymous mutation could be inserted 
either by gene synthesis (synthesising new construct with the desirable mutation) 
(Runckel et al., 2013) or by Multiple site-directed mutagenesis (Seyfang and Jin, 
2004). Based on this, two JC105B new constructs containing unique tags could be 
made. Subsequently, these two unique constructs can be co-transfected into HeLa 
cells, and the virus generations can be monitored at several passages through NGS. A 
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provisional design for this experiment is illustrated in Figure 6-4. The experimental 
design involves a PCR amplification that produces a 570nts fragment. By having 
amplicons at this size, a) no further fragmentation steps are needed and the 
amplicons can be directly sequenced, b) it will allow the forward and reverse reads to 
span the junction at sites detectable by ViReMa, and c) it will preserve a suitable 
length of the amplicon for the sequencings, for example even if the whole insertion 
has resolved, the remaining fragment (321nts) will still be valid enough to serve as a 
template for the sequencing with 300nts paired-end reads. The generated reads that 
spanned the junction location will then be detected by ViReMa, separated into a new 
FASTQ file and aligned by Bowtie2 with the paired-end aligning mode. For 
example, as the tag mutations depicted in the Figure 6-4 by x’s or o’s, if the aligned 
paired-end reads have x’s at their 5’ side and o’s at their 3’ side, this means that the 
resolution happened in trans. The experiment, as described here, is based on two 
individual constructs; with some experimental modification this could be expanded 
to include a pool of colonies.   
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Figure 6-4 NGS provisional experimental design to determine the resolution mechanism  
To determine whether the resolution process occurred in cis or trans, two synthesised JC105B constructs 
containing unique tags can be used to co-transfect HeLa cells. The top panel describes the specifications of the 
proposed tests. The constructs are recombinants between PV1 (black line) and PV3 (grey line) that enclose an 
insertion (grey dashed-line) of 249 nts length. The junction location (red oval) is located downstream to the 
insertion. The NGS reads (black arrows) are 300 nts length; the small dotted line indicated the sites at which they 
span the junction location. The locations of the primers are demonstrated by the small blue arrows. The suggested 
PCR fragment length is 570nts (blue line) to allow the reads to span the junction within sites that are detectable 
by ViReMa. The two constructs are the same apart from the unique tags they carry at each side of the insertion. 
These tags are depicted as ‘x x x x’ in construct 1 and ‘o o o o ‘ in construct 2 and they are 10 nts length. The 
bottom panel illustrates the two possible mechanisms with a random example of 100 nts being resolved (deleted) 
from the construct. If resolution occurred in trans where the two constructs should recombine to generate a 
resolved (shorter) recombinant, the generated recombinant would possess a unique tag that has o’s on its 5’ side 
and x’s on the 3’ side. If the resolution occurred in cis, however, the resulted molecule would have the same tags 
as the original constructs.  
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6.6.5 Real-Time PCR amplification  
One of the limitations of this study is the lack of possibilities to calculate the 
frequency of recombination, which would provide an exact measurement of the 
proportion of recombinants. To accurately calculate the frequency of recombinants, 
the recombination products would need to be measured soon after their formation, 
before any form of selection takes place. This is made possible by repeating the 
experiment with real-time PCR as described by Jarvis et al. (Jarvis and Kirkegaard, 
1992). In their study they optimised a condition under which the amount of PCR 
products was linearly proportional to the amount of input template, which allowed 
them to quantify recombinants soon after their generation. The same approach can be 
adapted to modify the current experiment.  
6.6.6 Study intra- and interspecies recombinants 
Both intra and interspecies recombination have been documented to occur between 
enterovirus members, and in a preliminary study using the CRE-REP assay, 
recombinants between species B enterovirus were successfully recovered. However, 
it failed to detect recombination between species C and species B (as viable virus 
progeny). This may have been due to direct genetic incompatibility i.e. the generated 
recombinants were not viable, or possibly due to the lack of opportunity for both 
viruses to meet within the same replication complex (Figure 6-1 step 3). These 
possibilities could be addressed by repeating the experiments to include intra or 
interspecies viruses. 
6.6.7 Study recombination in vivo   
The experimental system described in this project provides a platform to study 
recombination in vitro by directly infecting cells with the two viruses. It would be 
beneficial to apply the method used in this experiment to study recombination within 
an in vivo system. This can be achieved by injecting a solution that contains both 
viruses directly into the spine of mice (intrathecally). Subsequently, within a short 
period of time, tissue would be removed from different regions of the mouse 
including the sites surrounding the injection locations. The samples would then be 
prepared for NGS and analysed by ViReMa. Unfortunately, this might need to 
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include more than one mouse in order to increase the absolute number of 
recombinants. This would allow for the study of recombination in a natural system, 
which in turn could provide for a broader understanding of the criteria that governs 
the selection. For example, a correlation between the type of recombination and the 
location of tissues could be established. Would recombinants that had more chance 
to travel to a distant tissue have more chance to resolve into precise recombinants?  
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